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PARTI 
GENERAL INTRODUCTION 
Chapter 1 
OBJECTIVES OF THE THESIS 
Hypertension is a common and potentially serious complication of pregnancy, 
and has always been one of the focal points of dietary advice to pregnant women. 
In particular the salt content of food has received much attention since the turn 
of the century (Chesley 1978; Green 1989). 
Especially in The Netherlands, obstetricians, general practitioners and midwives 
generally continue prescribing low salt diets in the prophylaxis of this disorder. 
This practice is prompted by the believe that excessive retention of sodium and 
water is the main cause of pregnancy induced hypertension (Cramer 1906; 
Zangemeister 1916; De Snoo 1937). It would of course be of immense importance 
if the incidence of pregnancy induced hypertension could be substantially 
diminished by a relatively simple intervention like a reduced dietary salt intake. 
As yet, however, there is no convincing evidence that this is the case. 
In 1986, a multicentered research project was initiated in The Netherlands 
to evaluate the effect of dietary sodium restrictioh -when started early in the 
2nd trimester of pregnancy and continued up to delivery- on the incidence of 
hypertension during pregnancy. The centres participating in this research, which 
is still continuing, are: Catharina Hospital in Eindhoven, Groot Ziekengasthuis 
in Den Bosch and the University Hospital St Radboud in Nijmegen (Grants 
by the Dutch 'Praeventiefonds')· 
For a future explanation of the final results of the multicentered study, whatever 
they may turn out to be, a proper understanding of the implications of sodium 
restriction for the adaptation of the maternal body to the growth of the fetus 
and the placenta is essential. This has, up to now, not been studied. One of 
the main reasons for this is undoubtedly that it takes a highly motivated group 
of pregnant women in which several parameters have to be studied simultaneously 
in a longitudinal randomized fashion, which is a very laborious undertaking. 
Since sodium balance and volume homeostasis are closely interrelated, long 
continued reduced salt intake in all likelihood influences the changes in the 
cardiovascular and endocrine systems which accompany pregnancy. 
Therefore the research conducted at the St Radboud Hospital, described in 
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the present thesis, also embraced studies related to sodium and volume homeos-
tasis. 
Cardiac function and sodium homeostasis are interrelated in a number of 
ways. A remarkable discovery in this area of fairly recent date is that the heart 
is not only a muscular pump but also has an endocrine function. The hormone 
which is produced, atrial natriuretic peptide (ANP), appears to be involved in 
the regulation of fluid and electrolyte homeostasis. ANP, secreted by atrial 
myocytes in response to atrial distension, induces natriuresis, diuresis, vaso-
dilatation and inhibits the renin-aldosterone system. 
Although a massive amount of publications has appeared since the structure 
of ANP was elucidated in 1984, the actions of this hormone in relation to 
physiologic changes during pregnancy have scarcely been studied. 
An interesting model to assess the various physiologic alterations during normal 
pregnancy is the puerperium, as after delivery these alterations occur in reversed 
order in a relatively short time. Puerperal sodium and volume balance-related 
parameters have nevertheless been studied only fragmentarily so far. 
The objectives of this thesis can be summarized as follows: 
1. to study cardiovascular and endocrine changes related to sodium and volume 
balance during normal pregnancy and puerperium, with special attention to 
atrial natriuretic peptide 
2. to study effects of chronic dietary sodium restriction on maternal physiological 
changes that accompany normal pregnancy 
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Chapter 2 
SUMMARY OF PHYSIOLOGICAL CHANGES 
IN NORMAL PREGNANCY 
In this chapter a synopsis is presented of the major gestational changes in 
the volumes of body fluid, the cardiovascular system and the control of sodium 
excretion. 
CHANGES IN THE VOLUMES OF BODY FLUID 
Total body water increases about 7-10 litres during normal pregnancy, the 
increase divided almost evenly between the fetus and mother. In the mother 
most of this increase is extracellular, involving intravascular and interstitial spaces. 
During the first trimester, blood volume begins to increase reaching a level 
approximately 1500 ml (40%) above non-pregnant values (of about 4000 ml) 
at around the 30th week of gestation. Thereafter, blood volume remains stable 
until term. Part of the increase in blood volume results from an increase in 
the total volume of red cells. Red cell mass reaches values 250-450 ml (18-
30%, depending on whether or not supplemental iron is given) above non-pregnant 
levels (of about 1400 ml). A larger proportion of the increase in blood volume, 
however, is caused by an expansion of plasma volume to a level, at the 32nd 
week of pregnancy, about 1250 ml (50%) larger than that in the non-pregnant 
state (of about 2600 ml). As the rise in red cell mass is proportionally less 
than that of plasma, hematocrit values fall during pregnancy. 
(For more detailed reviews see: Chesley 1972a; Hytten 1980; Hytten 1985; 
Lindheimer et al., 1986) 
CARDIOVASCULAR CHANGES 
Cardiac output begins to rise during the first 10 weeks of pregnancy, reaching 
a peak of 30-45% (on average 1.5 1/min) above non-pregnant levels at around 
the 30th week. Thereafter the weight of current evidence indicates that cardiac 
output probably remains elevated until term. The increased output of the heart 
is achieved both by an increase in heart rate (by around 15 bpm in late pregnancy) 
and an increased stroke volume (by around 10 ml). It appears that in early 
pregnancy the contribution of stroke volume is the greatest factor and near term 
the increase in heart rate predominates. 
(For more detailed reviews see: Kerr 1968; Walters and Lim, 1975; Martin 1980; 
Metcalfe et al., 1986; Sullivan 1986a; De Swiet 1988; Wallenburg 1988; Robson 
et al., 1989). 
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Blood pressure decreases early in pregnancy and reaches a nadir between 
16-28 weeks during which period the decrements in systolic and diastolic pressures 
average 5 and 12 mm Hg respectively. This results in a fall in mean arterial 
blood pressure and a widening of the pulse pressure. During the third trimester 
of pregnancy blood pressure increases gradually to values approaching those 
post partum. 
(For more detailed reviews see: De Swiet 1988; Brinkman III 1989; Barron 
et al., 1990). 
Since cardiac output increases during pregnancy and blood pressure decreases, 
there is obviously a decrease in total peripheral vascular resistance. This change 
is due to both the establishment of new vascular beds and to a general relaxation 
of peripheral vascular tone. The reason for this decrease in vascular tone is 
not established, but it is presumed to be the consequence of increased vasodilatory 
substances such as prostaglandins, estrogens and possibly progesterone (Reviews: 
Gant et al., 1980; Gant et al., 1987; Pederson 1988). 
CHANGES IN FACTORS CONTROLLING SODIUM EXCRETION 
Pregnancy has a pronounced effect on glomerular filtration rate (GFR). It 
rises early in pregnancy (6th week) and reaches values 40-50% above non-
pregnant levels by the end of the first trimester. This means that the kidneys 
receive an additional filtered load of 5000 to 10000 mmol of sodium daily. 
As normal pregnancy is characterized by a total accumulation of about 900 
mmol of sodium (3-5 mmol daily), such an increase must be accompanied by 
a parallel increment in tubular reabsorption. Obviously there is a fine balance 
between factors promoting sodium excretion and those enhancing sodium 
retention. 
Factors which tend to promote sodium excretion in pregnancy include next 
to the increase in GFR: increased progesterone production, increased antidiuretic 
hormone concentrations, decreased renal vascular resistance and perhaps in-
creased ANP secretion. Increased concentrations of aldosterone, angiotensin II, 
deoxycorticosterone, estrogens, placental lactogen and prolactin all tend to 
decrease sodium excretion. 
Plasma sodium concentrations are known to decrease during pregnancy. The 
decrease is the result of water retention in slight excess of solute and is evidenced 
by an approximately 10 mOsm /kg decrease in plasma osmolality. 
(For more detailed reviews see: Atherton and Green, 1983; Lindheimer and 
Katz, 1986; Lindheimer et al., 1987; Gallery and Brown 1987a, 1987b; Brown 
1988). 
This thesis focuses on atrial natriuretic peptide, the renin-angiotensin-aldos-
terone system and progesterone. Therefore some introductory information about 
these determinants of sodium balance is given. 
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Atrial natriuretic peptide 
In 1981 De Bold and colleagues demonstrated that when extracts of atrial 
tissue were given intravenously to rats a large diuresis and natriuresis occurred 
promptly. The structure of the hormone concerned, atrial natriuretic peptide 
(ANP), was elucidated in 1983 (Flynn et al., 1983; Currie et al., 1984; Atlas 
et al., 1984; Kangawa and Matsuo, 1984). Since then ANP has received attention 
as a potentially important mediator in the homeostasis of sodium and fluid volume. 
The precursor form of this peptide, containing 126 amino acids, (1-126)hANP, 
is stored in perinuclear granules of atrial myocytes (the prefix 'h' indicates 
'human'). The major form isolated from plasma is (99-126)hANP, made up by 
the final 28 amino acids of the carboxy-terminal fragment of (l-126)hANP 
(Sugawara et al., 1985; Thibault et al., 1987). 
Expansion of the intravascular volume stimulates the release of ANP by the 
heart (Lang et al., 1985; Yamaji et al., 1985). Although plasma ANP levels 
have been found to correlate with atrial pressure (Bates et al., 1986; Raine et 
al., 1986; Hirata et al., 1987), it seems to be the stretch of the atrial wall rather 
than the intracavitary pressure itself which is the main determinant for ANP 
release (Ledsome et al., 1985; De Bold et al., 1986; Edwards et al., 1988a). 
The effects of this cardiac hormone, as demonstrated in both in vitro and 
in vivo experiments, have already extensively been reviewed by others (Needleman 
and Greenwald 1986; Genest and Cantin, 1987; Lang et al., 1987; Goetz 1988; 
Raine et al., 1989). In short, the actions of ANP include an enhanced diuresis 
and natriuresis, vasodilatation and a shift of intravascular fluid into the interstitial 
space probably by increasing capillary hydraulic conductivity and postcapillary 
resistance (Trippodo et al., 1986; Huxley et al., 1987). Furthermore ANP opposes 
the actions of the renin- angiotensin-aldosterone system; it blocks angiotensin-
induced aldosterone secretion by the adrenal cortex, it inhibits renin secretion 
by the kidneys and its natriuretic action opposes the sodium-retaining action 
of aldosterone (Atlas and Laragh, 1986). The effects of ANP result in a lowering 
of the circulating blood volume and a decrease in blood pressure. 
The schematic overview in figure 2.1 shows how ANP links the heart, the 
kidneys, the adrenals and the blood vessels in a complex hormonal system involved 
in volume and pressure homeostasis. 
A review of the literature on ANP in pregnancy is given in chapter 4. 
Renin-angiotensin-aldosterone system 
The renin-angiotensin-aldosterone system plays a major role in blood pressure 
regulation and in fluid and electrolyte balance. Renin is a proteolytic enzyme 
produced in the juxtaglomerular apparatus (the latter consisting of modified 
myoepithelial cells of the afferent arteriole at the pole of the glomerulus). Its 
substrate (renin substrate or angiotensinogen) is found in the oj-globulin fraction 
of the plasma and synthesized in the liver. When renin is released into the 
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Figure 2 1 Schematic diagram of the effects of ANP 
Atriopeptigcn (1- l26hANP) is stored in granules in atrial cardiocytes Elevated vascular 
volume results in the release of atnopeptm (99-126hANP), which acts on the kidney 
(glomeruli and papilla) to increase the glomerular filtration rate (GFR), renal blood flow 
(RBF), urine volume (UV) and sodium excretion (UNa) and to decrease the release of 
renin Nalnuresis and diuresis are also facilitated by the suppression of aldosterone and 
the release of arginine vasopressin (AVP) Diminution of vascular volume provides a 
negative feedback that suppresses circulating levels of ANP Reprinted by permission 
of The New England Journal of Medicine (314, 824, 1986) 
bloodstream its enzymatic action splits off a chain of 10 amino acids, angiotensin 
I, from the substrate. Angiotensin I is subsequently converted to the active 
octapeptide hormone angiotensin II by angiotensin converting enzyme (ACE). 
This last step is thought to take place primarily in the pulmonary circulation, 
where ACE is bound to the vascular endothelium. 
The interrelationships of the components of this system are summarized in 
figure 2.2. 
The most prominent effects of angiotensin II are vasoconstriction and the 
stimulation of adrenal secretion of aldosterone, which in turn causes sodium 
retention and kahuresis in the distal tubulus of the kidney. 
Angiotensin II is eventually broken down to other peptide fragments by 
'angiotensinases' present in tissues and in blood. At least one of these fragments, 
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Figure 2 2 A schematic presentation of the interrelationships of the components of the renin-
angiotensm-aldosterone system (modified from Sullivan, 1986b) 
angiotensin III, is considered to be of biological importance. This peptide has 
a smaller pressor effect than angiotensin II, but is a highly effective stimulator 
to aldosterone secretion. 
Close to 90% of the renin in the circulation is normally enzymatically inactive 
and present as prorenin. In the kidney, prorenin functions as the biosynthetic 
precursor (zymogen) of (enzymatically active) renin. If prorenin in plasma (in 
vivo) is converted into active renin is as yet unknown. 
(For more detailed reviews see: Peach 1977; Skeggs 1977; Davis 1977; Keeton 
and Campbell, 1981; Carey and Sen, 1986; Sealey and Laragh, 1990). 
Normal pregnancy is associated with striking adjustments of the renin-
aldosterone system. Plasma levels of renin substrate show a continuous rise during 
pregnancy, probably due to the stimulatory effect of estrogens on the liver. Plasma 
concentrations of both active renin and prorenin are increased, but the increase 
in prorenin is much greater. This is already the case in the first trimester. The 
fact that, in contrast with other conditions in which the release of renin by 
the kidney is stimulated, prorenin is more elevated than active renin may indicale 
that in pregnancy a large fraction of circulating prorenin is of extrarenal origin. 
The exact sites of secretion, however, are as yet unknown but the ovary, uterus 
and placenta are possible candidates. Plasma renin activity, which reflects the 
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capacity of plasma to generate angiotensin I, is high during gestation because 
of the increase in both substrate and renin concentrations. 
Aldosterone rises in the first gestational trimester and continues to increase steadily 
throughout the course of gestation. 
The changes in the components of the renin-angiotensin-aldosterone system 
during pregnancy are discussed in greater detail in chapter 9 and 12. 
(References are given in chapters 9 and 12. For more detailed reviews see: 
Chesley 1975; Lindheimer et al, 1977; Nolten and Ehrlich, 1980; Symonds 
1981; Sealey et al, 1986; Broughton Pipkin 1988; Symonds 1988; August and 
Sealey, 1990). 
Progesterone 
At the same time as the rise in glomerular filtration rate, plasma progesterone 
concentrations begin to increase. This rise continues until term. Progesterone 
is capable of causing natriuresis by inhibiting the salt-retaining action of 
aldosterone and other mineralocorticoids at the site of the distal tubulus, increasing 
proximal tubular sodium rejection and by producing vasodilatation and decreased 
renal arteriolar resistance. 
It has been claimed that there is a causal relationship between its increased 
placental production and the parallel increase in adrenal aldosterone secretion. 
However, this has never been made clear nor is it certain to what extend 
progesterone is involved in the acute regulation of sodium excretion (Reviews: 
Lindheimer et al, 1977; Gallery and Brown, 1987a). 
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Chapter 3 
METHODOLOGY 
STUDY POPULATIONS 
The longitudinal prospective randomized trial concerning the effects of chronic 
dietary sodium restriction (chapters 11 and 12) was performed in 42 nulliparous 
women. Six women dropped out for reasons specified in chapter 11, leaving 
36 women of whom 17 women had been assigned to a low sodium and 19 
women to an ad libitum sodium intake, for further evaluation. 
The longitudinal ANP studies as described in chapters 6.1 and 6.2 were 
conducted in a group of women who remained normotensive throughout 
pregnancy. This study group comprised 17 of the 19 women just mentioned 
(as 2 women had become hypertensive) and in addition 6 nulliparous women 
who were not included in the randomized study. 
The groups studied in the other chapters (chapters 5, 6.3, 7.1, 7.2, 8 and 9) 
were all different and there was no overlap of women between these study 
populations. 
All pregnancies were singleton and accurately dated by last menstrual period, 
pregnancy test and one or two ultrasound investigations before the 12th gestational 
week. Women used no medication other than iron and in some cases vitamin 
supplements. Except those in the randomized trial they were not restricted in 
their dietary intake of sodium. 
ECHOCARDIOGRAPHY 
Both Motion-mode (M-mode) and two-dimensional (cross-sectional) echocar-
diography were used. All echocardiographic examinations were performed within 
the department of cardiology (head: Professor Dr. T. van der Werf, St Radboud 
Hospital) by the same investigator. The recordings were obtained with a phased 
array wide angle Toshiba Sonolayergraph (model SSH-1 OA), using a transducer 
with a frequency of 2.25 MHz with a focus-point at 7.5 cm. The women were 
situated in the left lateral position and had been at rest for 15 minutes. All 
recordings were obtained at end-expiration. The transducer was placed in the 
third or fourth intercostal space near the left parasternal border for the parasternal 
echocardiographic recordings and near the cardiac apex for the apical four 
chamber view. 
M-mode echocardiographic paper strips were recorded with a Toshiba line 
scan recorder (model LSR-20B) at a paper speed of 100 mm/s for the left 
ventricular dimensions and at a speed of 50 mm /s for the left atrial dimensions. 
. , 1 j ι , ι I . , ι ! ι I . , . I . I . , . Ι ι Ι ι , ι I . I . Ι ι Ι 1 , ι Ι 1 , . , 
Figure 3.1. Diagram and echocardiogram illustrating how a one-dimensional view of the heart through 
the left ventricle is obtained by M-mode echocardiography. aML, anterior mitral valve 
leaflet; Ao, aorta; CH, chordae tendineae; EN, endocardium; EP, epicardium; IVS, inter 
ventricular septum; LA, left atrium; LV, left ventricle; LVIDd, left ventricular inner 
dimension at end-diastole; LVIDS, left ventricular inner dimension at end-systole; LVPW, 
left ventricular posterior wall; pML, posterior mitral valve leaflet; PPM, posterior papillary 
muscle; RV, right ventricle 
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The axial resolution of the apparatus was equal to or less than 1 mm, using 
an AIUM (American Institute of Ultrasound in Medicine) phantom. The two-
dimensional echocardiographic images were recorded on videotape by a Sony 
U-matic VO-5800 PS videocassette recorder. 
A modified standard lead II electrocardiogram was recorded simultaneously 
on both the M-mode echocardiographic paper strip and on the video tape. Final 
analysis of the registrations was performed off line from the echocardiograms 
using a digitising Kontron C-200 computer. For all echocardiographic parameters 
the results are expressed as the mean value of 5 successive cardiac cycles. 
teft ventricular dimensions 
Left ventricular inner transverse dimensions were measured by M-mode 
echocardiography. Figure 3.1 illustrates how a one-dimensional view of the heart 
through the left ventricle is obtained by M-mode echocardiography. Guided by 
the two-dimensional image the M-mode line selector was positioned just below 
the tips of the free edges of the mitral valve leaflets, perpendicular to the long 
axis of the left ventricular cavity. Left ventricular inner transverse dimensions, 
both end-diastolic and end-systolic, were measured according to the leading 
edge-to-edge principle from the endocardial surface of the left side of the 
interventricular septum to the endocardial surface of the left ventricular posterior 
wall. The end-diastolic dimension was measured at the R-peak of the QRS-
complex of the simultaneously registered electrocardiogram. The end-systolic 
dimension was measured at the time of the maximal anterior movement of the 
posterior wall. This is in accordance with the definitions of Teichholz et al., 
whose method was used for the calculation of the left ventricular end-diastolic 
and end-systolic volumes (Teichholz et al., 1976). Left ventricular stroke volume 
was calculated by subtracting the end-systolic volume from the end-diastolic 
ventricular volume. The cardiac output was computed by multiplying stroke 
volume with the mean maternal heart rate of seven subsequent cardiac cycles. 
All calculations were performed with the Kontron C-200 computer. The co-
efficient of variation of measurements of left ventricular inner dimensions in 
this department is 4%, with a follow up of about 1 year (Fast 1989). 
Left atrial transverse dimension 
The left atrial transverse diameter at end-systole was measured by M-mode 
as well as two-dimensional echocardiography from the standard parasternal long 
axis view. Guided by the two-dimensional standard parasternal long axis view 
the M-mode line selector was positioned perpendicular to the long axis of the 
atrium, using the aortic valve leaflets as a landmark (figure 3.2). The left atrial 
transverse diameter was measured, at the moment of the maximal anterior 
movement of the posterior aortic wall, from the anterior side of the posterior 
aortic wall to the anterior side of the posterior left atrial wall. 
Figure 3.2. Diagram and echocardiogram illustrating how a one-dimensional view of the heart through 
the left atrium is obtained by M-mode echocardiography. Ao, aorta; AAoW; anterior 
aortic wall; ALA, anterior wall of the left atrium; IVS, interventricular septum; LA, left 
atrium; LAIDS, left atrial inner transverse dimension at end-systole; LV, left ventricle; 
LVPW, left ventricular posterior wall; PLA, posterior wall of the left atrium; PPM, posterior 
papillary muscle; RV, right ventricle 
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Measurement of the left atrial transverse diameter at end-systole in the two-
dimensional images was also performed from the standard parasternal long axis 
view. The maximal atrial size, at end-systole, usually coinciding with the end 
of the T-wave of the electrocardiogram was found by moving the videotape 
forwards and backwards The transverse diameter was then measured by drawing 
a straight line from the posterior side of the posteriorly visible part of the aortic 
annulus, perpendicular to the imaginary long axis of the atrium, to the left atnal 
posterior wall (figure 3.3). 
Right and left atrial areas 
Right and left atrial area recordings were obtained by two-dimensional 
echocardiography by planimetry from the standard apical four chamber view 
at end-systole. 
End-systole was defined in the same manner as for calculating the left atrial 
transverse diameter from the two-dimensional images. Atrial tracing, both of 
the left and right atrium, was done along the optical inner boundary of the 
atnal cavity (figure 3 4). In case of echographic drop-outs of the interatrial septum 
the outlining was completed by a straight line between the two neighbouring 
inner borders of the visible adjacent clear echoes. At the level of the atrio-
ventricular valves the two visible parts of the valvular annulus concerned, were 
connected by a straight line as well. Care was taken to exclude the endings 
of the pulmonary veins from the left atnal area and the endings of the cavai 
veins from the right atrial area. 
Figure 3 3 Standard parasternal long axis view of the heart at end-systole by two-dimensional 
echocardiography The dotted line indicates how the anlenopostenor dimension of the 
left atrium was measured Ao, Aorta, AoV, aortic valve, CH, chordae tendineae , IVS, 
interventricular septum, LA, left atnum, LV, left ventricle, LVPW, left ventrical postenor 
wall, PPM, posterior papillary muscle, RV, right ventricle 
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Figure 3 4 Standard apical four chamber view of the heart at end-systole by two-dimensional 
echocardiography The dotted lines indicate how the areas of the right and left atria 
were measured IAS, inter-atnal septum, IVS, interventricular septum, LA, left atnum, 
LV, left ventricle, MV, mitral valve, RA, right atnum, RV, right ventricle, TV, tricuspid 
valve 
THE SAMPLING AND HANDLING OF BLOOD 
Antecubital venous blood samples were taken after 15-30 minutes rest in 
left lateral position. Blood for measurements of electrolytes and hematocrit was 
drawn in 10 ml 'Corvac' vacutainer glass tubes (Monoject; Sherwood Medical; 
no. 8881-302015) and 5 ml EDTA vacuum glass tubes (Becton Dickinson; no. 
606452) respectively. Blood for determination of ANP (2x5 ml) was collected 
in EDTA tubes as well, immediately put on ice and centrifuged within 30 min 
at 40C for 10 min at 1500xg. Then, before storage 200 kalliknen inactivator 
units aprotinin /ml plasma (Trasylol; Bayer AG; Leverkusen, F.R.G.) was added. 
The handling of samples of amniotic fluid (chapter 7.1) and ovarian follicular 
fluid (chapter 7.2) was similar to that of blood. For the measurements of all 
other hormone concentrations in plasma 10 ml of blood was drawn in vacutainer 
tubes containing 1 ml of 0.105 M buffered citrate solution as anticoagulant 
(Becton Dickinson; no. 366003). These samples were transported and centnfuged 
within 30 min at room temperature. All plasma samples were stored in polystyrene 
tubes at -800C until assayed. 
To minimize the effects of between assay variability, all hormone samples from 
one subject were analyzed in the same assay run. 
ANALYTICAL METHODS 
The places where the various analytical procedures were performed are mentioned 
between parenthesis. 
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Electrolytes, hematocrit and urinary protein 
(Laboratory of Obstetrics and Gynaecology, St Radboud Hospital Nijmegen, head 
drs.P. Houx) 
Concentrations of sodium and potassium in plasma and urine were measured 
by flame photometry. The samples were diluted with distilled water and LiCl 
was used as an internal standard. The determination of creatinine in urine is 
based on the Jaffé reaction. The method comprises the formation of a red colour 
by reaction of creatinine with picrate in an alkaline solution and the developed 
colour is measured spectrophotometrically at 490 nm. The results of sodium 
and potassium in urine were expressed both as mmol /24 h specimen and mmol 
excreted /mmol of creatinine. The latter method was used as a check for adequacy 
of urine collections. 
The venous hematocrit was measured by the microhematocrit method according 
to standard laboratory procedures. 
Quantitative determination of urine protein was performed with the turbidimetric 
estimation method which makes use of sulfosalicylic acid. 
Radioimmunoassays 
Atrial natriuretic peptide 
(Department of Experimental and Chemical Endocrinology, St Radboud Hospital 
Nijmegen, head: Professor Dr.ThJ. Benraad) 
ANP was measured with a radioimmunoassay (RIA) (Rosmalen et al., 1987) 
after prior extraction of the plasma on Sep-рак C-18 columns (Waters Assoc, 
USA). Recovery of (99-126)hANP added to plasma was 96% and intra- and 
interassay coefficients of variations were respectively 8.6 (n=7) and 11.6% (n=6). 
Results are expressed as picograms per ml. 
HPLC-analysis 
The immunoreactive profile of ANP was studied using high pressure liquid 
chromatography (HPLC) analysis. 
HPLC-analysis was performed on concentrated extracts (Sep-рак C-18) using 
a Supeico C-18 (5 ¿¿m)-column (25 cm) with a flowrate of 2 ml per min. The 
initial solvent composition was acetonitrile-distilled water-TEA (20:80:0.1 v/ 
ν /ν) (Baker Fine Chemicals). A linear gradient was used from 20-34 % acetonitrile 
in 30 min and subsequently to 80% acetonitrile at 40 min. Fractions were collected 
each minute and assayed in duplicate. (99-126)hANP eluted at 27% acetonitrile 
(fraction 16) (Tan et al., 1987a). 
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Renin, prorenin, renin substrate, plasma renin activity and angiotensin converting 
enzyme 
(Department of Internal Medicine I, Dijkzigt Hospital Rotterdam, head: Professor 
Dr.M.A.D.H. Schalekamp) 
Plasma active renin and prorenin concentrations were measured by indirect 
radioimmunoassay. In this assay active renin was measured by its capacity to 
generate angiotensin I (ANGI), quantified by RIA, from saturating amounts of 
purified sheep renin substrate as described previously (Dcrkx et al., 1978; Derkx 
et al., 1986). Renin concentration is expressed as microunits of the MRC (Medical 
Research Council) human kidney renin standard per ml (Bangham et al., 1975). 
Prorenin has to be activated before it can be measured by the indirect radioim-
munoassay. This was done by adding Sepharose-bound trypsin in a concentration 
of 0.25 mg/ml (Derkx et al., 1983). Prorenin concentration was calculated as 
the difference between renin concentration after trypsin-activation and renin-
concentration before activation. Plasma renin activity (PRA) was measured by 
incubating the plasma samples without the addition of sheep substrate (Derkx 
et al., 1986). The concentration of renin substrate was determined as the maximal 
quantity of angiotensin I generated during incubation at 390C and pH 7.5 with 
an excess of purified renin (Derkx et al., 1986). The results of plasma renin 
activity and renin substrate measurements are expressed as respectively picomoles 
ANGI generated by 1 ml plasma during 1 h and picomoles per ml. Measurements 
of angiotensin converting enzyme were carried out with the help of an assay 
described before (Boomsma and Schalekamp, 1983), and plasma concentrations 
are expressed as units per 1. 
The intra- and interassay coefficients of variation for the different components 
of the renin-angiotensin system ranged from 4-6 % and from 6-9% respectively. 
Aldosterone and free aldosterone 
(Department of Experimental and Chemical Endocrinology, St Radboud Hospital 
Nijmegen, head: Professor Dr.ThJ. Benraad) 
Aldosterone was determined by radioimmunoassay after extraction and paper 
chromatography (De Man and Benraad, 1977). Two ml plasma was incubated 
for 30 min at room temperature with 3H-aldosterone (7500 dpm). Dichlorome-
thane (15 ml) was added and, after 2 min shaking, the mixture was centrifuged 
for 2 min at 1000 rpm in a table centrifuge. The upper layer was discharged 
and the organic layer dried under an air-stream at 400C. The residue was dissolved 
in dichloromethane and chromatographed in a Bush Bj-type system, toluene/ 
methanol / water ( 10:5:5) on Whatman-1 paper. The chromatogram was scanned 
for radioactivity and the appropriate area was eluted with 1 ml 0.2% ethylene 
glycol. Part of the eluate was assayed for radioactivity to determine recovery, 
and part was used in the radioimmunoassay. 
The intra- and interassay coefficients of variations were 7.9 (n=14) and 12.0% 
(n= 10) respectively. 
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Plasma concentrations of free aldosterone were calculated from the percentage 
free aldosterone multiplied by the plasma concentration of total aldosterone. 
The percentage free aldosterone was measured by equilibrium dialysis in a 
'Dianorm equilibrium dialyser' (Diachema A.G., Switzerland). A plasma aliquot 
of 180 μΐ containing 100.000 dpm of 3H-aldosterone was dialysed for 3 hours 
at 370C against 180 μ\ of 0.05M phosphate buffer of pH=7.4 containing 0.1M 
NaCl. The percentage free aldosterone in the original sample f0 was calculated 
according to the formula (Oppenheimer and Surks, 1964; Ross, 1980): 
f0 = ((CQ /C2)-(vl/v0)+l)-4x100%), where 
c 0 = the concentration of radioactivity in the original sample, 
Cj = the concentration of radioactivity in dialysate at equilibrium, 
vt = the total volume in the dialysis system and 
v0 = the volume of the original sample present in the dialysis system. 
The intra- and interassay coefficients of variation were 4.2 (n=20) and 3.9% 
(n=21 ) respectively. 
The results of the measurements of plasma concentrations of aldosterone and 
free aldosterone are expressed as picomoles per 1. 
Progesterone 
(Department of Experimental and Chemical Endocrinology, St Radboud Hospital 
Nijmegen, head: Professor Dr.ThJ. Benraad) 
Plasma and follicular fluid progesterone concentrations were determined after 
extraction and chromatography. Plasma (0.2 ml) and follicular fluid (0.05 ml) 
were incubated with 10.000 dpm of 3H-progesterone (specific activity 55 Ci/ 
mmol; Amersham Int, UK) for at least 2 h. The samples were extracted with 
15 ml of diethylether and the organic residues applied to Whatman-1 paper. 
Chromatography was performed in a Bush B3 solvent (petroleum-ether (80/ 
110): toluene: methanol: water=10:5:12:3) system, whereafter the paperlanes 
were scanned for radioactivity. The progesterone peaks were eluted in 2 ml 
0.1 M borate buffer of pH 8.0 containing 0.5% w/v bovine serum albumin. 
The eluates were used for RIA. Intra- and interassay variations were 5.3% (n=12) 
and 6.4% (n=9) respectively. Progesterone concentrations are expressed as 
nanomoles per I. 
DIETARY INTAKE ANALYSIS 
Dietary intake (Chapters 11 and 12) was analyzed by means of the dietary 
history technique. This is a standardized method designed to measure the average 
nutrient intake of an individual during a considerable period of time (Burke, 
1947). The dietary history interview was completed by a cross-check which 
checks possible omissions and minimizes errors in estimating amounts of food 
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eaten (Reed, 1954). The average daily intake of food was then calculated in 
terms of total energy (kJ), proteins (g), fat (g), carbohydrates (g), calcium (mg), 
sodium (mmol) and potassium (mmol) with the help of a composition table 
of food values, specific for The Netherlands (Compendium dieetpreparaten en 
voedingsmiddelen, 1987). 
STATISTICAL ANALYSIS 
(Departments of Obstetrics and Gynaecology, Dr.H. WJongsma (head: Professor 
Dr.T.K. A.B. Eskes) and Medical Statistics, Ir.T. de Boo (head: drs.W.H. Doesburg), 
St Radboud Hospital, Catholic University, Nijmegen) 
Differences between measurements during pregnancy on the one hand and 
6 weeks post partum on the other (Chapter 6) were analyzed by the Wilcoxon 
matched-pairs signed-ranks test. The level of significance per comparison was 
taken to be 0.10:k (k=number of comparisons). Due to the interdependency 
of the values at the subsequent time points, the overall type I error is probably 
nearer to 5% than to 10%. The results of the serial measurements during the 
Puerperium were analyzed in the same manner (Chapters 8 and 9). 
Possible relations between ANP and the other variables during pregnancy 
(Chapter 6) as well as the relations between the hormonal parameters and the 
sodium excretion and diuresis in the puerperium (Chapters 8 and 9) were evaluated 
in a way described by Steel and Torrie (1984). For the n, pairs of observations 
of each woman, the Pearson's coefficient of correlation (r,) was determined. 
Then for each r, the Fisher transform z, was calculated, and for each pair of 
variables the weighted mean z
w
 was determined. For each pair of variables 
the к (к = number of women) individual correlation coefficients were tested 
for homogeneity by calculating the weighted sum of squared deviations 
Σ,ίη, - ЗХг, - z
w
)2 and referring it to a X2 table with k-1 degrees of freedom. In 
case of homogeneous correlation coefficients a pooled mean value of г and 
a 95% confidence interval (CI) were obtained by back converting z
w
 to r, with 
inclusion of an adjustment for bias. If the 95% CI does not include the value 
0 the correlation is significant at the p=0.05 level. 
To compare the results of serial measurements after the start of the low sodium 
diet with those in the ad libitum sodium intake control group (chapters 11 and 
12), the distribution-free statistical test described by Koziol et al. (1981) was 
used. This test is suitable for the comparison of response curves when missing 
values are present. P-values were considered significant at the 5 percent level. 
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PART II 
ATRIAL NATRIURETIC PEPTIDE (ANP) 
DURING PREGNANCY 
Chapter 4 
REVIEW OF THE LITERATURE AND 
INTRODUCTION TO THE STUDIES 
ANP LEVELS DURING NORMAL HUMAN PREGNANCY 
In view of the hemodynamic alterations during pregnancy, described in chap-
ter 2, one might expect changes in plasma levels of ANP. 
Table 4.1 lists the studies published up to december 1989. Eighteen studies 
had a cross-sectional study design, of which respectively 11 showed higher ANP 
levels at various gestational ages and 7 demonstrated similar ANP levels during 
pregnancy as compared to non-pregnant controls. As hormonal and hemodynamic 
values vary widely between individuals, ANP levels can best be studied lon-
gitudinally in individual subjects. In 4 studies serial measurements were made, 
comparing ANP levels during pregnancy with those some time after delivery 
(Steegers et al., 1987b; Fiévet et al., 1988; Maialino et al., 1988; Milsom et 
al., 1988). Only Milsom et al. (1988), using unextracted plasma, reported higher 
ANP levels during pregnancy than those 12 weeks post partum. In the other 
three longitudinal studies no significantly different ANP concentrations at any 
point of time during pregnancy as compared with 6-8 weeks after delivery were 
reported. 
In conclusion, up to now there is no consensus in the literature as to whether 
cardiac ANP secretion and plasma ANP levels are increased in normal pregnancy. 
One of the important factors to be considered in the evaluation of cross-
sectional studies on plasma ANP levels in pregnant women appears to be the 
number of subjects studied as all investigators found a substantial overlap between 
pregnant and non-pregnant values. Furthermore differences in the designs of 
the studies with regard to parity, sodium intake, posture and sampling conditions 
could contribute to the inconsistent results reported in the literature, as all these 
factors are likely to influence the results of ANP measurements (Campbell and 
MacGillivray, 1972; Sagnella et al., 1985; Solomon et al., 1987; Tan et al., 1987b). 
Diurnal variation of ANP secretion could also play a role (Donckier et al., 1986; 
Table 4 I Review of the literature on ANP levels dunng normal human pregnancy 
Authors 
Cusson et al 
Otsuki et al 
Thomsen et al 
Visser et al 
Grégoire et al 
Jackson et al 
Thomsen et al 
Miyamoto et al 
Hévet et al 
Di Lieto et al 
Marlettini et al 
Grace et al 
Doniec et al 
Shnvastav et al 
Hirai et al 
Elias et al 
Stratta et al 
Bond et al 
Rutherford et al 
Steegers et al 
Fiévet et al 
Maialino et al 
Milsom et al 
1985 
1987 
1987 
1987 
1987 
1987 
1988 
1988 
1988 
1988 
1989 
1987 
1987 
1988 
1988 
1988 
1988 
1989 
1987 
1987b 
1988 
1988 
1988 
Study 
design 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
CS 
LO 
LO 
LO 
LO 
LO 
Gestational 
period studied 
12-42 wks 
l·1 to 3"1 trim 
3rd trim 
29 38 wks 
24-36 wks 
ls ,to3 ,dtrim 
1* to 3rd trim 
28 - 39 wks 
24 36 wks 
3 8 - 4 1 wks 
P'toS^trim 
lsl to 3rd tnm 
term 
H to 3'd trim 
lsl - З"1 trim 
term 
Ist to 3 r d trim 
l ! l to3 r d tnm 
14-40 wks 
36-40 wks 
24 - 36 wks 
22 - 36 wks 
12-36 wks 
number 
of time 
points 
1 
4 
1 
1 
1 
3 
3 
3 
1 
1 
5 
2 
1 
2 
3 
1 
7 
3 
4 
3-5 
1 
3 
3 
Controls 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
NP 
-
6 wks pp 
2 months ρ 
6 wks pp 
3 months ρ 
Pregnancy Extraction 
versus step in 
controls Remarks assay 
с 
-
_ 
_ 
с 
a 
a 
_ 
-
с 
a 
_ 
a 
с 
-
a 
с 
a 
b 
-
a 
с 
+ 
+ 
+ 9 
+ 
+ 
+ 
+ 
+ 
+ 9 
9 
+ 
+ 9 
-
+ 
+ 
+ 
+ 
+ 
-
CS, cross sectional, LO, longitudinal, NP, non-pregnant, wks, weeks, tnm, tnmester, pp, post partum, t, significantly higher, =, not significantly 
different, a, no change during pregnancy, b, nulliparae only, c, gradual increase during pregnancy 
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Tan et al., 1987a) although, in contrast to non-pregnant individuals, no clear 
diurnal rhythm in normal pregnant women was found (Miyamoto et al., 1988; 
Sumiokietal.,1989). 
Measured concentrations of immunoreactive ANP are highly dependent on 
the applied assay methodology used, especially on whether or not a pre-extraction 
procedure is included. Most of the studies used different assays and, as shown 
in table 4.1, several of them did not include a pre-extraction step. Extraction 
of plasma samples is useful for eliminating substances which cause non-specific 
interference in the assay (Richards et al., 1987; Poole et al., 1988). 
Also the specificity of the antibody used against (99-126)hANP is of importance, 
as besides (99-126)hANP other molecular forms of ANP circulate in human 
blood (Yandle et al., 1987; Limura et al., 1987). Pathologic conditions of chronic 
volume overload are known to be associated with changes in the observed 
distribution of ANP in its various forms (Marumo et al., 1988). Therefore, in 
theory, the comparison of plasma ANP levels between non-pregnant and pregnant 
individuals may be confounded by a typical pregnancy-related increase in the 
secretion of one or more other molecular forms of ANP than (99-126)hANP, 
as human pregnancy represents a state of chronic hypervolemia. To our knowledge 
this has not yet been investigated. 
Another factor that can influence ANP concentrations during pregnancy might 
be an increased degradation of ANP in blood by circulating peptidases originating 
from the placenta as has been described with regard to vasopressin and oxytocin 
(Davison et al., 1989; Burd et al., 1987). This has not been studied either. 
All authors who reported ANP levels to be elevated during pregnancy attributed 
this phenomenon to the well known gestational increase in blood volume. 
However, almost no attempt was made to study the relationships between ANP 
concentrations and the concurrent maternal hemodynamic changes. Only Milsom 
et al. (1988) studied ANP levels simultaneously with stroke volume and cardiac 
output. Although they concluded that changes in plasma ANP appear to be 
related to changes in maternal central hemodynamics, these relations were not 
statistically evaluated. As the release of ANP is predominantly elicited, at least 
in the non-pregnant state, by stretch of the atrial wall, above all the relationship 
between atrial size and plasma concentrations of ANP seems to be important 
for the understanding of the regulatory mechanisms of ANP secretion during 
pregnancy. No such data however are available in the literature. Furthermore, 
considering the effects of this peptide, changing ANP activity might also be 
part of the renal and cardiovascular homeostasis during pregnancy. Only 
Marlettini et al. (1989), in a cross-sectional study, tried to assess possible 
relationships between ANP and blood pressure, kidney function, plasma sodium 
and urinary sodium excretion at several time points during pregnancy. ANP 
appeared to be significantly correlated with systolic blood pressure only. No 
serial studies have been conducted yet in this respect. 
There is growing evidence that the synthesis of ANP is not confined to the 
heart, but occurs also in other tissues throughout the body (Gardner et al., 1986). 
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Therefore, extracardiac secretion of ANP, as for example by the placenta, can 
not be ruled out as a possible cause of changing ANP concentrations during 
pregnancy, especially as placental cell cultures have been reported to produce 
ANP (Craig et al., 1987). Others suggested that ANP is also present in amniotic 
fluid (Martin et al., 1988), which might point at a site of ANP production in 
the fetoplacental unit. The presence of ANP binding sites in human placentas 
(Sen 1986; Hatjis and Grogan, 1988) suggests that either fetal or maternal ANP 
may be involved in placental hemodynamics, fluid shift and electrolyte transport. 
Lastly the ovary may well be a site of ANP secretion. In non-pregnant women 
ANP immunoreactivity has been found in the corpus luteum (Vollmar et al., 
1988). Because of this finding, one might expect ANP immunoreactivity to be 
present in human ovarian follicular fluid. This, however, has not yet been reported 
in the literature. The speculation that the ovary is involved in determining ANP 
concentrations during pregnancy as well is not illegitimate as such comparable 
involvement has been made likely with regard to some components of the renin-
angiotensin system (Derkx et al., 1987b; Sealey et al., 1987a). 
APPENDIX: ANP LEVELS IN HYPERTENSIVE PREGNANCY 
Although our own results are confined to normotensive pregnancies only, this 
paragraph is inserted to complete the survey of the literature on ANP in pregnancy. 
In contrast to the results of ANP measurements during normal pregnancy, 
there seems to be agreement with regard to ANP levels found in preeclampsia. 
All studies but two (Doniec-Ulman et al., 1987; Stratta et al., 1988) investigating 
this hypertensive state of pregnancy reported elevated concentrations of ANP 
as compared with normotensive pregnant controls (Otsuki et al., 1987; Visser 
et al., 1987; Miyamoto et al., 1988; Hirai et al., 1988; Elias et al., 1988; Cowan 
et al., 1988; Miyamoto et al., 1989; Hatjis et al., 1989), and concentrations 
seem to rise further with the severity of the disease (Thomsen et al., 1987; 
Grégoire et al., 1987; Fiévet et al., 1988; Di Lieto et al., 1988; Bond et al., 
1989). 
Enhanced ANP levels do not seem to be in agreement with the hemodynamic 
findings in this disease. Plasma volume (Chesley 1972b) and right atrial pressure 
(Visser et al., 1987) are reported to be lower than in normal pregnancy. 
One explanation for enhanced ANP secretion could be an increase in left 
atrial pressure secondary to an increase in end diastolic filling pressure which 
correlates with the mean arterial pressure, as demonstrated in essential hyper-
tension (Strauer 1986; Sagnella et al., 1986). However, pulmonary wedge pressure 
seems to be lower in preeclamptic women (Groenendijk et al., 1984). Increased 
plasma ANP levels in preeclampsia may also be related to ventricular production 
of ANP associated with increased afterload or an altered distensibility of the 
myocard. Other factors such as a decreased clearance of this peptide (Anderson 
1987) or a decreased end-organ responsiveness may be involved as well. The 
precise mechanisms responsible for the increased ANP concentrations in patients 
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with hypertension in pregnancy remain unknown and require further investigation. 
Increased ANP secretion in this condition may reflect a mechanism of 
compensation that operates in response to water and sodium retention. It may 
also prevent further enhancement of generalized vasoconstriction by vasorelaxant 
activity (Miyamoto et al., 1989). It has also been suggested that high ANP levels 
could be involved in normalizing the decreased placental blood flow, charac-
terizing this disease (Chemtob et al., 1989). The hypovolemia in preeclampsia 
is associated with a hypostimulation of the renin-aldosterone system (Weir et 
al., 1973). Elevated ANP secretion in this disease might explain this apparent 
paradox as ANP is capable of decreasing plasma volume by inducing diuresis, 
natriuresis and a shift of plasma into the interstitium and suppressing the secretion 
of renin and aldosterone. So next to providing a compensatory mechanism to 
the elevation in blood pressure, high ANP concentrations may also contribute 
to some of the pathophysiologic features of preeclampsia. 
Whether enhanced ANP secretion is primary or secondary to the cause of 
preeclampsia is as yet unknown. 
INTRODUCTION TO THE STUDIES 
In view of the discussion arising from the available literature on ANP during 
normal pregnancy the following studies were initiated: 
- Studies to scrutinize the influence of certain physiological conditions which 
may affect the measurement and interpretation of ANP levels in pregnancy, 
viz.; dietary sodium intake, posture, degradation of ANP in blood and profile 
of circulating immunoreactive forms of ANP (chapter 5). 
- Serial studies of ANP concentrations throughout pregnancy in relation to 
concomitant maternal cardiovascular and sodium balance related parameters 
(chapter 6.1), with special attention being paid to the relationship between 
ANP and right and left atrial size (chapter 6.2). 
- Serial measurements of ANP starting before conception and continued during 
the first trimester of pregnancy (chapter 6.3). 
- The ascertainment of ANP immunoreactivity in amniotic fluid at midgestation 
and during labour (chapter 7.1). 
- The ascertainment of ANP immunoreactivity in human ovarian follicular fluid 
(chapter 7.2). 
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Chapter 5 
THE INFLUENCE OF A NUMBER OF 
PHYSIOLOGICAL CONDITIONS ON ANP LEVELS 
IN PREGNANCY; DIETARY SODIUM INTAKE, 
POSTURE, DEGRADATION OF ANP IN BLOOD 
AND PROFILE OF CIRCULATING 
IMMUNOREACTIVE FORMS OF ANP 
INTRODUCTION 
As reviewed in chapter 4, the reported data on plasma concentrations of ANP 
during normal pregnancy are conflicting. Unchanged as well as increased plasma 
levels have been reported. This discrepancy in results could be due to differences 
in study design, analytical methods and population characteristics. 
One difference could be the amount of dietary sodium intake, as in non-
pregnant individuals a reduction in sodium intake was shown to lower plasma 
concentrations of ANP (Sagnella et al., 1985; Solomon et al., 1987). 
Another interfering factor might be posture. Intracavitary atrial pressures 
are higher in the supine position than those in the upright position in the non-
pregnant state (Katkov and Chestukhin, 1980). As plasma concentrations are 
correlated positively with atrial pressure (Rodeheffer et al., 1986), one would 
expect posture-related differences in plasma levels of ANP to occur. 
To our knowledge neither of these relationships have been studied with reference 
to pregnant women. This study was therefore initiated to investigate the effects 
of dietary sodium restriction as well as posture on plasma concentrations of 
ANP during normal pregnancy. Plasma concentrations of ANP as measured 
in these pregnant women during unrestricted sodiumintake were compared with 
values found in a control group of healthy non-pregnant females. 
To assess the possible influence of circulating enzymes from the placenta 
on the degradation of ANP in blood, blood samples from two additional groups 
of pregnant and non-pregnant women to which exogenous human ANP ((99-
126)hANP) was added were incubated for one hour at 370C, after which the 
respective recovery values were assessed and compared. 
The comparison of plasma ANP levels in pregnant and non-pregnant women 
may, in theory, be confounded by a typical pregnancy-related increase in the 
secretion of one or more other molecular forms of ANP than (99-126)hANP. 
One method to investigate the molecular forms of ANP in plasma is separation 
of ANP-immunoreactivity on a high pressure liquid chromatography (HPLC) 
column. Therefore plasma from one pregnant and one non-pregnant woman 
was subjected to HPLC analysis. 
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ANP is an antagonist of aldosterone in that it blocks its secretion and opposes 
its sodium retaining action (Atlas and Laragh, 1986). No results have been 
published so far concerning the relationship between the changes in the con-
centrations of ANP and aldosterone in response to sodium restriction or change 
in posture in pregnancy. 
Therefore, simultaneously with investigating the effects of sodium restriction 
and posture on concentrations of ANP, the effects on plasma levels of aldosterone 
were investigated. As a large proportion of aldosterone in plasma is protein 
bound (Dunn et al., 1981), concentrations of total aldosterone do not necessarily 
accurately reflect the changes which may occur in the levels of free (non-protein 
bound) aldosterone, and, in connection herewith, the physiological activity of 
this steroid. Measurements of plasma concentrations of total aldosterone as well 
as free aldosterone were therefore included in this study. 
MATERIAL AND METHODS 
Study population. 
Ten healthy pregnant women entered the study after informed consent was 
obtained. The experimental protocol was approved by the committee on human 
experimentation of the University Hospital St Radboud. Seven women were nulli-
parous. Up to their participation in the study they had uneventful, normotensive 
pregnancies (diastolic blood pressure < 90 mmHg by sphygmomanometry, taken 
as the point of muffling, phase IV, of the Korotkoff sounds) (Davey and 
MacGillivray, 1988). At the start of the study the mean gestational age was 
219 days (range 203-234 days). The mean age of the women was 30 years 
(range 26-45 years). 
Each woman was studied twice as an out-patient, once during an unrestricted 
sodium intake (day 0) and again on day 6 of a low sodium diet (approximately 
20 mmol /day). On both occasions the protocol was carried out at the same 
time of day. The low sodium regime was started on day 1. Dietary guidance 
was given by oral and written instruction supplied by the hospital dietitian. Urine 
samples were collected over 24 h on day 0 and on days 1, 2, 3, 4 and 5 of 
the low sodium diet for measurement of sodium and creatinine. 
On both days 0 and 6, at the same time of day, venous blood was withdrawn 
from women who were in two different postures. Blood samples were taken 
when the women had been sitting quietly for at least 15-30 min. Subsequently 
the women were situated in the left lateral position and 15-30 min later blood 
samples were taken again. 
Concentrations of ANP in plasma were also measured in a control group 
of thirty healthy non-pregnant females (not standardized for the day of the cycle) 
in left lateral position. They were using neither medicines nor oral contraceptives. 
The age of these women ranged from 20 to 40 years. 
37 
Degradation of ANP in pregnanq/. 
In two additional groups of women the degradation of ANP in blood was 
studied. Blood (12 ml) was obtained from 10 healthy non-pregnant females 
who were using neither medicines nor oral contraceptives and from 10 women 
during the third trimester of normal pregnancy (range 203-266 gestational days). 
The age in these groups varied from 18 to 40 years and from 25 to 36 years 
respectively. 
Four ml of blood were used for the determination of the endogenous 
concentration of ANP in plasma. After addition of synthetic (99-126)hANP 
(approximately 12.0 pg/ml plasma) the remaining 8 ml of blood were separated 
into two polystyrene tubes. One tube was centrifuged immediately (reference 
value) while the other was incubated for 60 min at 370C prior to centrifugation. 
All plasma samples were processed in the same assay for determination of 
immunoreactive ANP values. Recovery was determined as the ANP value in 
blood incubated for one hour divided by the corresponding ANP reference value 
(xl00%). 
Profile of ANP immunoreactivity in plasma 
The immunoreactive profile of ANP was studied using HPLC analysis in one 
healthy woman during normal pregnancy (at 28 weeks) and in one healthy non-
pregnant woman. 
Statistical analysis 
The Wilcoxon matched-pairs signed-ranks test was used to test the effects 
of sodium restriction and postural change on the plasma concentrations of ANP, 
aldosterone and free aldosterone. In order to compare levels of ANP in plasma 
in the pregnant and non-pregnant women and to test differences in ANP recovery 
in pregnant versus non-pregnant women the Wilcoxon-Mann-Whitney two-
sample test was used. Correlations between the changes in the concentrations 
of hormones expressed in percentages were determined by calculation of the 
Spearman correlation coefficient (r). 
RESULTS 
The individual values of 24h urinary sodium excretion are shown in figure 
5.1. The urinary sodium /creatinine ratio and 24h urinary sodium excretion showed 
a gradual decrease in response to the low sodium diet (table 5.1). 
Concentrations of ANP on day 0 and day 6 in the sitting and left lateral 
position are shown in figure 5.2. 
Sodium restriction caused a significant decrease in ANP (p<0.01) and an 
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3 L 5 
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Figure 5.1. Individual values (patient numbers 1 to 10) of urinary sodium excretion. 
increase in aldosterone and free aldosterone (p<0.01) in both positions. On both 
days 0 and 6 mean concentrations of ANP were higher in the left lateral position; 
this difference, however, did not reach statistical significance (p<0.20). 
Corresponding concentrations of aldosterone and free aldosterone are depicted 
in figure 5.3. Aldosterone and free aldosterone were significantly lower in the 
left lateral position on both occasions (p<0.01). 
Changes in concentrations of ANP in response to sodium restriction were 
correlated neither with those in aldosterone nor those in free aldosterone (table 
5.2). Posture-related changes in concentrations of ANP were significantly 
inversely correlated with those of aldosterone and free aldosterone. These 
interrelationships, however, disappeared during a low sodium intake. Changes 
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Table 5 1 Urinary sodium excretion in response to a low sodium diet Values are means with range 
given in parenthesis 
Unnary sodium 
(mmol/24 h) 
Urinary sodium / 
creatinine ratio 
dayO 
day I 
day 2 
day 3 
day 4 
day 5 
126 
(76 , 173) 
87 
(24 , 148) 
60 
(15 , 103) 
53 
( 1 3 , 7 7 ) 
36 
(17,75) 
34 
(12,75) 
98 
(8 0 , 1 2 8) 
78 
(2 5 , 1 0 3) 
50 
( 1 6 , 9 1 ) 
48 
( 1 2 , 7 3 ) 
33 
( 1 6 , 7 1 ) 
29 
( 1 1 , 6 8 ) 
sitting left lateral 
univstncM sodium intake 
sitting left lateral 
low sodium intake 
Figure 5 2 Individual values of concentrations of ANP in plasma in sitting position and left lateral 
position during an unrestricted sodium intake and on day 6 of a low sodium diet (the 
patient numbers correspond with those in the other figures) The honzontal bars represent 
the mean values 
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Figure 5 3 Individual values of concentrations of aldosterone and free aldosterone in plasma in 
sitting position and left lateral position during an unrestricted sodium intake and on 
day 6 of a low sodium intake (the patient numbers correspond with those in the other 
figures) The horizontal bars represent the mean values 
in concentrations of aldosterone and free aldosterone were significantly correlated 
on every occasion. 
No significant correlation was found between changes in the concentrations of 
ANP or (free) aldosterone and the decrease in sodium excretion or the extent 
of negative sodium balance over the five days of sodium restriction. 
ANP values in the group of pregnant women during an unrestricted sodium 
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Table 5 2 Correlations between the proportional changes of plasma concentrations of atrial natnuretic 
peptide (% ANP), aldosterone (% A) and free aldosterone (% FA) in women on an unrestricted 
sodium diet or a low sodium diet and in the sitting position or left lateral position 
%ANP %A 
% ANP - % FA 
% A - % FA 
correlation between unrestricted 
and low sodium intake 
sitting position 
0 08(NS) 
-0 07 (NS) 
0 94 « 0 01) 
left lateral position 
0 33 (NS) 
-0 21 (NS) 
0 96 « 0 01) 
correlation between sitting and 
left lateral position 
unrestricted low sodium 
sodium intake intake 
-0 64 « 0 05) -0 10(NS) 
-0 64 « 0 05) -0 12(NS) 
0 98 « 0 01) 0 98 « 0 01) 
The results represent the Spearman correlation coefficients (P values are given in parenthesis) 
NS, not significant 
intake, in either position, were not significantly different from those obtained 
in the control group of thirty non-pregnant females (mean 38.2 pg/ml, range 
16.0-93.9 pg/ml). 
The results of the recovery experiment are shown in table 5.3. The recovery 
of ANP in blood after one hour incubation at 370C from pregnant women (mean 
70%, range 49-89%) did not differ significantly from the recovery in blood from 
non-pregnant females (mean 74%, range 59-84%). 
Figure 5.4 shows the HPLC-profile of ANP in plasma from a pregnant and 
non-pregnant woman. No major differences between the two patterns could be 
demonstrated. Both types of plasma showed the major peak (fraction 16) 
corresponding to (99-126)hANP (Tan et al., 1987a). 
DISCUSSION 
Effects of dietary sodium restriction. 
The findings of the present study demonstrate that a low-sodium diet induces 
a significant decrease in plasma concentrations of ANP in normal pregnancy. 
These results are in agreement with other reports in which a reduction of sodium 
intake in non-pregnant healthy subjects also lowered plasma concentrations of 
ANP (Sagnella et al., 1985; Solomon et al., 1987). 
The mechanisms by which the secretion of ANP during pregnancy is mediated 
by the intake of sodium is not known. Intracavitary atrial pressure is known 
to be positively correlated with plasma levels of ANP (Rodeheffer et al., 1986). 
Sodium restriction during pregnancy has been shown to decrease plasma volume 
(Brown et al., 1988). The ensuing diminished venous return of blood to the 
heart will decrease the atrial pressure and consequently ANP release. We were 
however unable to demonstrate any significant correlation between changes in 
concentrations of ANP and the decrease in sodium excretion or the extent of 
negative sodium balance over the five days of sodium restriction. It has been 
suggested by Brown et al. (1988) that changes in extracellular fluid volume 
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Table 5 3 Concenlrations of ANP in plasma (pg/ml) before and immediately after the addition 
of exogenous ANP and after one hour incubation at 370C Values are means with range 
given in parenthesis 
before addition 
of ANP 
after addition 
of ANP 
after one hour 
incubation at 370C 
pregnant 
women(n=10) 
50 2 
(20 0,85 3) 
64 0 
(35 4,102 8) 
44 0 
(28 9 87 4) 
non-pregnant 
women (n—10) 
53 6 
(29 9,76 0) 
65 3 
(45 2 , 8 6 5) 
47 4 
(34 8,60 3) 
ANP (pg/ml) 
U -ι 
12 
10-
8-
i (99-126)hANP 
• pregnancy ( 28weeks ) 
[ j non-pregnant 
detection limit 
I I I ' ' ' I ' ι ' ' ' ' ' г 
20 24 28 32 36 40 
Fractions 
Figure 5 4 HPLC profile ofimmunoreactivc ANP in plasma from one pregnant and one non pregnant 
woman The main immunoreactive component corresponds to (99 126)hANP 
(fraction 16) 
during pregnancy are not followed by proportional changes in plasma volume 
This putative disproportion may be due to compensatory processes such as a 
buffering of sodium from the interstitial space into the circulation The lack 
of a clear correlation between ANP and sodium balance may be due to some 
physicochemical process of this kind An alteration of the sensitivity of renal 
ANP receptors due to a change in dietary sodium intake may also be involved 
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(Weidmann et al., 1986). The decrease in concentrations of ANP coinciding 
with the increase in concentrations of aldosterone and free aldosterone, as observed 
in our study, is in concord with the expected physiological salt-retaining response 
to a reduction in sodium intake and is consistent with the interaction between 
the two hormone systems in the non-pregnant state (Sagnella et al., 1987). No 
significant correlations between changes in concentrations of ANP and changes 
in concentrations of aldosterone and free aldosterone in response to sodium-
restriction could however be found. The nature and physiological significance 
of the relationship between these hormones in maintaining sodium balance during 
pregnancy requires further investigation. 
Effects of posture. 
In non-pregnant subjects in the upright position, lower (Solomon et al., 1987) 
as well as similar (Lijnen et al., 1987) concentrations of ANP were found as 
compared with those in the supine position. During pregnancy mean levels of 
ANP in sitting position were lower than those in left lateral position, although 
the differences were not statistically significant. The direction of change in levels 
of ANP to postural change seems to be individually determined, as concentrations 
of ANP in all but one woman responded the same way during both unrestricted 
and low sodium intake. By what regulatory or confounding factors the direction 
of change of concentrations of ANP is determined remains unclear. Concen-
trations of aldosterone and free aldosterone were significantly higher in the sitting 
position than in the left lateral position. Weinberger and colleagues (1977), 
however, found a non-significant increase in concentrations of aldosterone 
following postural change from lateral recumbency to the upright position. Our 
observations are in agreement with those made in non-pregnant subjects by 
Balikian et al. (1968). They showed that an increase in secretion rather than 
a decrease in the metabolic clearance rate is the major factor regulating changes 
in concentrations of aldosterone induced by postural change. The upright position 
is known to stimulate sympathetic nervous activity resulting in an increase in 
plasma catecholamines, plasma renin activity and aldosterone (Robertson et al., 
1979a; Robertson et al., 1979b). Higher levels of aldosterone in sitting position 
may also be due to venous pooling in the limbs, resulting in a decrease in renal 
blood flow, thereby yielding higher renin secretion. Posture related changes in 
concentrations of ANP were significantly inversely correlated with those of 
aldosterone and free aldosterone. This may lead to the conclusion that ANP 
during pregnancy inhibits aldosterone secretion just as it was found to do in 
the non-pregnant state (Anderson et al., 1986a). However this interrelationship 
disappeared during low sodium intake during which other determinants of 
aldosterone activity seem of greater importance. 
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Comparison of levels of ANP in pregnant- and non-pregnant women 
Concentrations of ANP in the pregnant women (studied in the third trimester 
of pregnancy) did not differ significantly from ANP values in the non-pregnant 
control group, both in the sitting position and in the left lateral position. As 
there is no difference in the degradation of ANP in blood between pregnant 
and non-pregnant women, this finding may indicate that ANP secretion is not 
increased during that gestational period. It is unlikely that the comparison of 
ANP levels in and outside pregnancy is confounded by a (theoretically possible) 
substantial pregnancy-related secretion of one or more molecular forms (in-
terfering with the RIA) other than (99-126)hANP, as no major differences could 
be detected between the immunoreactive profile of ANP in plasma from a pregnant 
and a non-pregnant woman. 
In conclusion, concentrations of circulating ANP during pregnancy vary with 
dietary sodium intake and may in individual women also vary with posture. 
This should be taken into account when interpreting levels of ANP as reported 
in the literature. Our results suggest that ANP contributes, together with 
aldosterone to the maintenance of sodium balance in normal pregnancy, although 
the physiological significance of the relationship between these hormonal systems 
requires further investigation. 
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Chapter 6 
ATRIAL NATRIURETIC PEPTIDE IN NORMAL 
PREGNANCY; LONGITUDINAL STUDIES 
6.1. ANP AND RELATED HEMODYNAMIC AND URINARY 
PARAMETERS 
INTRODUCTION 
In view of the regulatory mechanisms of ANP secretion known so far, one 
might speculate that the rise in circulating volume during pregnancy induces 
an increase in ANP secretion and plasma ANP concentrations. As hemodynamic 
and hormonal values vary widely between individuals, ANP levels during 
pregnancy were studied serially in individual subjects. In order to investigate 
the relationships between ANP and the concurrent hemodynamic changes, stroke 
volume, heart rate, cardiac output, left ventricular and atrial dimensions, he-
matocrit and weight were studied as well (the latter two as indices for plasma 
volume and total body water). 
In view of the effects of this peptide, changing ANP activity might to some 
extent also be involved in the regulation of renal and cardiovascular homeostasis 
during pregnancy. In order to assess this possibility, additional measurements 
were made of blood pressure, systemic vascular resistance, plasma sodium 
concentrations and 24 h diuresis and natriuresis. As the adaptation to pregnancy 
of the maternal cardiovascular system might change with advancing parity 
(Campbell and MacGiUivray, 1972) the study was confined to nulliparous women 
only. 
MATERIAL AND METHODS 
Twenty-three healthy nulliparous women were included in the study after 
informed consent was obtained. The experimental protocol was approved by 
the committee on human experimentation of the University Hospital St Radboud 
in Nijmegen. They all had normotensive pregnancies. One woman experienced 
premature delivery at 34 weeks. The mean age was 25 years (range 18-33 
years). Women entered the study between weeks 11 and 16 of pregnancy (mean 
14 weeks). 
Echocardiographic registrations, blood pressure and weight measurements, 
samples of blood and 24 h urine collections were obtained in a longitudinal 
fashion at the gestational weeks 14, 20, 28, 32, 36, 38 and again 6 weeks 
46 
pg/ml 
au -
6 0 -
40-
20-
0-
atrial natriuretic peptide 
uX. 
— t 1 
4^ V-
1 1 1 1 
...I 
1 
¿ 2 -
3 8 -
34 -
30 
o i 
left atrial dimension 
. JLUK 
mm 
ml 
78 
70 
stroke volume 
y>-\K 
Ы 
62 
Β ί -
Ο 
bpm 
90 
8 6 -
82 
78 
'•I 74 
70 
66-
62-
-, o i 
τ 1 гт-
heart rate 
¡/ 
4 
-\ 1 n -
l/min(·) 
-
54 -
so-
ie -
42
 ; 
0 -
left ventricular dimension 
1 -
1
— ι 
^ ^
л
- ~
1
-
и
^ 1 
— I 1 1 π 1 
8 cardiac output 
dyn/s/cm" (о) 
-1700 
'systemic vascular resistance 
1300 
900 
500 
14 20 28 32 3638 6 14 20 28 32 36 38 6 
gestational weeks weeks gestational weeks weeks 
post partum post partum 
Figure 6.1 1. Mean values of plasma levels of atrial natriuretic peptide, stroke volume, heart rate, 
cardiac output, systemic vascular resistance and left atrial and ventricular diameters 
during pregnancy and 6 weeks post partum. Bars represent the SEM. Asterisks (*) 
indicate significant differences from values 6 weeks post partum. 
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post partum. Weight was recorded with an accuracy of 0.05 kg (Mettler TE / 
J). Venous blood samples and blood pressure recordings were obtained in left 
lateral position after 15-30 minutes rest. Systolic, diastolic and mean arterial 
blood pressure (MAP) were taken at the right upper arm with an automatic 
microcomputer assisted instrument (Medtek BPI 520). 
Systemic vascular resistance (SVR) was derived from MAP and cardiac output 
(CO) by the equation SVR=(MAP:CO)x80 dyn/s/cnr5. 
All investigations were performed between 13.00 and 17.00 h, each individual 
woman being seen invariably at the same hour of the day. 
Statistical analysis 
Differences between the values measured during pregnancy and those measured 
6 weeks post partum were analyzed by the Wilcoxon matched-pairs signed-
ranks test. The level of significance per comparison was taken to be 0.017, 
according to the line of thought explained in chapter 3. 
RESULTS 
The results of the serial measurements of ANP and cardiac parameters are 
shown in figure 6.1.1. ANP levels were significantly increased at the 20th week. 
Thereafter, however, they did not differ significantly from those 6 weeks after 
delivery. Mean values of stroke volume were higher during pregnancy, although 
no significant differences could be demonstrated. Both maternal heart rate and 
cardiac output were significantly elevated throughout pregnancy. The left atrial 
diameter was already significantly increased by week 20 of pregnancy, whereas 
the left ventricular diameter (at end-diastole) showed no major changes. 
Figure 6.1.2. presents the serial course of hematocrit, blood pressure, plasma 
sodium concentrations, urinary sodium /creatinine ratio and 24 h urinary volume 
and sodium excretion. Hematocrit values were significantly lower throughout 
pregnancy as compared to 6 weeks post partum. Systolic, diastolic and mean 
arterial blood pressure were significantly lower at weeks 20 and 28 of pregnancy 
and rose again during the 3rd trimester. Concentrations of sodium in plasma 
were significantly lower throughout pregnancy as compared with 6 weeks after 
delivery. No significant changes could be demonstrated in diuresis and natriuresis. 
Table 6.1.1 lists the weighted means and the 95% confidence interval of the 
individual coefficients of correlation of ANP with the cardiovascular and urinary 
variables. Correlations varied widely between individuals. Weight, systemic 
vascular resistance and systolic blood pressure were weakly though significantly 
inversely correlated with ANP. 
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significant differences from values 6 weeks post partum. 
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Table 6 I I Correlalions coefficients of ANP with hemodynamic and urinary variables during 
pregnancy 
left atrial diameter 
left ventricular diameter 
stroke volume 
heart rate 
cardiac output 
hematocrit 
weight 
systemic vascular resistance 
blood pressure 
systole 
map 
diastole 
plasma sodium 
24 h urinary volume 
24 h unnary sodium excretion 
urinary sodium /creatinine ratio 
weighted mean 
0 05 
-0 02 
0 19 
0 02 
0 23 
(-0 98,0 81)» 
-0 35* 
-0 27* 
-0 25* 
-0 22 
-0 22 
0 22 
-0 05 
0 05 
013 
95% confidence interval 
-0 24,0 33 
-0 26,0 23 
-0 07 ,041 
-0 23,0 27 
-0 02,0 45 
-0 54,-0 12 
-0 49,-0 02 
-0 48,-0 03 
-0 45,0 04 
-0 45,0 04 
-0 04, 0 45 
-0 29,0 19 
-0 20,0 28 
-0 11,0 36 
* p<0 05 In case correlation coefficients were not homogenous only the range of Pearson's coefficients 
is presented (#) 
DISCUSSION 
Plasma ANP concentrations were significantly elevated during mid-pregnancy 
as compared to 6 weeks post partum. 
As described in chapter 2 human pregnancy is characterized by a marked 
increment in blood volume. Intravascular volume remains elevated up to delivery. 
However, ANP levels during the third trimester of pregnancy were not 
significantly different from those 6-7 weeks post partum, which confirms some 
cross sectional (Doniec-Ulman et al., 1987; Grace et al., 1987; Elias et al., 1988; 
Shrivastav et al., 1988; Hirai et al., 1988; Stratta et al., 1988; Bond et al., 1989) 
as well as serial studies (Fiévet et al., 1988; Maialino et al., 1988). Only Milsom 
et al. (1988) showed a continuous rise in serially measured concentrations of 
ANP in plasma, reaching maximal values in the third trimester of pregnancy, 
values significantly higher than 3 months after delivery. They used a direct assay 
which could be subject to interference from plasma proteins (Poole et al., 1988). 
Our findings even revealed a tendency for plasma ANP concentrations to 
decline during the second half of pregnancy (week 20 versus week 38, p<0.05 
by the Wilcoxon matched-pairs signed-ranks test). Furthermore plasma levels 
did neither correlate with stroke volume, cardiac output, left atrial diameter 
nor hematocrit. The results of the serial measurements of these hemodynamic 
parameters confirm those reported in the literature (see for detailed reviews 
chapter 2) and are in accordance with a state of hypervolemia. 
There are several possible explanations for the apparent lack of correlation 
between the intravascular volume expansion during pregnancy and concentrations 
of ANP in blood. 
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Elevated ANP secretion may be balanced by an enhanced rate of clearance, 
which can not be ruled out in this study, or an increased distribution volume 
so that circulating levels are unchanged or even decline. The latter possibility 
could explain the significant inverse correlation of ANP with body weight as 
almost 50% of the gain in weight is due to an increase in total body water 
(Hytten, 1980). This correlation also emerged in a cross-sectional study of Cusson 
et al. (1985). 
It is also possible that the increased intravascular volume is not sensed by 
atrial volume receptors throughout pregnancy. A buffering of potential increases 
in atrial wall tension could be due to the functional enlargement of the maternal 
vascular compartment resulting from the peripheral vasodilatation and the 
enlarged uterine vascular bed. 
Pressure of the uterus on the inferior vena cava, thereby reducing the venous 
return of blood to the heart, could also prevent atrial pressure to rise, though 
this was unlikely to occur in our study in view of the left lateral position in 
which blood samples were taken. 
As the left atrial diameter showed a significant increase during pregnancy 
some rise in atrial pressure and enhanced stretch of the atrial wall however 
can not be ruled out. Therefore a change in the relation between ANP secretion 
and atrial volume receptors could be involved as well. 
In healthy non-pregnant individuals ventricular secretion of ANP is negligible, 
but in situations of chronic volume overload the amount of ventricular secretory 
granules increase (Edwards et al., 1988b). Therefore, in theory, the hypervolemia 
during pregnancy could have a similar effect. However, the ventricular end-
diastolic dimension showed no major changes during pregnancy, and no corre-
lation with ANP levels could be demonstrated, which makes a substantial 
contribution of ventricular ANP to the concentrations in plasma unlikely. 
In view of the natriuretic and diuretic effects of ANP we looked for a putative 
role of this peptide in the regulation of some parameters of sodium and water 
balance during pregnancy. Natriuresis and diuresis showed some fluctuations, 
but no significant differences as compared to 6 weeks post partum were found. 
Concentrations of sodium in plasma were significantly lower throughout preg-
nancy, which together with the decrease in plasma osmolarity is a consistent 
occurrence with gestation (Lindheimer et al., 1987). No significant correlations 
were found of ANP with plasma sodium concentration and 24 h urinary volume 
and sodium excretion, which confirms the results of other workers (Stratta et 
al., 1988; Marlettini et al., 1989). 
Blood pressure decreased during pregnancy and by the second trimester systolic, 
mean and diastolic pressure were significantly lower than levels 6 weeks after 
delivery. In the second half of pregnancy blood pressure slowly increased 
approaching non-pregnant values during the last weeks before delivery. This 
confirms the results of MacGillivray et al. (1969). Since cardiac output showed 
an increase, the decline in blood pressure must be due to a marked decrease 
in peripheral resistance. Systemic vascular resistance calculated from the mean 
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arterial pressure divided by the cardiac output was found to be significantly 
lower throughout pregnancy as compared to 6 weeks post partum. This change 
is probably attributable to both the establishment of the uterine vascular bed 
and to a general relaxation of vascular tone. Several agents may decrease vascular 
reactivity to vasopressor agents during pregnancy, including progesterone and 
prostaglandins (Gant et al., 1987). ANP may also be involved since it has been 
shown that isolated vessels or vascular preparations partially constricted by the 
application of pressor agents relax when ANP is added (Winquist 1986; Hughes 
et al., 1988). The finding of weak though significant inverse correlations of 
ANP with the systemic vascular resistance and systolic blood pressure might 
favour this hypothesis. 
In conclusion ANP levels seem to rise during the first half of pregnancy, 
reaching significantly higher levels as compared to 6 weeks after delivery. 
Thereafter plasma ANP concentrations tend to decline towards levels not 
significantly different from those during the non-pregnant state. This may be 
due to either a diminished secretion of ANP by the atria or a dilution effect 
brought about by the increase in total body water. ANP activity might to some 
extent be involved in the decrease in vascular resistance and blood pressure 
observed in normal pregnancy. 
It remains to be determined whether ANP, which primarily seems to be a 
hormone protecting against situations of acute volume overload (Anderson et 
al., 1986b), is of any significant physiologic importance in the adaptation of 
sodium and fluid balance during the chronic hypervolemic state of pregnancy. 
6.2. ANP AND ATRIAL SIZE 
INTRODUCTION 
Although many studies have reported elevated ANP levels during normal 
pregnancy, the postulated links between the gradual increase in intravascular 
volume, atrial stretch and ANP release have not been made clear. No data have 
been published yet on plasma ANP levels during pregnancy in relation to right 
or left atrial size. 
In the non-pregnant state, rather acute changes in circulating volume are known 
to be closely related in time to changes in both right and left atrial size and 
the concentration of ANP in plasma (Cannella et al., 1988). However, simul-
taneous measurements of ANP and the left atrial diameter (chapter 6.1 ) suggested 
that during pregnancy such relation is absent. 
Therefore a second study was performed to evaluate more thoroughly the 
changes in atrial size during pregnancy. Plasma concentrations of ANP were 
now studied longitudinally during pregnancy in relation to right and left atrial 
areas as well as to the left atrial diameter as measured by both M-mode and 
two-dimensional echocardiography. 
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MATERIAL AND METHODS 
The same study population was used as described in chapter 6.1. Right and 
left atrial area recordings were obtained by two-dimensional echocardiography. 
The left atrial transverse diameter was measured by M-mode (which results 
were also presented in chapter 6.1) as well as two-dimensional echocardiography. 
In two women however the two-dimensional echocardiographic recordings were 
unsuitable for further evaluation. Consequently the results presented in this chapter 
relate to the remaining twenty-one women. 
The two-dimensional echocardiographic atrial dimensions were ascertained at 
the same gestational periods as in the study presented in chapter 6.1, weeks 
32 and 38 being left out because it was expected that their inclusion would 
not provide additional relevant information. 
Statistical analysis 
Differences between the four weeks during pregnancy on the one hand and 
6 weeks post partum on the other, were analyzed by the Wilcoxon matched-
pairs signed-ranks test. The level of significance per comparison was now taken 
to be 0.025 as explained in chapter 3. 
RESULTS 
The results of the serial measurements of plasma ANP levels and atrial 
dimensions during pregnancy are shown in figure 6.2.1. Mean concentrations 
of ANP in plasma were significantly elevated at week 20, as compared with 
6 weeks after delivery. After the 20th week ANP levels were not significantly 
different from those 6 weeks post partum. Mean values of the areas of the 
right and left atrium and the left atrial diameter showed a gradual rise during 
gestation. Right and left atrial areas were significantly increased at the 36th 
week as compared with 6 weeks after delivery. Left atrial diameter was already 
significantly increased by week 20 of pregnancy. The increase continued through 
the 36th gestational week. 
Table 6.2.1 lists the pooled weighted means and the 95% confidence interval 
of the individual coefficients of correlation of ANP with the atrial dimensions 
(all correlations appeared to be homogeneous). ANP was neither significantly 
correlated with right or left atrial areas nor with the diameter of the left atrium. 
DISCUSSION 
As atrial wall tension seems to be the main determinant of ANP release, 
knowledge of any change in atrial dimensions is of importance for understanding 
ANP secretion during pregnancy. However, to date right atrial size during 
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Table 6 2 I Coefficients of correlations of ANP with atrial dimensions 
weighted mean 95 % confidence interval 
right atrial area -0 06 -061 ,053 
left atrial area 0 24 -0 36.0 70 
left atrial diameter -0 09 -0 56, 0 42 
left atrial diameter (M-mode) -0 07 -0 52,0 41 
pregnancy has never been studied at all and left atrial dimensions have only 
been assessed by M-mode echocardiography. 
In contrast to the pattern of change in ANP levels, right and left atrial areas 
as well as the diameter of the left atrium were all significantly increased in 
the third trimester of pregnancy. Neither of these atrial parameters appeared 
to be significantly correlated with the concentration of ANP in plasma, whereas 
in the non-pregnant state left atrial diameter and ANP concentration in the 
central circulation have been reported to be positively correlated (Rodeheffer 
et al., 1986). 
One explanation for the lack of correlation between plasma ANP and atrial 
size during pregnancy could be that the atrial dimensions were not measured 
correctly. However two-dimensional echocardiographic determination of atrial 
size is known to be highly correlated with angiocardiographic measurements 
(Gonska et al., 1984). Besides, in our study the increase in the diameter of 
the left atrium was demonstrated by two different techniques of echocardiography. 
Furthermore, such a rise in left atrial diameter (by M-mode echocardiography) 
has been previously reported by others as well (Katz et al., 1978; Robson et 
al., 1989). 
Another explanation could be that atrial size is an incomplete index for atrial 
stretching. The degree of atrial stretch is not only related to atrial dimensions 
but also depends on intracavitary atrial pressure and on atrial wall distensibility. 
These variables however can only be determined by invasive techniques. Right 
atrial pressure and pulmonary capillary wedge pressure during pregnancy have 
been reported to be within normal non-pregnant limits (Bader et al., 1955; Visser 
et al., 1987; Mashini et al., 1987). However no serial measurements have been 
made so far. An absence of rise in atrial pressure in the presence of an increase 
in circulating volume could be due to the functional enlargement of the maternal 
vascular bed, together with a structural increase in cardiac dimensions due to 
cardiac hypertrophy during pregnancy as reported by Robson et al. (1987b; 1989). 
A different explanation for ANP levels not to be continuously elevated in 
case of long term hypervolemia can be that atrial volume receptors are reset 
or have a decreased sensitivity during chronic atrial dilatation. This thought 
is supported by the observation that, in contrast to non-pregnant women, head 
out water immersion did not induce an increase in plasma ANP concentrations 
in pregnant women (Doniec-Ulman et al., 1987), assuming that this procedure 
will lead to an increase in central plasma volume during pregnancy as has been 
demonstrated in non-pregnant individuals (Greenleaf et al., 1981). 
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In rat pregnancy it has been shown that despite an increased intravascular volume 
of 70%, cardiac content of ANP is similar to that in virgin rats (Kristensen 
et al., 1986), which might suggest that the regulation of ANP secretion during 
pregnancy takes place around a new volume 'set-point'. 
In conclusion, our results show that plasma ANP concentrations during 
pregnancy are not related to atrial size. This might point at an altered mechanism 
of ANP secretion, which may be part of a physiological adaptive process to 
sustain the hypervolemia of pregnancy. 
6.3. ANP IN THE FIRST GESTATIONAL TRIMESTER 
INTRODUCTION 
To date only few data have been published with regard to measurements 
of plasma ANP levels during the first trimester of pregnancy. There are no 
studies in which early gestational ANP levels were compared with those before 
conception. 
In the present study ANP levels together with hematocrit values were studied 
in a longitudinal fashion starting before conception and extended to the 6th 
and 10th week of pregnancy. 
MATERIAL AND METHODS 
Thirty-five healthy women were included in the protocol after informed consent 
was obtained. The study was conducted within the frame of the research project 
'primary prevention of congenital anomalies (PPAA)' at the St Radboud Hospital. 
The experimental protocol was approved by the committee on human exper-
imentation of the University Hospital St Radboud. Six women failed to conceive 
and four women were excluded from the study because of spontaneous abortions. 
So twenty-five women remained for further evaluation. Seventeen of them were 
nulliparous. The mean age was 26 years (range 19-35 years). 
Serial measurements of plasma ANP concentrations and hematocrit were made 
once before conception (range 1-5 months; not standardized for the day of the 
cycle) and subsequently during the 6th and 10th gestational week. Blood samples 
were taken in left lateral position after 15-30 min of rest. 
Differences between the two weeks during the first gestational trimester on 
the one hand and in the preconceptional period on the other were analyzed 
by the Wilcoxon matched-pairs signed-ranks test. P-values were considered 
significant at the 0.05 level. Correlations between the changes in the concen-
trations of ANP and hematocrit values (preconception versus 10th gestational 
week) expressed in percentages were determined by calculation of the Spearman 
correlation coefficient (r). 
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week Bars represent the SEM Asterisks (*) indicate significant differences from 
preconceptional values *p<0 05, **p<0 01 
RESULTS 
The results of the serial measurements of ANP and hematocrit are shown 
in figure 6.3.1. 
ANP levels were significantly higher whereas hematocrit values were sig-
nificantly lower during the 1 Oth gestational week as compared with preconception. 
The mean increase in ANP was 46 % (range -43, 267 %) and the mean decrease 
in hematocrit was 6 % (range -6, 27 %). The proportional changes of plasma 
ANP concentrations and hematocrit values were not significantly correlated (r=-
0.06, p=0.80). 
DISCUSSION 
Already during the embryonic period of pregnancy impressive maternal 
cardiovascular adaptations take place. Plasma volume, stroke volume, heart rate 
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and cardiac output are significantly increased by week 8 of gestation (Clapp 
et al., 1988; Robson et al., 1989). 
ANP levels showed a gradual increase during this period of pregnancy, reaching 
significantly higher values at the 10th gestational week as compared to those 
before conception. These are the first serial data on ANP concentrations in early 
pregnancy. In a cross-sectional study Thomsen et al. (1988) reported elevated 
first trimester ANP levels as well, whereas others found no significant differences 
as compared to non-pregnant controls (Grace et al., 1987; Bond et al., 1989; 
Jackson et al., 1987; Hirai et al., 1988; Stratta et al., 1988; Marlettini et al., 
1989). 
It is tempting to speculate that the increase in ANP levels is related to the 
rise in circulating volume which might cause atrial pressure and atrial wall stretch 
to increase. Although hematocrit values showed a significant decline the mag-
nitude of changes in ANP and hematocrit were however not significantly 
correlated. 
This can mean either that the increase in plasma volume is not the prime 
determinant of the rise in ANP, or that hematocrit by itself does not proportionally 
represent the size of plasma volume. It is likely that red cell mass increases 
as well during this period (Hytten 1985). 
The physiological meaning of rising ANP levels in early pregnancy remains 
unelucidated. In view of the effects of this peptide some involvement in the 
early decrease in systemic vascular resistance and blood pressure (Clapp et al., 
1988) or the 40-50% increase in glomerular filtration rate and renal plasma 
flow (Atherton and Green, 1983) can not be ruled out. 
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Chapter 7 
INDICATIONS OF EXTRA-CARDIAC ATRIAL 
NATRIURETIC PEPTIDE SECRETION 
7.1. IMMUNOREACTIVITY OF ANP IN AMNIOTIC FLUID 
INTRODUCTION 
Although it was first believed that the synthesis and secretion of ANP was 
confined to the atrial myocytes, there is growing evidence that these processes 
occur also in other parts of the body (Gardner et al., 1986). 
Martin et al. (1988), using a direct assay, reported that amniotic fluid contains 
detectable levels of ANP, which might point at a site of ANP production in 
the placental unit. However, the direct assay is subject to interference from non-
specific substances (Poole et al., 1988). Furthermore they did not measure 
simultaneous ANP concentrations in plasma. 
We tried to reproduce these findings by measuring ANP-immunoreactivity 
in mid-trimester amniotic fluid as well as in amniotic fluid obtained during term 
delivery, and measured plasma ANP concentrations simultaneously. In order 
to assess the possibility that in amniotic fluid it was not ANP corresponding 
to plasma (99-126)hANP that was being measured (but some other molecular 
form of ANP), we compared the immunoreactive profile of ANP in amniotic 
fluid, using high pressure liquid chromatography (HPLC) analysis, with that in 
plasma. 
MATERIAL AND METHODS 
Study-population 
In twelve healthy women (seven nulliparas) who underwent amniocentesis 
for genetic diagnostic reasons between 15 and 17 weeks of gestation, samples 
of amniotic fluid and maternal blood were obtained. Amniotic fluid was also 
collected in another group of nine women (six nulliparas) during artificial rupture 
of membranes during the first stage of labour (38-41 weeks of pregnancy). All 
amniotic fluid samples were (macroscopically) free of blood contamination. The 
mean age (±SD) in these groups was respectively 34.0 ± 4.8 and 28.9 ± 4.3 
years. Neonatal outcome was normal in all women. 
In both groups maternal blood was obtained immediately following the 
collection of amniotic fluid after 5 minutes rest in left lateral position. The handling 
of amniotic fluid prior to radioimmunoassay was similar to that of plasma. 
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Figure 7 1 1 Concentrations of atrial natriuretic peptide in plasma and amniotic fluid during the 
2nd trimester of pregnancy (by amniocentesis) and during the first stage of term delivery 
Horizontal bars represent the means 
The immunoreactive profile of ANP in amniotic fluid and plasma was studied 
by using HPLC analysis. For this purpose two amniotic fluid samples were 
obtained from two different women during the first stage of labour after uneventful 
pregnancy. The profile of ANP m plasma from a pregnant woman (for this 
profile also see chapter 5) was taken as control. 
Statistical analysis 
The significance of the difference between ANP levels in mid-trimester and 
term amniotic fluid was tested by the Wilcoxon-Mann-Whitney two-sample test 
with 0.05 as the level of significance. Possible relations between corresponding 
ANP levels in amniotic fluid and plasma were evaluated by determination of 
the Spearman coefficient of correlation (r). 
61 
RESULTS 
ANP-immunoreactivity could be demonstrated in amniotic fluid obtained by 
mid-tnmester amniocentesis as well as in amniotic fluid collected during delivery 
(figure 7.1.1). 
Amniotic ANP levels in every woman from both groups were lower than 
the corresponding maternal plasma concentrations. ANP levels in amniotic fluid 
during delivery were significantly higher than those in fluid obtained by mid-
trimester amniocentesis (p<0.01). 
No significant correlation was found between ANP levels in plasma amniotic 
fluid in the mid-trimester group of women (n=12, r—0.33, p=0.70). Amniotic 
and plasma ANP concentrations appeared to be significantly inversely correlated 
during delivery (n=9, r=-0.67, p=0.0499). 
A representative HPLC-profile of ANP-immunoreactive material in amniotic 
fluid is shown in figure 7.1.2. Amniotic fluid did not exhibit the major peak 
in plasma corresponding to (99-126)hANP. 
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Figure 7 1 2 Representative HPLC-profiles of ANP in amniotic fluid and plasma 
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DISCUSSION 
Immunoreactive-ANP was detected in all amniotic fluid samples. Concen-
trations of ANP in amniotic fluid were low in relation to those in plasma, although 
significantly higher during delivery than in mid-pregnancy. ANP levels were 
considerably lower than those reported by Martin et al. (1988), which ranged 
from 456 to 2768 pg/ml. The difference may be due to the fact that Martin 
et al. did not include an extraction step prior to radioimmunoassay. 
The nature and the origin of this immunoreactive material however is as yet 
unknown. The results of HPLC-analysis indicate that (99-126)hANP, the main 
immunoreactive component in human plasma, does not substantially contribute 
to the ANP-immunoreactivity in amniotic fluid. This may point at the presence 
of other molecular forms of ANP in this fluid compartment. 
The finding that levels in plasma are not positively correlated to those in 
amniotic fluid makes placental transfer of maternal ANP unlikely. No satisfactory 
explanation was found to account for the significant inverse relationship between 
concentrations of ANP in corresponding samples of plasma and amniotic fluid 
during delivery. 
As Craig et al. (1987) reported the production of ANP by placental cultures, 
a placental origin of some molecular form of ANP can not be ruled out. ANP 
is known to be a circulatory hormone in the human fetus as well (Yamaji et 
al., 1986; Robillard et al., 1988; Weiner et al., 1988; Gardner et al., 1989; Panos 
et al., 1989). Therefore, in theory, immunoreactive forms may also originate 
from the fetal urine, as has been shown in sheep by Cheung et al. (1987). The 
analyzed amniotic peptide may then be a residual plasma form, cleared from 
blood by the fetal kidney, or a polypeptide produced in the fetal kidney tubules 
as such a peptide called urodilatin, corresponding to (95-126)hANP has been 
extracted from human urine (Schulz-Knappe et al., 1988). 
To conclude, amniotic fluid shows signs of ANP-immunoreactivity, which may 
be due to other molecular forms than (99-126)hANP, the main immunoreactive 
component of ANP present in plasma. 
7.2. IMMUNOREACTIVITY OF ANP IN OVARIAN FOLUCULAR FLUID 
INTRODUCTION 
In addition to the well known natriuretic, diuretic and vasorelaxant activities, 
ANP also appears to exert endocrine functions, including the modulation of 
steroid synthesis in a variety of steroidogenic tissues. ANP has been shown to 
inhibit aldosterone synthesis in adrenal glomerulosa cells (Kudo and Baird, 1984), 
and to stimulate testosterone production in mouse Leydig cells (Mukhopadhyay 
et al., 1986). 
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Next to the adrenal cortex and the testis, the ovary is an important site of 
steroidogenesis (Savard et al., 1965). Both immunoreactive ANP as well as ANP 
receptors have been identified in the corpus luteum (Vollmar et al, 1988; Kim 
étal., 1987). 
If the ovary is capable of ANP synthesis and secretion, one should expect 
ANP to be present in human ovarian follicular fluid. To our knowledge, this 
has not yet been reported. 
Rat ANP has been shown to stimulate progesterone secretion in cultured human 
granulosa-lutein cells (Pandey et al., 1987). Therefore, in theory, ovarian ANP 
could play a modulating role in the progesterone synthesis in the human 
preovulatory follicle as well. 
In view of these findings we carried out an investigation to determine whether 
ANP-immunoreactivity is present in preovulatory ovarian follicular fluid and 
whether follicular ANP levels hold any relation with follicular progesterone 
concentrations. 
MATERIAL AND METHODS 
Population 
In 15 otherwise healthy women in an in vitro fertilization program samples 
of blood and ovarian follicular fluid were obtained. The mean age (±SD) was 
32.9 ± 3.9 years. The experimental protocol was approved by the committee 
on human experimentation of the University Hospital St Radboud. In 10 patients 
(No. 1-7,13,14,15) follicular development was stimulated with clomiphene citrate 
(ClomidR, Merrill Dow Pharmaceuticals Ltd.,Staines, UK) 100 mg daily for cycle 
days 3 through 7, and with human menopausal gonadotrophin (HumegonR, 
Organon, Oss, The Netherlands) 150IU daily intramuscularly from day 6 onwards. 
In the other 5 women (No. 8-12) pituitary suppression was performed with 
Buserelin11 (Hoechst (UK) Ltd., Hounslow, Middlesex, UK) 900 μg daily by nasal 
spray from day 1 onwards and follicular development stimulated with HumegonR 
225 IU daily intramuscularly from day 3 onwards. In all patients 10.000 IU 
human chorionic gonadotrophin (PregnylR, Organon, Oss, The Netherlands) were 
administered intramuscularly 34-36 hours before follicle puncture. Follicular 
fluid was recovered by the transvaginal route, using ultrasound guidance. Samples 
with obvious blood contamination were not assayed. In twelve patients (No. 
1-12) fluid samples aspirated from more than one follicle were put together 
before analysis. In three women (No. 13,14,15) fluid samples from respectively 
4, 3 and 8 follicles were collected separately. Estimates of follicular diameter 
were grouped as 11-15, 16-20, 21-25, 26-30, 31-35 mm. Venous blood samples 
were taken after the procedure when the women had been at rest for 30 minutes 
in supine position. 
The handling of follicular fluid prior to radioimmunoassay was similar to that 
of plasma. 
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Statistical analysis 
Correlations were evaluated by determination of the Pearson's coefficient of 
correlation (r). 
RESULTS 
As shown in table 7.2.1, in all women ANP-immunoreactive material was found 
in ovarian follicular fluid, ranging from 3.3 - 60.1 (median 7.8) pg/ml. Plasma 
ANP levels ranged from 28.9 - 120.0 (median 47.0) pg/ml. In contrast to all 
other women, one patient (No. 4) showed a higher ANP level in follicular fluid 
than in plasma. Follicular progesterone concentrations were higher compared 
to those in plasma. 
No significant correlation was found between ANP levels in corresponding 
plasma and follicular fluid samples (n= 10, r—0.17, p=0.64). Neither a significant 
correlation could be demonstrated between plasma ANP concentrations and 
follicular progesterone levels (n=9, r=0.40, p=0.29) nor between follicular ANP 
and follicular progesterone levels (n=l 1, r=-0.53, p=0.10). 
Table 7.2.2 shows ANP and progesterone concentrations as measured in 15 
fluid samples, each derived from one follicle. In both patients in which follicular 
diameters were measured (No. 14,15), highest ANP levels were found in the 
largest follicles. The individual results in each woman do not suggest a relation 
between follicular ANP and follicular progesterone levels. 
DISCUSSION 
As no correlation was found between plasma and follicular ANP concentrations, 
transfer from plasma to follicle is questionable, however can not be ruled out. 
This suggests that follicular ANP could have its origin in the ovary itself. Ovarian 
secretion of ANP could explain the observation in one woman of higher ANP 
levels in follicular fluid than in plasma, and the occurrence of highest ANP 
levels in the largest follicles. Hence, the human ovary could well be a site of 
ANP secretion. Supporting evidence is provided by the recent finding that ANP-
immunoreactivity is also present in follicular fluid of pig ovarian follicles (Kim 
et al., 1989). 
The physiological significance of ovarian ANP-immunoreactivity is as yet 
unknown. If follicular ANP concentrations reflect ovarian ANP synthesis, then 
our results do not suggest a linear relationship between ovarian ANP and 
progesterone secretion. As known there is asynchrony in follicular development, 
and accordingly the pattern of steroid synthesis differs in many follicles (Fowler 
et al., 1978), which explains the differences in follicular progesterone concen-
trations as found in our study. This might also explain the lack of correlation 
between follicular ANP and progesterone preovulatory, as it is not known how 
ovarian ANP activity changes throughout follicular development up to ovulation. 
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Table 7.2.1. Concentrations of ANP (pg/ml) and progesterone (P, nmol /I) in follicular fluid and 
plasma 
Patient No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Follicular fluid 
ANP 
4 9 
5 2 
16.0 
60.1 
7.0 
3.3 
24.0 
10.5 
8 6 
5 2 
8.9 
4.9 
Ρ 
16329 
15150 
22147 
1651 
21680 
20565 
1633 
39329 
11884 
48353 
15382 
--
Plasma 
ANP 
34.5 
28.9 
52.9 
35.1 
65.6 
— 
--
120 0 
50.5 
43.7 
90.2 
41.6 
Ρ 
16.3 
24 8 
4 3 
— 
7.6 
.-
--
30 1 
14.3 
— 
198 
14.3 
Table 7.2.2. Concentrations of ANP (pg /ml) and progesterone (P, nmol /1) in fluid from 15 separate 
follicles. 
Patient No. Follicular fluid 
No Diameter (mm) ANP 
13 
14 
15 
1 
2 
3 
4 
I 
2 
3 
1 
2 
3 
4 
5 
6 
7 
8 
;; 
— 
--
21-25 
11-15 
11-15 
31-35 
26-30 
21-25 
16-20 
16-20 
16-20 
16-20 
11-15 
4.3 
8.8 
6.0 
4.0 
8.0 
4.3 
5 7 
127 
10.0 
8.4 
7.8 
8.1 
7.0 
5 7 
88 
11373 
8997 
23558 
33158 
3581 
19876 
13960 
47093 
22827 
35925 
24186 
37241 
49363 
39845 
49077 
Next to influencing ovarian steroidogenesis, ANP could also play a role in the 
control of follicular fluid homeostasis in which it may interact with the local 
renin-angiotensin system, known to be present in the ovary (Derkx et al., 1987a; 
Palumbo et al., 1989) as well. 
Further studies are required to understand both the physiological significance, 
the regulating factors of secretion, the molecular forms and the exact origin 
of ovarian ANP. 
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The speculation that the ovary in some way could be involved in determining 
ANP concentrations during pregnancy as well is not illegitimate as such 
comparable involvement has been made likely with regard to some components 
of the renin-angiotensin system (Derkx et al. 1987b; Sealey et al., 1987a). 
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PART ΠΙ 
THE NORMAL PUERPERIUM 
Chapter 8 
ELEVATED LEVELS OF ATRIAL NATRIURETIC 
PEPTIDE IN THE EARLY PUERPERIUM 
INTRODUCTION 
Normal pregnancy is characterized by impressive physiological maternal 
cardiovascular changes. The volume expansion of extracellular fluid with 6 to 
8 litres occurs simultaneously with a gradual retention of approximately 900 
mmol of sodium (as described in chapter 2). 
After delivery the homeostasis of sodium and volume has to adapt to the 
non-pregnant state in a relatively short time. This process of adaptation is 
accompanied by impressive hemodynamic changes (Robson et al., 1987a, 1987b), 
enhanced diuresis (Davison and Dunlop, 1984) and natriuresis (Chesley et al., 
1959). The mediating hormonal mechanisms, however, are still largely unknown. 
One factor that may be involved is atrial natriuretic peptide as it is considered 
to be a major contributor to the cardiovascular control of volume homeostasis 
(chapter 2). 
Therefore in a first, orientating study plasma ANP levels were serially studied 
throughout the puerperium. Simultaneous measurements were made of hema­
tocrit, plasma renin activity and aldosterone. 
A second study, performed on a different group of women, was initiated to 
assess relations between post partum hormonal changes and puerperal natriuresis 
and diuresis. Its results are presented in chapter 9. 
MATERIAL AND METHODS 
Study population 
Eleven healthy nulliparous women, who intended to breast feed after delivery, 
were included in the study during the third trimester of pregnancy after informed 
consent was obtained. They had uneventful, normotensive pregnancies. Two 
women were excluded from further evaluation; one required a caesarean section 
because of cephalopelvic disproportion while the other woman experienced post 
partum haemorrhage (1500 ml). 
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The remaining nine women vaginally delivered healthy appropriate for gestational 
age infants at term (37-41 weeks). The mean age (± SD) was 27 + 5 years. 
Neither epidural anaesthesia nor intravenous fluid administration were required 
during parturition. Estimated blood loss at delivery in these women was lower 
than 600 ml. They all were breast feeding up to the 6th week after delivery. 
Blood was collected once during late pregnancy (mean 268, range 251-281 
gestational days) and serially throughout the puerperium starting within 24 hours 
after delivery (mean 18 hours, range 13-22 hours post partum). Subsequent 
measurements were made on days 2, 4, 6, 10, 14, 21, 28 and 42 post partum 
at approximately the same time of day (between 0800 and 1200 hours am). 
Venous blood samples were taken when the women had been at rest for at 
least 10 min in left lateral position. 
In contrast to the methodology used in the other studies in this thesis (described 
in chapter 3), plasma renin activity (PRA) in this particular study was measured 
using the Phadebas Angiotensin I test (Pharmacia Diagnostics, Sweden), whereas 
concentrations of aldosterone in plasma were measured with a direct radioim-
munoassay (De Man et al., 1980). 
Statistical analysis 
Differences between the measurements in late pregnancy and the puerperium 
on the one hand and those on the 42nd day post partum on the other were 
analyzed by the Wilcoxon matched-pairs signed-ranks test. The level of sig-
nificance per comparison was taken to be 0.011 (for explanation see chapter 3). 
RESULTS 
The results of the serial measurements of ANP, plasma renin activity, 
aldosterone and hematocrit are presented in figure 8.1. No statistically significant 
difference was found between ANP levels in late pregnancy and those 42 days 
post partum, which confirms the previous observations discussed in chapter 6.1. 
ANP levels, however, were significantly elevated during the first two puerperal 
days. 
Plasma renin activity and aldosterone concentrations were significantly elevated 
during pregnancy. Following delivery they showed a rapid decline towards levels 
not different from those 6 weeks afterwards. Hematocrit values decreased 
immediately after delivery followed by a rise after the 2nd puerperal day. However, 
hematocrit remained significantly lower up into the 3rd puerperal week as 
compared with values 42 days post partum. 
Correlation coefficients of ANP with hematocrit, plasma renin activity and 
aldosterone are presented in table 8.1. ANP was significantly correlated with 
hematocrit values during the first six puerperal days. 
However, during late puerperium (days 10-42 post partum) this interdepen-
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Table 8 1 Correlation coefficients of ANP with hematocrit, plasma renin activity (PRA) and 
aldosterone in early (days 1 -6 post partum) and late puerpenum (days 10-42 post partum) 
ANP - Hematocrit 
ANP -PRA 
ANP - Aldosterone 
days 1 - 6 
post partum 
-0 75* 
(-0 87,-0 54) 
-0 38* 
(-0 65,-0 02) 
-0 12 
(-047.0 25) 
days 10-42 
post partum 
-0 04 
(-0 35,0 28) 
-0 32* 
(-058,-001) 
-0 34* 
(-0 60,-0 03) 
Results are weighted means with 95% confidence intervals given in parenthesis * p<0 05 
dency disappeared. Throughout the puerperium, ANP was inversely correlated 
with plasma renin activity. ANP and aldosterone were only significantly correlated 
during the late puerperium. 
DISCUSSION 
This study demonstrates that maternal plasma ANP levels are elevated during 
the first few days post partum which confirms earlier observations by Rutherford 
et al. (1987). 
They compared one plasma ANP determination 3-5 days post partum with 
the mean of 4 serial measurements during pregnancy from the second trimester 
onwards. They however did not investigate the course of ANP levels throughout 
the puerperium. 
Since the initial publication of our findings (Steegers et al., 1987a,1987b), 
five studies from other workers have appeared. In two longitudinal investigations 
(Malatino et al., 1988; Duprez et al., 1989) a clear increase in ANP levels was 
found as well somewhere during the first five days post partum. Others found 
no significant change in ANP concentrations in the early puerperium (Shrivastav 
et al., 1988; Milson et al., 1988; Bond et al., 1989). Two of them however 
compared cross-sectional data (Shrivastav et al., 1988; Bond et al., 1989). 
Although cardiac output and stroke volume increase during labour and delivery 
(Kjeldsen 1979; Robson et al., 1987c) the post partum increase in ANP probably 
cannot be attributed to these events. In seven out of the nine women highest 
ANP levels did not occur on the first day after delivery. Moreover the plasma 
half-life of (99-126)hANP is 3.1 minutes (Yandle et al., 1986), so that an increase 
during labour will soon be diminished. 
Plasma volume is known to increase in early puerperium (McLennan and 
Lowenstein, 1959; Landesman and Miller, 1963).This is probably caused by 
a shift of interstitial body fluid, accumulated during pregnancy, from the 
extravascular space into the circulation. The factors initiating this 'release' of 
fluid from the interstitium are as yet unknown. It is probable that the increased 
concentrations of estrogens during pregnancy contribute to a structural change 
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in the ground substance of connective tissue, which enables the interstitium to 
contain more water (Hytten 1980). The sudden withdrawal of placental estrogens 
post partum may therefore be involved in liberating the excessive interstitial 
fluid. The shift of this fluid into the circulation results in the decrease in hematocrit 
values, a phenomenon also observed by others (Taylor et al., 1981). This fluid 
shift may also explain the significant inverse correlation between ANP and 
hematocrit values during the first week after birth. An increase in venous return 
can lead to a rise in intracavitary atrial pressure, atrial stretch and hence ANP 
secretion. The described chain in events is in accordance with the observation 
by Robson et al. (1987d) that left atrial dimensions 24 and 48 h after delivery 
are larger than during late pregnancy as well as 2 weeks post partum. 
Hematocrit values in the 3rd puerperal week were still lower as compared 
to 6 weeks post partum. This suggests that plasma volume remains expanded 
over that period of time. ANP levels, however, did not remain elevated after 
the first puerperal days and no correlation with hematocrit values could be 
demonstrated from the 10th up to the 42nd day. One might speculate that the 
chronically elevated intravascular volume during the puerperium causes a change 
in the relationship between volume, atrial volume receptors and ANP secretion 
similar to the situation during pregnancy (chapter 6.2). 
Plasma renin activity and aldosterone were significantly increased during 
pregnancy as compared with 6 weeks post partum, pointing at an enhanced 
activity of the renin-angiotensin-aldosterone system. This is a well known 
phenomenon during pregnancy (Symonds 1981). Both components of the system 
showed a rapid decline after delivery. 
ANP can be considered to be a functional antagonist of the renin-angiotensin-
aldosterone system (Atlas and Laragh, 1986). As puerperal ANP levels were 
significantly inversely correlated with PR A and to a lesser extend with aldosterone 
concentrations, the increase in ANP after delivery may also be involved in a 
quick fall post partum of the components of the salt conserving renin-aldosterone 
system. 
The physiologic relevance of high ANP levels after delivery is still unknown, 
although one could speculate that enhanced natriuretic and diuretic ANP activity 
as well as such an interplay with the renin-aldosterone system might be related 
to the puerperal excretion of fluid and sodium, accumulated during pregnancy. 
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Chapter 9 
HORMONAL CONTROL OF NATRIURESIS AND 
DIURESIS IN THE NORMAL PUERPERIUM 
INTRODUCTION 
The growth of the fetoplacental unit induces profound changes in the hormonal 
systems controlling the homeostasis of sodium and volume. The salt-conserving 
renin-aldosterone system is markedly stimulated (Symonds 1981), whereas the 
placental production of progesterone might promote natnuresis (Ehrlich et al., 
1962; Kleinhout and Eskes, 1971). Furthermore atrial natriuretic peptide (ANP) 
may be involved as has been discussed in chapter 6.1. 
Delivery brings about a sudden withdrawal of the humoral factors of feto-
placental origin. This necessitates a resetting of the homeostasis of sodium and 
volume in a relatively short time. The subsequent physiological changes are 
only studied fragmentarily so far. 
The present study was undertaken to investigate body weight, blood pressure, 
plasma concentrations of sodium, ANP, progesterone and various components 
of the renin-aldosterone system as well as natriuresis and diuresis during the 
first week after delivery of the fetoplacental unit. 
MATERIAL AND METHODS 
Clinical Studies 
Nine healthy primiparous women (age, 20-31 yr) were included in the study 
after informed consent was obtained. They had uneventful normotensive singleton 
pregnancies and vaginally delivered healthy appropriate for gestational age infants 
at term (39-42 weeks). Neither epidural anaesthesia nor intravenous fluid 
administration were required during parturition. Estimated blood loss at delivery 
ranged from 300 to 750 ml (mean 490 ml). All women were breast feeding 
up to the 6th week after delivery. 
Women were studied daily between 8.00 and 12.00 a.m. during the first seven 
days after delivery and again 6 weeks post partum. After 15-30 min rest in 
left lateral position the blood pressure was taken on the right arm with a 
sphygmomanometer. Diastolic blood pressure was recorded at the phase IV 
Korotkoff sound. Then blood (25 ml), in the same position, was withdrawn from 
the right cubital vein. The first blood sample was obtained within 24 hours 
after delivery (mean 15 hours, range 5 - 23 hours post partum). 
The following parameters in blood were studied; hematocrit, sodium, atrial 
natriuretic peptide (ANP), renin (enzymatically active), prorenin which is the 
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inactive precursor (zymogen) of renin, renin substrate (angiotensinogen), plasma 
renin activity, aldosterone and progesterone. 
Daily collection of 24 h urine specimens was started the morning after delivery 
at 8.00 a.m. (mean 13 hours, range 2 - 24 hours post partum). In addition 
the daily amount of fluid intake was recorded in a standardized manner. 
Values of body-weight, blood pressure, hematocrit, and plasma sodium during 
the last 2 weeks of pregnancy were obtained retrospectively from the patient 
charts. To be able to compare puerperal hormone concentrations with those 
in pregnancy, 30 normotensive nulliparous women (maternal age, 20-30 yr) 
in late pregnancy (36-39 weeks) acted as controls. 
Additional hormone measurements were made in 30 normal non-pregnant 
women (age, 20-38 years) between the 1st and 12th day of the menstrual cycle. 
None of these subjects had used a hormonal method of contraception and none 
had been pregnant for at least one year. In this way puerperal hormone values 
6 weeks after delivery could be compared with those in the non-pregnant state. 
Statistical analysis 
Within patient differences between the seven puerperal days and 6 weeks 
post partum were analyzed by the Wilcoxon matched-pairs signed-ranks test. 
The level of significance per comparison was taken to be 0.014 (see chapter 
3). Comparisons between the control groups of pregnant and non-pregnant women 
were made using the Wilcoxon-Mann-Whitney two-sample test. 
RESULTS 
Blood pressure, body weight, hematocrit and plasma sodium 
As shown in figure 9.1 systolic and diastolic blood pressure were higher during 
several days after delivery as compared to 6 weeks post partum. After delivery 
maternal weight continued to decrease, however, it remained elevated throughout 
the first puerperal week. The difference in weight between that of late pregnancy 
and as measured on day 1 was on average 3.9 kg larger than could be accounted 
for by the expulsion of the child and placenta and the blood loss during delivery. 
Hematocrit values decreased after delivery and remained significantly lower 
throughout the first week. Plasma sodium concentrations, on the other hand, 
reached higher mean values on days 3, 4 and 5 than those 6 weeks after de-
livery.These differences, however, were not statistically significant. 
ANP, renin, renin substrate, PRA, aldosterone and progesterone 
The results of serial hormone measurements during the first seven days after 
delivery and 6 weeks post partum together with pregnant and non-pregnant 
75 
Blood pressure(mmHg) -
lio-
so 
70 
50-
V 
¿-Ч^Ч^ч 
systolic 
Л ч - ^ > ^ 
Y diastolic 
* - ^ 
0 ι 1 ι 1 1 1 1 1 1 
Hematocrit (·/.) 
38 
36 
34-
32 
Maternal body weight (kg) -
72 
68 
64-
60 
oï 
· — i , 
--* 
—ι ι 1 1 1 1 1 1 
Plasma sodium (mmol/l) 
140 
13Θ 
136-
134 
!-*>* 
0 ^ ι 1 ι 1 1 1 1 1 1 —r- 0 ι 1 ι 1 1 1 1 1 1 _ — ι - , 
preg- 1 2 3 4 5 6 7 6 weeks preg- 1 2 3 4 5 6 7 6 weeks 
nancy days post partum post nancy days post partum post 
partum partum 
Figure 9 1 Mean values of systolic and diastolic blood pressure, weight, hematocrit and plasma 
sodium during late pregnancy, the first puerperal week and б weeks post partum Bars 
represent the SEM Weight immediately after delivery (+) was calculated as the difference 
between weight recorded during late pregnancy and the sum of weights of child and 
placenta and estimated blood loss during delivery Asterisks (*) indicate significant 
differences from values 6 weeks post partum 
control values are presented in figure 9.2. Gestational plasma concentrations 
of ANP (p<0.01), aldosterone (p<0.01), renin (p<0.01), and progesterone 
(p<0.01) as well as plasma renin activity (p<0.01) were significantly elevated 
as compared to non-pregnant control values. 
Early puerperal values of ANP were significantly elevated on the 2nd day 
post partum. Plasma levels of progesterone and all components of the renin-
aldosterone system decreased during the first puerperal week. Renin and 
aldosterone levels fell within 24 h towards concentrations not significantly 
different from those 6 weeks post partum. Prorenin and renin substrate con­
centrations also diminished after delivery but remained significantly elevated 
throughout the first puerperal week. Plasma renin activity was still significantly 
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elevated on day 2. Progesterone reached levels not significantly different from 
those 6 weeks after delivery on day 3. 
Mean hormone values 6 weeks post partum all fell within the 95% confidence 
interval of normal non-pregnant control values. 
Diuresis and natriuresis 
Urine variables during respectively the first week and 6 weeks after delivery, 
are shown in table 9.1. Median values of 24 h urinary volume were higher 
during most of the first 7 days after delivery as compared to 6 weeks post 
partum, however, these differences were not statistically significant. The intake 
of fluid was significantly lower on the 3rd day post partum. The calculated 
difference between fluid intake and urinary volume (fluid balance) was signif-
icantly smaller during several days. Sodium excretion expressed as mmol sodium 
per day as well as sodium /creatinine ratio showed no significant differences 
although median values from the 2nd day onwards were higher as compared 
to 6 weeks post partum. As all women showed a marked increase in diuresis 
and natriuresis on one of the 7 puerperal days, table 9.1 also shows the median 
and range of the individual extreme values of 24 h urinary volume, fluid balance 
and sodium excretion. 
Correlation coefficients of hormonal plasma concentrations with urinary 
parameters are depicted in table 9.2. Twenty-four h sodium excretion and the 
sodium /creatinine ratio were significantly, inversely correlated with renin, plasma 
renin activity, aldosterone and progesterone. The difference between fluid intake 
and urinary volume was significantly correlated with ANP, renin and plasma 
renin activity, whereas in relation to aldosterone and progesterone no significant 
correlations could be demonstrated. Twenty-four h urinary volume was not 
significantly correlated with any of the hormones. 
DISCUSSION 
Compared with those of non-pregnant controls, plasma levels of ANP, renin, 
prorenin, renin substrate, aldosterone and progesterone as well as plasma renin 
activity were significantly elevated during pregnancy, which confirms findings 
previously reported in the literature (Wilson et al., 1980; Oats et al., 1981; Hsueh 
et al., 1982; Dörr et al., 1989; for ANP references see chapter 4). 
Hormonal concentrations during the early puerperium showed marked alter-
ations. Plasma ANP levels increased during the first few days post partum which 
is in agreement with our previous observations (chapter 8). As discussed before 
the rise in ANP is probably caused by a shift of extravascular interstitial fluid 
into the circulation, which subsequently leads to the observed decrease in 
hematocrit values. Such an autogenous water load, leading to acute hypervolemia 
in the early puerperium may, in conjunction with a return of vascular tone -
Table 9 1 Urine variables during the 1st week post partum 
Variable 
Unnary 
volume (ml) 
Fluid 
intake(ml) 
Fluid 
Balance(ml) 
Unnary 
sodium 
(mmol /day) 
Sodium/ 
creatinine 
ratio 
1 
1 
1470 
(835,2300) 
1950 
(1050,2475) 
270 
(-125,1255) 
97 
(40,157) 
109 
(29,135) 
2 
1350 
(660,2075) 
2050 
(1325,2425) 
690 
( 150,1360) 
134 
(38,218) 
100 
(3 2,17 4) 
days post partum 
3 
1385 
(680,2120) 
1375* 
(1250,2200) 
75* 
(-535,1540) 
150 
(75,284) 
139 
(5 9,20 0) 
4 
1370 
(770,3215) 
1800 
(950,3175) 
215 
( 180,2365) 
136 
(99,258) 
128 
(8 2,18 6) 
5 
1355 
(970,2050) 
2050 
(775,2400) 
510* 
( 915,1615) 
136 
(76,324) 
12 1 
(5 3,22 7) 
6 
1085 
(600,1895) 
1825* 
(1025,2625) 
455* 
( 60,1605) 
150 
(94,197) 
119 
(7 7,24 0) 
7 
1405 
(600,1895) 
2250 
(1050,2950) 
745 
(285,1525) 
130 
(87,152) 
114 
(7 1,189) 
median and range 
of individual 
extreme values 
dunng the 1 st week 
post partum 
1860a 
(1285,3215) 
1350ь 
(775,1850) 
I25 b 
(-915,285) 
205a 
(133,324) 
19 2a 
(9 9,24 0) 
6 weeks 
post partum 
1135 
(790,1960) 
2000 
(1650,2900) 
785 
(440,2110) 
125 
(56,187) 
107 
(5 1,172) 
Results are median values (range is presented in parenthesis) Results of 24 h urine determinations are presented below the day urine collection 
was started 
Asterisks (*) indicate significant differences from 6 weeks post partum 
a, highest individual values, b, lowest individual values 
00 
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Table 9 2 Correlation coefficients of plasma hormone concentrations with unnary variables as 
measured dunng the first week post partum. 
ANP 
renin 
prorenin 
plasma renin 
activity 
renin substrate 
aldosterone 
progesterone 
UNa 
018 
(-0 14,0 47) 
-0 62* 
(-0 79,-0 37) 
-0 26 
(-0 54,0 07) 
-0 57* 
(-0.76,-0 31) 
-0 13 
(-0 44,0 20) 
- 0 3 1 * 
(-0 57,0 00) 
-0 33* 
(-0 58,-001) 
UNa/UCr 
0 17 
(-0 15,0 46) 
-0 63* 
(-0 79,-0 38) 
-0 39* 
(-0 63,-0 08) 
-0 60* 
(-0 77,-0 34) 
-0 26 
(-0 54,0 07) 
-0 34* 
(-0 60,-0 03) 
-0 39* 
(-0 63,-0 09) 
FI-UVol 
-031* 
(-0 57,-0 01) 
0 49* 
(0 20,0 70) 
-0 09 
(-0 40, 0 24) 
0 42* 
(0 11,0 65) 
-0 22 
(-0 51,0 11) 
0 28 
(-0 04,0 55) 
-0 06 
(-0 37,0 26) 
UVol 
0 26 
(-0 06,0 53) 
-0 20 
(-0 49,0 14) 
-0 59,0 98» 
-0 22 
(-0.51,0 11) 
0 29 
(-0 03,0 56) 
0 03 
(-0 29,0 34) 
-0.86,0 86» 
Results are weighted means (95 % confidence interval in parenthesis) *p<0 05 In case correlation 
coefficients were not homogeneous only the range of Pearson's coefficients is presented (#) UNa, 
24 h urinary sodium excretion, UNa/UCr, unnary sodium / creatinine ratio, Fl, fluid intake; UVol, 
24h urinary volume 
decreased during pregnancy (Abdul-Karim and Assali, 1961)-, also be responsible 
for the elevation in systolic and diastolic blood pressure during the early 
Puerperium observed in both our and other studies (Walters et al., 1986). 
The components of the renin aldosterone system showed a steady decline 
after delivery. However the disappearance rates of prorenin and renin substrate 
were slower than those of the other components, which has been reported before 
(Weir et al., 1975; Jadoul et al., 1982; Sealey et al., 1985; Derkx et al., 1987b). 
During pregnancy most, if not all, of the renin is of renal origin, whereas 
most of the plasma prorenin comes from other sources. During the first trimester 
the ovary is in all likelihood the main source of elevated levels of prorenin 
(Derkx et al., 1987b, Sealey et al, 1987a). In the second and third trimesters 
of pregnancy prorenin may also be secreted from placental and /or uterine tissue 
(Symonds et al., 1968; Brar et al., 1986; Shaw et al., 1989). The contribution 
from the placenta, however, cannot account for most of the prorenin in plasma 
in the last trimester because the post partum fall of prorenin, as shown in our 
study, takes at least 7 days, yet the half life of prorenin is only 1-2 h (Derkx 
et al., 1978; Sealey et al., 1980). This, however, does not exclude the possibility 
that the uterus is an important factor in determining plasma levels of prorenin. 
Renin substrate originates from the maternal liver, and its production during 
gestation is increased due to the stimulatory effect of high oestrogen levels from 
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placental origin (Immonen et al, 1983) Whether the slow decrease post partum 
reflects a gradual decrease in hepatic production despite a quick fall in oestrogen 
levels (Tulchinsky 1980), a slow clearance from the tissues or synthesis of renin 
substrate from extrahepatic origin, is as yet unknown 
The raised substrate levels explain why plasma renin activity remains elevated 
for 2 days, as renin concentrations dropped to non-pregnant values within 24 h. 
The quick fall in progesterone concentrations after delivery is most likely 
due to the expulsion of the placenta at birth, which is known to be the major 
source of progesterone secretion dunng pregnancy (Ryan 1980) The fact that 
progesterone levels remained, however, elevated for three days as compared 
to values 6 weeks after delivery despite the half life in blood of 20 min (Tulchinsky 
1980), could be due to puerperal activity of the corpus luteum of pregnancy 
(Weiss and Rifkin, 1975) 
The difference between fluid intake and urinary volume 6 weeks after delivery 
amounted 800 ml which probably reflects the perspiratie insensibilis If one 
assumes that the insensible loss of water is the same during the first week after 
delivery, it is obvious that the early puerpenum is characterized by a negative 
fluid balance The average cumulative loss of water would then approximately 
be 3 I, which is more than the reported decrease of 2 3 1 in extracellular water 
(Chesley and Boog, 1943a) Possibly the insensible perspiration dunng the first 
week is less than estimated 6 weeks post partum 
In our study 3 9 kg of the fall in weight from late pregnancy to the first puerperal 
day could not be accounted for by the expulsion of the child, placenta and 
the amount of blood loss during delivery (as shown in figure 9 1) This may 
be explained by the loss of amniotic fluid (approximately 1 1), the loss of available 
water during delivery of nearly 2 1 (Chesley and Boog, 1943a), as well as enhanced 
diuresis dunng the first hours post partum Weight on day 7 was still higher 
compared with 6 weeks after delivery This is in agreement with the observation 
that after the first puerperal week a further loss in available water takes place 
(Chesley and Boog, 1943a) 
Each woman showed a clear increase in sodium excretion dunng one of the 
puerperal days studied Higher mean values of 24 h natnuresis were found on 
the days 3,4 and 5, at a time when plasma sodium levels were relatively high 
as well A shift of exchangeable sodium from the interstitial space into the 
circulation is the likeliest explanation for this phenomenon As the amount of 
sodium intake was not monitored, the extent of the negative sodium balance 
is unknown Others reported it to be 150 mmol during this penod (Chesley 
et al, 1959) 
Because the early puerpenum seems to be a state of hypervolemia, these events 
might be characterized as volume expansion induced diuresis and natnuresis 
In theory, ANP could be one of the main mediating factors in the puerperal 
renal excretion of sodium and fluid Indeed, puerperal ANP levels were actually 
found to be significantly correlated with fluid balance Although no correlation 
could be demonstrated with sodium excretion, ANP might have an initiating 
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effect during the first puerperal days when the activity of renin is still somewhat 
elevated. High puerperal ANP levels may also be involved in the rapid decline 
of the concentrations of the components of the salt conserving renin-aldosterone 
system, as a significant inverse correlation was demonstrated between the two 
hormonal systems after delivery (chapter 8). Furthermore, the reduction of renin 
and aldosterone as a response in acute hypervolemia in non-pregnant rats was 
shown to be blocked by a monoclonal antibody directed against ANP (Stasch 
et al., 1988). 
In view of the correlations found in our study it seems that during early 
Puerperium renin and aldosterone appear to be involved in the renal handling 
of sodium, similar to that in the non-pregnant state. 
In view of the natriuretic effects of progesterone in both non-pregnant (Oparil 
et al., 1975) and pregnant subjects (Ehrlich et al., 1962; Kleinhout and Eskes, 
1971) one could expect progesterone levels to be positively correlated with sodium 
excretion. However early puerperal progesterone levels appeared to be inversely 
correlated with sodium excretion. Whether this is due to any relevant antina-
triuretic effects of progesterone or unknown confounding variables is as yet 
unknown. 
The increase in plasma ANP and the fall in renin and aldosterone are probably 
of much more importance. 
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PART IV 
(PATHO)PHYSIOLOGICAL IMPLICATIONS OF 
CHRONIC DIETARY SODIUM RESTRICTION 
DURING PREGNANCY; A LONGITUDINAL 
PROSPECTIVE RANDOMIZED CLINICAL STUDY 
Chapter 10 
INTRODUCTION 
10.1. DIETARY SODIUM RESTRICTION DURING PREGNANCY; 
A HISTORICAL REVIEW 
INTRODUCTION 
Hypertension affects 6-20% (depending on the definitions used) of all pregnant 
women and ranks amongst the 4 most common causes of maternal as well 
as perinatal mortality in the world (MacGillivray 1983; Chesley 1984; Turnbull 
1987). The disease is called preeclampsia when hypertension occurs after the 
20th gestational week together with proteinuria. It develops with increasing 
frequency as pregnancy approaches term, and the occurrence seems to be confined 
to the human race only. It is predominantly a disease of primigrávidas, char-
acterized by a typical renal lesion (Spargo et al., 1959; Spargo et al., 1976) 
which, together with the accompanying hypertension and proteinuria disappears 
entirely after delivery. The diagnosis of preeclampsia in multiparas is wrong 
in most cases, due to underlying disorders such as diabetes, chronic antecedent 
hypertension and chronic renal disease. The most serious complication of 
preeclampsia is an attack of seizures, called eclampsia. 
The exact origin of the word eclampsia remains unclear but most text books 
state that it is derived from a Greek word which from the 16th century onwards 
has subsequently been translated as epilepsy, brightness and shining forth (Chesley 
1972c). 
The etiology of this disease is still unknown, and already in the beginning 
of this century Zweifel called it 'the disease of theories' (Zweifel 1913; Zweifel 
1916). Many pathophysiological factors and mechanisms have been linked with 
the cause and nature of preeclampsia. However most hypotheses missed any 
scientific base to justify the many prophylactic and therapeutic approaches applied 
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in the management of the disease. Although the Greek at the time of Hippocrates 
already seemed to recognize preeclampsia (Chesley 1974), up to the turn of 
this century medical care was primarily focused on the eclamptic patient. Zuspan 
and Ward (1964) wrote that in the treatment of eclampsia "the patient has 
been blistered, bled, purged, packed, lavaged, irrigated, punctured, starved, 
sedated, anesthetized, paralyzed, tranquillized, rendered hypotensive, drowned, 
been given diuretics, had mammectomy, been dehydrated, forcibly delivered and 
neglected". 
Next to toxic metabolites of the ovum and the placenta (explaining the origin 
of the word 'toxemia') and several renal, immunologic and vascular factors, 
nutritional factors have been held responsible for the development of hypertension 
in pregnancy (Chesley 1978). Especially the salt content of food has received 
much attention since the turn of the century (Boodt 1975; Green 1989). The 
conception that salt is intimately associated with the etiology of pre-eclampsia 
and eclampsia has been ingrained in the mind of many obstetricians, general 
practitioners and midwives for a long time. By the late 1940s it was considered 
daring to allow pregnant women, especially those with preeclampsia, to eat a 
diet containing a normal amount of salt. Up to this day, although more in Europe 
than in the U.S.A. where the use of salt restriction became less popular in the 
1960s, the first thought regarding the prophylaxis as well as the treatment of 
this hypertensive disease of pregnancy often is sharp reduction in the dietary 
intake of salt. However, the question whether a low sodium diet is beneficial 
or detrimental is still subject to worldwide discussion. 
This chapter is an attempt to review the major milestones in obstetric research 
in the past 90 years, which have lead to the wide spread use of salt-restriction 
during pregnancy. 
Salt restriction in the prophylaxis of eclampsia. 
The relationship between water and salt retention in non-pregnant individuals 
was first demonstrated by Widal and Javal (1903). They showed that edema 
could be diminished or aggravated by respectively decreasing and increasing 
the amount of dietary salt intake. 
Cramer (1906) reported the use of salt restriction to abolish severe edema 
during pregnancy in 5 patients. He may have been the first to advocate salt 
restriction in the prophylaxis of eclampsia, as he held salt retention to be primary 
to the development of edema. 
Zangemeister (1916), weighing more than 300 women several times during 
the latter half of pregnancy, pointed out the correlation between gain in weight 
and edema. He postulated that the cause of preeclampsia and eclampsia was 
an abnormally large retention of water reflecting in high weight gain and edema 
(hydrops gravidarum), which accordingly were regarded as the most important 
signs of incipient eclampsia. In his view the development of edema also lead 
to an increase in brain pressure, thereby causing convulsions. He treated three 
85 
cases of eclampsia by trephining the skull (Zangemeister 1911). The dura was 
not pulsating and when it was opened cerebrospinal fluid and brain tissue exuded. 
Zangemeister considered that this was evidence of cerebral edema. As he held 
water retention to be primary and salt retention to be secondary the chief stress 
in clinical management was lead upon the abstinence from liquid. Yet Zan­
gemeister also restricted his patients in the dietary intake of salt to enable his 
patients to refrain from drinking. 
In contrast with Zangemeister, De Snoo*, a Dutch obstetrician, believed that 
primary salt retention was most important, leading to detectable edema in 70% 
of all pregnant women and a concurrent increase in weight (De Snoo 1916; 
De Snoo 1918). In 1913 he stated for the first time that a low sodium diet 
would be beneficial for all pregnant women (De Snoo 1913). This hypothesis 
of De Snoo, who was inspired by an oral presentation by Widal (Widal 1907) 
was partly based on the work of Bar (1907) who had conducted salt balance 
studies in 7 women some time before and after delivery. 
Bar concluded that where after delivery a dietary intake of 15-20 g NaCl 
(250-350 mmol Na) was normally excreted in the urine, the threshold value 
of salt intake above which some degree of retention occurred was reduced during 
normal pregnancy to 6-7 grams (100-120 mmol Na). According to De Snoo 
the retention of salt also resulted in an increased concentration of salt in blood 
as reported by Zangemeister (1903) and a subsequent increase in blood pressure 
during normal late pregnancy observed by others (Morris Siemens and Golds-
borough, 1908;Sakurai 1910). 
He considered this rise in blood pressure to be a compensatory mechanism which, 
by increasing natriuresis, could lower the salt content of the blood but, however, 
not that of the interstitium. 
De Snoo concluded that edema during pregnancy is not a physiological sign, 
but expresses excessive salt and subsequent water retention as a consequence 
of a diminished tolerance for salt due to heightened affinity of the tissues under 
the influence of the products of conception, which is only partly balanced by 
an increase in blood pressure. He therefore judged this condition as pathological, 
emanating from a relatively high intake of salt. The fact that the surplus of 
salt was quickly excreted after delivery proved to him that the retention of salt 
could not be due to diminished kidney function as it is unlikely that any renal 
disorder would recover immediately after delivery. 
The use of salted foods in the civilized world, in his opinion also explained 
*Klaas De Snoo was born January 16th in 1877 in Gccrtvliet (The Netherlands). He became a 
medical student at the University of Utrecht in 1895 and graduated in 1902 In 1905 he accepted 
a post as a teacher at the midwifery school ('Rijkskweekschool voor Vroedvrouwen') in Rotterdam 
where he took over management as director in 1906 In 1926 he was appointed as professor 
in Obstetrics and Gynecology at the University of Utrecht as successor of professor В J Kouwer He 
ended his professorship when he was 71 years of age. From 1904 onwards, he published 147 
articles on several obstetrical topics in national as well as international journals and wrote 6 text 
books He died April 1st in 1949 (Plate 1949, Heyster 1950) 
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why eclampsia is a disease typical for human pregnancy and does not, or very 
rarely occur in animals. 
De Snoo also contributed the low incidence of eclampsia in women from 
the West Indies and Africa to their relatively low intake of salt of 4 grams 
daily (De Snoo and Remmelts, 1938). 
He convincingly showed that the occurrence of edema could be prevented 
by a salt-poor diet by investigating weight loss after delivery (De Snoo 1918). 
In 71 women a clear relationship was found between the severity of the edema 
during late pregnancy and puerperal weight loss (ranging from 2.1 to 14 kg). 
The same study was conducted in 47 women who were fed a salt-poor diet 
4 to 50 days before delivery. Twenty-four of these women who continued to 
consume a salt poor diet on average lost only 1.4 kg, whereas 22 women who 
started eating normal salted food after delivery even gained 0.7 kg during the 
first 12 puerperal days. 
As De Snoo as well had studied the relation between edema and eclampsia, 
he became convinced that by "curing'* the edema of pregnancy by a salt poor 
diet the occurrence of eclampsia could be prevented. The observation that 
eclampsia could also be prevented despite a further increase of the severity 
of the edema during a rigid restriction of the intake of salt strengthened him 
in his belief that it was not the edema itself but the excess of salt that was 
directly related to the outburst of convulsions. 
Next to salt retention he later recognized that hypertension was closely related 
to eclampsia (De Snoo 1919; De Snoo 1920; De Snoo 1923a; De Snoo 1923b; 
De Snoo 1926a; De Snoo 1926b; De Snoo 1948). He considered these as two 
distinct features of one underlying gestational 'toxemic disease'; a disease of 
which the etiological determinants derive from the trophoblast. Already in 1908 
he proposed a placental theory of eclampsia based on the occurrence of eclamptic 
fits in a patient presenting with a mole pregnancy (De Snoo 1908). De Snoo 
hypothesized that the retention of salt leading to a structural change of tissues 
throughout the body and edema as well as the high blood pressure causing 
vascular cramps would in the end result in repetitive discharges of a 'cramp 
centre' in the brain stem, clinically presenting as eclampsia. It appeared to him 
that women who had a normal blood pressure practically never got eclampsia, 
neither did women who had lived for at least two or three days on water and 
a salt-poor diet. He considered this of the greatest importance in the practice 
of the prophylaxis, because in measuring the blood pressure next to weighing, 
one possessed the means of early diagnosing the danger of eclampsia and 
subsequently to prevent the onset of eclampsia by means of salt restriction. In 
neither of his publications he claimed that the restriction of salt was very effective 
in lowering the blood pressure. 
One example of his graphical presentations of the effects of a salt poor diet 
is shown in figure 10.1.1. One should realize that by taking the blood pressure 
by palpation, as was generally done at first, the sphygmomanometer from Riva-
Rocci merely indicated systolic values (De Moulin 1981). 
87 
ι 
σ> 
Χ 
Ε 
Ь 
Οι 
ί -
Ο 
ІЛ 
ІЛ 
ΟΙ 
ο. 
•α 
ο 
ο 
χι 
υ 
ο 
UÌ 
> 4 
180 
160 
U0 
120 
-4 · 
CSI 
СП 
υ 
χ 
100J 
16 
12 
= θ 
= Ù 
delivery г66 
62 S 
от 
Φ 
58 * 
> ч 
Ό 
О 
Χ) 
с 
50 
pregnancy 
ι ι ι ι ι ι" ι i'"f"i days 
Puerperium 
low sodium intake 
l i 1 
ad libitum 
sodium intake 
га 
ε 
ІЛ 
φ 
-О 
Figure 10.1.1. Graphical presentation (redrawn from De Snoo, 1919) of the clinical course of a 
primiparous woman admitted to the hospital presenting with moderate edema and 
a systolic blood pressure of 180 mmHg (Riva Rocci). During bed-rest and a low 
salt diet bodyweight decreases and the edema disappears completely before delivery, 
reflected in the absence of a further decrease in weight post partum. Blood pressure 
lowers as well, however remains elevated up to the first days after delivery. 
Next to 71 detailed case-reports (De Snoo 1918; De Snoo 1919) in which 
he showed beneficial effects of salt restriction, his statistics on the incidence 
of eclampsia in patients with 'toxemia' during a 30 years period justified in 
his opinion the postulate "without salt retention, no eclampsia" which he upholded 
in several publications in international journals (De Snoo 1934; De Snoo 1937; 
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De Snoo 1938a; De Snoo 1938b, De Snoo 1939). His data on the incidence 
of eclampsia in preeclamptic patients (De Snoo 1926b; De Snoo 1937) can 
be spread over four periods. From 1907 to 1911 salt restriction was not yet 
applied in the prophylaxis of eclampsia. As director of the midwifery school 
in Rotterdam (The Netherlands) he introduced the use of salt-poor diets in 1912, 
and continued this policy when he became professor and chairman at the university 
clinic of Obstetrics and Gynecology in Utrecht (The Netherlands) in 1927. Table 
10.1.1 (modified data) shows the incidence of eclampsia in preeclamptic patients 
occurring respectively within the first 2 days and from the 3rd up to the 7th 
day after admission to the clinic. 
Table 10 11 Incidence of eclampsia (%) in women with pre-eclampsia after admission to the clinic 
(Modified data from De Snoo, 1937) 
days after admission 
0 - 2 3-7 
Rotterdam 
no salí reitriLtion 
1907 - 1911 (n= 349) 2 6 
sail resine lion 
1912- 1926(n=1219) 18 
Utrecht 
1927 - 1930 (n= 279) 0 4 
1931 - 1936 (n= 536) 1 7 
n= number of admitted preeclamptic women 
De Snoo believed that only if a salt-poor diet was given for at least two 
days a prophylactic effect could be expected. After the implication of a salt-
free diet as routine therapy in 1912 the incidence of convulsions after the 2nd 
day of admission at the clinic in Rotterdam significantly decreased from 1.4% 
to 0.16% (Chi square test, p<0.01). When he took over the management in 
Utrecht with the old nursing staff he wrote "it took three years of hard work 
before I had banished eclampsia " (De Snoo 1937). Indeed in the period 1931-
1936 not a single case of eclampsia seemed to have occurred in his clinic later 
than two days after the patient had been admitted. In interpreting these figures 
one should however also take into account that the clinical management included 
absolute bed rest and that he had introduced systematic prenatal care. Women 
were seen on average 5 times during pregnancy starting in the 7th gestational 
month. 
In three studies from the Women's Hospital in Sydney (Hamlin 1952; Stevenson 
1952; Hughes 1956) also a sharp reduction in the incidence of eclampsia was 
reported. During the years 1936-1947 the average incidence of eclampsia was 
14 
0.2 
14 
0 
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relatively constant at 0.2%. After the introduction in 1948 of a low salt, high 
protein, high vitamin, low-carbohydrate diet in the control of weight gain and 
(digital) edema together with increased antenatal supervision, the incidence of 
eclampsia during the time period 1950-1955 decreased to nearly 0%. No claim, 
however, was made that pre-eclampsia is preventable as well. Of course it is 
hard to tell which of the several dietary interventions, next to the restriction 
of salt will have had the most impact. Furthermore, there seemed to have been 
a concurrent change in admission policy. Patients were admitted to the hospital 
at an earlier stage of the disease than in the preceding time period. 
Salt restriction in the prophylaxis of preeclampsia 
Although De Snoo had not demonstrated any beneficial effect of salt restriction 
with regard to the prevention of pre-eclampsia or the treatment of the disease 
he placed as many as 25% of all pregnant women on a salt-poor diet and 
subsequently wrote "It would be well if women were forbidden the use of salt 
in the second half of their pregnancy. There would then be far fewer cases 
of serious toxemia, and it would practically put an end to eclampsia" (De Snoo 
1937). This has certainly contributed to the wide spread practice of salt restriction 
throughout the world, not only in the prophylaxis of eclampsia but also that 
of pre-eclampsia in perfectly healthy pregnant women. 
Dieckmann and Kramer (1941) stated that the prevention and treatment of 
edema are dependent on the limitations in the diet of the principal components 
of edema fluid, namely sodium chloride and water. The curtailment of sodium 
chloride in the diet would in their opinion present fewer difficulties and cause 
less discomfort to the patient than the restriction of water. They advised that 
the diet of normal pregnant women should be salt-poor every fourth week as 
a prophylaxis against the development of pre-eclampsia. 
Chesley and Annitto (1943b) selected, as women likely to develop pre-
eclampsia, 237 clinically normal subjects who had an excessively large retention 
of water early in the third trimester. These women were assigned in rotation 
to 3 groups: (a) controls, (b) restricted salt and fluid intake and (c) restricted 
salt and forced fluid intake (in accordance with the line of thought of De Snoo). 
The incidence of preeclampsia in the group of patients who restricted both salt 
and fluid intake was not different from those in the control group. However, 
the incidence of preeclampsia was lower in the patients who restricted salt and 
forced fluids (7.9% versus 22.5% in the control group). Confined to primigrávidas 
this difference was smaller (14.3% versus 25.9%). 
In an extraordinary reversal of the ideas of De Snoo, Robinson in the late 
fifties (Derby, England) advocated a high-salt diet during pregnancy. From 1954 
to 1957 she tried to assess the effects of either a high or low intake of dietary 
salt on the incidence of toxemia (Robinson 1958). This study was prompted 
by the concern that the addition of extra salt to the diet, which in her clinic 
was applied in order to lessen and prevent leg cramps (Robinson 1947) might 
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increase the incidence of toxemia. She alternately instructed 2077 women either 
to take more salt in their diet (salty meat, salt butter, added salt at table) or 
to reduce the daily dietary intake of salt (avoiding salty foods and no added 
salt at table). Due to, among things, miscarriages respectively 1019 and 1000 
women remained for further evaluation. Half of the number of women in both 
groups were first seen and instructed before the 20th gestational week. Patients 
were considered to have toxemia if their blood-pressure rose above 140/90 
mmHg, or if they had edema and albuminuria without a rise in blood pressure. 
Some data (modified) from this study are shown in table 10.1.2. 
Table 10.1.2. The incidence of toxemia reported by Robinson (1958). 
salt suppletion salt restriction 
Number of women in study groups 1019 1000 
Toxemia (%) 4 10 
Number of nulliparas in study groups 144 146 
Toxemia (%) 11 26 
The reported incidence of toxemia in the group of women told to take less 
salt was higher as compared to that in the group advised to take more salt. 
As a vast majority of these patients were multiparas (86%) it is questionable 
in how many cases the diagnosis was correctly made. The incidence of toxemia 
in nulliparous women only, seemed to be higher as well in the salt restricted 
group (Chi-square test, p<0.01). The study was however badly controlled in 
that there was no assessment whatsoever as to whether these women actually 
adhered to the advice given to them. Furthermore no data were presented 
regarding the incidence of eclampsia. 
Gray et al. (1964) compared three groups of normal pregnant women during 
the third trimester of pregnancy who were placed on different intakes of sodium. 
The mean daily intakes of sodium were 127 mmol in the low sodium group 
(n=6), 167 mmol in the normal intake group (n=13) and 209 mmol in the 
high sodium intake group of women (n=9). Despite the fact that after a period 
of 4 weeks the women on higher sodium diets gained slightly more weight 
and retained more water as compared to the low sodium group, none of the 
women developed pre-eclampsia. However the intake of the sodium restricted 
group can hardly be classified as low. Furthermore the 4 week intervention 
period may have been too short and the number of patients too small to be 
able to detect any differences with regard to the prophylaxis of preeclampsia. 
No information was given on the number of primiparous women. 
Brewer (1969) started in the early sixties, partly as a result of Robinson's 
study, to abandon low sodium diets and to de-emphasize weight-control. As 
he considered toxemia as a metabolic disease caused by poor maternal-fetal 
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nutrition he made every effort to insure optimal, well-balanced nutrition for 
each patient including the salting of food to taste. 
Salt restriction in the treatment of pre-eclampsia. 
De Alvarez reported the results of the use of a 'neutral' (sodium-poor) diet 
in the treatment of 224 hypertensive pregnant women of whom 54% were 
primiparous (De Alvarez and Portland, 1947). Together with the diet, fluid was 
forced to a level sufficiently high to produce a urinary output approximately 
equal to the output of a normal individual. He believed, as did De Snoo, that 
forcing fluids in toxemic patients will not increase edema when given in com-
bination with a low sodium diet. More than 80% of his patients responded 
favourably to this method of medical treatment which, however, also included 
sedation, hospitalization and the administration of ammonium chloride to release 
the sodium from the tissues and the intercellular fluid retained by the sodium. 
Penning (1952) described beneficial effects of a low sodium diet in the 
management of chronic hypertension during pregnancy. 
Based upon the favourable effects of the suppletion of salt in normal pregnant 
women Robinson also advised 20 ambulatory patients with toxemia to take 
extra salt (Robinson 1958). It was calculated that they took about 200-300 
g of sodium-chloride daily! No additional treatment such as bed rest or sedatives 
was given. In all but 2 patients blood pressure returned to normal and edema 
disappeared. Detailed clinical data were presented, however, of only two patients 
and there is no indication of how many of these 20 women were nulliparous. 
Again no check was performed on dietary compliance. Although it seems unlikely 
that these women ingested as much salt as reported, Robinson concluded that 
"extra salt in the diet seems to be essential for the health of a pregnant woman". 
Zuspan and Bell (1961) conducted sodium balance studies in preeclamptic 
women. Dietary salt loading (approximately 5 grams daily) caused a marked 
sodium retention and worsening of clinical symptoms in moderately severe 
preeclamptic patients. In contrast to Robinson they concluded that "the excessive 
intake of salt is detrimental to the moderately preeclamptic patient". 
Mengert and Tacchi (1961) alternately gave 48 preeclamptic patients either 
a high or a low salt diet with a daily content of salt of 11 and 2 grams respectively. 
They observed no differences in the course of the disease between the two groups. 
The average values of the concentrations of sodium in the urine were approx-
imately the same in both groups which strongly suggests that, although no data 
were given on the 24 h urinary excretion of sodium, there was no real difference 
in sodium intake at all between the two groups. The two groups of women 
were also not comparable with regard to the severity of the disease at the start 
of the study and no information was given with regard to parity. 
Bower (1964) investigated the effects of different regimens of salt intake in 
the treatment of preeclampsia. Three groups of patients with daily salt intakes 
of 2 (n=341), 10 (n=201) and 25 grams (n=197) respectively were studied. 
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No differences could be demonstrated with regard to changes in systolic and 
diastolic blood pressure. Dietary compliance, however, was not checked and 
there is no indication as to how many women were nulliparous. 
In conclusion, no evidence has ever been produced that salt restriction helps 
in the prophylaxis of hypertension during pregnancy. However, De Snoo's view 
that, once preeclampsia has developed, sodium restriction prevents the occurrence 
of eclampsia, has never been convincingly contradicted. 
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10.2. INTRODUCTION TO THE STUDY 
In 1986, a multicentered trial was initiated in The Netherlands (Grants by 
the Dutch 'Praeventiefonds') to evaluate the value of dietary sodium restriction, 
when started relatively early in pregnancy, with regard to the prevention of 
hypertension in pregnancy. 
In this trial the participating clinics ( Catharina Hospital Eindhoven, Groot 
Ziekengasthuis Den Bosch and University Hospital St Radboud Nijmegen) follow 
the same study protocol with regard to the start of the diet (14th gestational 
week), time periods at which women are studied and antenatal visit procedures 
(such as obstetrical examinations, blood pressure measurements and routine 
laboratory tests). 
The results of this trial which is still continuing, will be evaluated in a few 
years time, but for a correct judgement of the clinical benefits or harm that 
a low salt diet might cause, a thorough understanding of the physiological or 
perhaps patho-physiological implications of chronic dietary sodium restriction 
is essential. 
As described in chapter 2, normal pregnancy is characterized by an increase 
in intravascular volume, rise in cardiac output, lowering of systemic blood pressure 
and a decrease in vascular resistance. The concomitant 50% increase in glomerular 
filtration rate together with the increase in hormonal natriuretic factors such 
as progesterone and possibly ANP, result in a marked increase in the amount 
of filtered sodium. This in turn is accompanied by an enhanced activity of the 
salt conserving renin-angiotensin-aldosterone system. 
In view of these gestational changes, it is obvious that sodium plays a key 
role in maintaining volume homeostasis during pregnancy. However, to date 
neither the cardiovascular nor the hormonal effects of chronic dietary sodium 
restriction have been properly studied. 
Therefore the study protocol in St Radboud Hospital was extended with various 
hemodynamic and hormonal measurements. 
To avoid confounding variables this particular study was performed in healthy 
nulliparous women, as the adaptation to pregnancy might change with advancing 
parity (Campbell and MacGillivray, 1972). 
The results of this study will be presented and discussed in two separate chapters: 
- effects of chronic dietary sodium restriction on weight gain and hemodynamics 
(chapter 11) 
- sodium-balance related endocrine effects of chronic dietary sodium restriction 
(chapter 12). 
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Chapter 11 
EFFECTS OF CHRONIC DIETARY SODIUM 
RESTRICTION ON WEIGHT GAIN 
AND HEMODYNAMICS 
INTRODUCTION 
Since sodium balance is the prime determinant of volume homeostasis, chronic 
sodium restriction could have extensive effects on numerous cardiovascular 
changes that accompany pregnancy. This chapter describes the effects of chronic 
dietary sodium restriction on maternal weight gain, food intake, blood pressure, 
hematocrit, M-mode echocardiographically determined left ventricular dimen-
sions and their derived parameters and pregnancy outcome. 
MATERIAL AND METHODS 
Study population. 
Forty-two healthy nulliparous women with singleton pregnancies were included 
after informed consent was obtained. The study protocol was approved by the 
committee on human experimentation of the University Hospital St Radboud 
in Nijmegen. Women entered the study between week 11 and 13 of pregnancy 
f mean 12 weeks). Randomly twenty-one of them were instructed to use a low 
sodium diet, containing approximately 20 millimoles of sodium a day. Ran-
domization took place by a closed envelope system. The low sodium diet was 
started in the 14th gestational week and stopped immediately after delivery. 
Dietary instructions in both word and writing as well as guidance throughout 
pregnancy were given by a trained dietitian. The remaining twenty-one women 
were asked to continue their ad libitum dietary intake. 
Four women in the low sodium group were excluded from the study. Two 
of them did not want to continue the low sodium regimen, in one patient the 
diagnosis of fetal trisomy 18 was made and one woman moved to another city 
during the study. In the ad libitum group two women dropped out because of 
respectively complications of uterine myomas and acute intestinal obstruction 
followed by surgery. So 17 women in the low sodium group and 19 women 
in the ad libitum group remained for further evaluation. The characteristics of 
these women are summarized in table 11.1. All women received iron suppletion 
(65-130 mg Fe++daily). 
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Table 11 1 Population characteristics 
number 
maternal age 
mean (range) 
gestational age at birth 
mean (range) 
breast feeding 
1st week post partum 
6sl week post partum 
oral contraceptives 
6st week post partum 
(η) 
(years) 
(days) 
(n) 
(n) 
Ad libitum 
19 
27 (22-35) 
279(241-292) 
12 
10 
1 
Low sodium 
17 
27 (20-34) 
278 (235-298) 
10 
7 
2 
Study protocol 
Echocardiographic registrations (as described in chapter 3), blood pressure 
and weight measurements, samples of blood and 24 h urine collections were 
obtained in a longitudinal fashion at weeks 12, 16,20,24,28, 32,36 of pregnancy 
and again 1 (without echocardiographic registrations) and 6 weeks post partum. 
All investigations were performed between 13.00 - 17.00 h, each individual 
woman being seen at invariably the same time of the day. 
Blood samples were taken in left lateral position after 15-30 min of rest. 
Systolic, diastolic and mean arterial blood pressure (MAP), were measured after 
5 minutes rest in sitting position with an automatic microcomputer assisted 
instrument (Dinamap 1846). Systemic Vascular Resistance (SVR) was derived 
from the equation SVR= (MAP:CO)x80 dyn.s.cm 5. 
The diagnosis of 'hypertension in pregnancy' was made if the diastolic blood 
pressure was ^  110 mmHg on any occasion or ^ 90 mmHg on two consecutive 
occasions ^ 4 h apart, in a woman known to be normotensive before 20 weeks' 
gestation (Davey and MacGillivray, 1988). Proteinuria in pregnancy was defined 
as a total protein excretion of ^ 300 mg per 24 h (Davey and MacGillivray, 
1988). The umbilical cord was clamped immediately after delivery of the child. 
Placental weight was recorded without cord and membranes. Weights of child 
and placenta were also related to the mean weight of its gestational age on 
a cernile chard for the Dutch population (Kloosterman 1970). 
Food intake 
A dietary intake analysis was first performed (in a way described in chapter 
3) at the start of the study in which the dietary habits before pregnancy were 
evaluated. To investigate dietary intake during pregnancy, the intake analysis 
was repeated between the 20th and 28th gestational week. The dietitian was 
instructed not to adjust the diets in the course of pregnancy in either group. 
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Statistical analysis. 
To compare the results of serial measurements after the start of the low sodium 
diet (weeks 16-36) with those in the ad libitum sodium intake group the Koziol 
test (see chapter 3) was used. To test differences between the two groups at 
12 weeks (start of the study) and 1 and 6 weeks post partum and to evaluate 
differences in dietary intake as well as birth weight of children and placentae 
the Wilcoxon-Mann-Whitney two-sample test was used. Differences within 
groups in dietary intake before and during pregnancy were tested by the Wilcoxon 
matched-pairs signed-ranks test. In all tests p-values were considered significant 
at the 5 percent level. 
RESULTS 
At the start of the study (12th week) significant differences were present in 
neither of the variables studied. 
Effects of dietary sodium restriction on natriuresis, weight gain and blood pressure 
As shown in figure 11.1, after the start of the low sodium diet in the 14th 
week urinary sodium excretion expressed as both mmol sodium per 24 h as 
well as mmol sodium per mmol creatinine decreased, reaching levels approx-
imately one third of those in the ad libitum group (p<0.01). After delivery when 
the diet was stopped, sodium excretion was similar in both groups. 
Mean maternal weight at 12 weeks was 69 kg (range 53-80 kg) in the low 
sodium group and 66 kg (range 53-83 kg) in the ad libitum group, which difference 
was not statistically significant. Weight gain as calculated from the 12th week 
onwards was significantly lower in the low sodium group (p<0.01). After the 
onset of the low sodium diet weight first decreased, followed by a lower weight 
gain each month resulting in a total weight gain approximately half of that 
in the ad libitum group. Weight at 1 and 6 weeks post partum was significantly 
lower in the former low sodium group as well. Puerperal weight in the former 
low sodium group dropped below the initial weight at 12 weeks whereas women 
in the ad libitum group had gained weight. 
Both systolic and diastolic as well as mean arterial blood pressure in the ad 
libitum group were lower in the second trimester of pregnancy as compared 
with puerperal values. Sodium restriction did not induce significant differences 
in blood pressure during pregnancy. One week post partum however, systolic 
and mean arterial blood pressure were significantly lower in the former low 
sodium group. 
Effects on cardiac output, systemic vascular resistance and hematocrit 
Stroke volume in the low sodium group (figure 11.2) was lower throughout 
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pregnancy as compared with the ad libitum group of women (p<0.05). Mean 
values of stroke volume in the ad libitum group were higher during pregnancy, 
whereas mean values in the low sodium group were lower as compared with 
6 weeks after delivery. 
Maternal heart rate, being higher during pregnancy, did not show major 
differences between both groups of women. 
Cardiac output was significantly lower during sodium restriction (p<0.05) 
and tended to be lower when expressed per kg body weight (p<0.10). 
In the group with an ad libitum sodium intake systemic vascular resistance 
decreased after the 12th week reaching values which were consistently lower 
throughout pregnancy as compared to 6 weeks post partum. After the onset 
of the low sodium diet however such a fall was absent and systemic vascular 
resistance during gestation was significantly higher than during an ad libitum 
sodium intake (p<0.05). 
In the ad libitum group mean hematocrit values were lower during mid-
pregnancy as compared with 6 weeks post partum. During sodium restriction 
hematocrit values tended to be lower as compared to the ad libitum group 
(p=0.05). Hematocrit values 1 and 6 weeks post partum, however, were 
significantly lower in the former low sodium group. 
Effects on food intake 
The results of the analysis of 24 h dietary intake before as well as during 
pregnancy are shown in table 11.2. Before pregnancy the dietary intake of 'total 
energy', protein, fat, carbohydrates and calcium was similar in both groups of 
women. During pregnancy, women in the ad libitum group significantly increased 
their intake of nutrients and calcium. Such increase was absent in the low sodium 
group, and the intake of nutrients and calcium were significantly lower as 
compared to the ad libitum group. 
Effects on pregnancy outcome 
Data concerning the outcome of pregnancy are shown in table 11.3. Respec-
tively 2 and 3 women in the ad libitum and low sodium group developed gestational 
hypertension, and in each group in one of them proteinuria was present. 
Gestational age at delivery and birth weights of child and placenta (as well 
as the centiles) were not significantly different between the two groups. 
The statistical significance of differences, in all variables studied, between 
the low sodium and ad libitum groups of women remains the same when the 
five women who developed gestational hypertension, are excluded from eva-
luation. 
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Table 11.2. Average 24 hour dietary intake in the ad libitum (n=19) and low sodium group (n=17). 
before pregnancy 
Ad libitum Low sodium 
pregnancy (20-28 wks) 
Ad libitum Low sodium 
Total Energy 
Protein 
Fat 
Carbohydrates 
Calcium 
(kJ) 
(g) 
(g) 
(g) 
(mg) 
9385 (2393) 
80(18) 
106(35) 
257 (78) 
878 (403) 
8886(1640) 
79(15) 
104(27) 
224 (70) 
914(514) 
11575 (351 im 
99 (33)## 
122 (48)## 
329 (92)## 
1421 (578)## 
9040(1960)** 
78 (25)* 
96 (29)*# 
251 (70)* 
877(517)** 
Results are mean values (SD). 
# p<0.05, ## p<0.01 significantly different from values before pregnancy in the same group 
* p<0.05> ** p<0.01 significantly different between the two groups during pregnancy 
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Table 11 3 Incidence of hypertension in pregnancy and birth weights of children and placentae 
Hypertension 
Proteinuria 
Gestational age at delivery 
mean (range) 
Weight child 
mean (range) 
Weight child in centiles 
<10 
10-49 
50-90 
>90 
Weight placenta 
mean (range) 
Weight placenta in centiles 
<10 
10-49 
50-90 
>90 
(11,%) 
(n,%) 
(days) 
(g) 
(n,%) 
(g) 
(n,%) 
Ad libitum 
2, 10 5 
1, 5 3 
279(241-292) 
3453(2630-4185) 
0, 0 
6,316 
11,579 
2,105 
586 (340-800) 
1, 5 3 
5,26 4 
8,42 1 
5,26 4 
Low sodium 
3,176 
1, 5 9 
278(235-298) 
3279(1890-4115) 
2,118 
6, 35 3 
6,35 3 
1\Π6 
544 (340-970) 
2,118 
4,23 5 
8,47 1 
3·,17 6 
"One of these women was suspect for a pregnancy induced glucose intolerance 
DISCUSSION 
Despite the fact that low salt diets have been commonly prescribed for almost 
a century this is, to our knowledge, the first report on maternal physiologic 
implications of chronic dietary sodium restriction. 
Although dietary instructions aimed at an intake of 20 millimoles of sodium 
per day, mean values of urinary sodium excretion were almost twice as high. 
One should bear in mind however, that it concerns healthy pregnant women 
who had to adhere to the salt reduced regimen within their households. 
Nevertheless they managed to reduce their sodium intake to levels approximately 
one third of values during an ad libitum intake. 
One of the most striking phenomena is the reduction in weight gain. As reviewed 
by others (Hytten 1980) Primigravidae normally gain on average 12 kg from 
the 12th week onwards, which corresponds with our results. Seven kg of this 
increase is due to maternal tissues, which can be attributed to the uterus (0.8 
kg), mammary glands (0.4 kg), blood (1.1 kg), extracellular extravascular fluid 
(1.7 kg) and fat stores (3.0 kg) (Hytten 1980). All these components of maternal 
weight gain could, in theory, be affected by dietary sodium restriction. 
Salt restriction has been shown to decrease the volume of extracellular body 
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fluid (Chesley 1943b). Furthermore, induction of natriuresis by diuretics reduced 
weight gain as well as total body water (Campbell and MacGillivray, 1975; 
MacGillivray et al., 1962). So the observed decrease in weight after the onset 
of the low salt diet and the reduction in total weight gain can probably be 
explained, at least to some extent, by a decrease in extracellular fluid. After 
delivery weight in the ad libitum group remained approximately 3 kg above 
the initial weight at 12 weeks which reflects the increase in maternal body 
fat as shown by others by using densitometry as well as skinfolds measurements 
(Van Raaij et al., 1987). However, after a low sodium intake during pregnancy 
puerperal body weight decreased below the initial weight at the 12th gestational 
week, which strongly suggests that fat accumulation was absent and that these 
women even emaciated during gestation. This corresponds with the results of 
the dietary intake analysis which showed that the rise in the daily intake of 
nutrients normally present in pregnancy, is absent when using a low salt diet. 
A low salt diet appears to be relatively unpalatable, which evidently leads to 
a reduced food intake. 
In the ad libitum group, systolic, diastolic and mean arterial blood pressure 
were lower up until late pregnancy ('midpregnancy dip') as compared with 6 
weeks after delivery; a well known phenomenon of normal pregnancy (Mac-
Gillivray 1969; Chesley 1976; Moutquin et al., 1985). Sodium restriction did 
not cause significant differences in blood pressure during pregnancy. One week 
post partum however, systolic and mean arterial blood pressure were significantly 
lower in the former low sodium group, and a slight rise as seen in the ad libitum 
group was absent. Such a rise as previously described in chapter 9, could be 
related to the puerperal rise of plasma volume (McLennan and Lowenstein, 1959; 
Landesman and Miller, 1963) together with a return of vascular tone, known 
to decrease during pregnancy (Abdul-Karim and Assali, 1961), to non-pregnant 
values. The rise in puerperal plasma volume is most likely due to a shift in 
body fluid, accumulated during pregnancy, from the extravascular space into 
the circulation. Relatively low systolic blood pressures could therefore point at 
a diminished water retention during pregnancy. 
Stroke volume, heart rate and thus cardiac output were elevated in the ad 
libitum group during pregnancy as compared to post partum, which confirms 
the results of many studies reviewed by others (see chapter 2). After the start 
of the diet stroke volume and cardiac output were significantly lower throughout 
pregnancy as compared to the ad libitum group of women. Also in relation 
to body weight cardiac output was low. We chose not to use a correction for 
body surface area because the formula normally used (Du Bois and Du Bois, 
1916) has never been validated for pregnant women. 
Plasma volume normally increases during pregnancy (Hytten 1985). A lower 
stroke volume could result from a decrease in plasma volume in response to 
the restriction of salt (Brown et al., 1988). However then one should expect 
hematocrit values to be higher throughout pregnancy as compared to the ad 
libitum group, which was not the case. During the second half of pregnancy, 
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hematocrit values were even lower as compared to the ad libitum group. If 
stroke volume is low due to a diminished intravascular volume, total blood volume 
must have decreased, which implies a reduction in red cell volume as well. 
This would also explain the surprisingly lower hematocrit values 1 and even 
6 weeks post partum at a time stroke volume is the same in both groups. A 
decrease in red cell volume could hypothetically result from a decrease in 
erythropoietin production due to for example nutritional deficits. Measurements 
of plasma volume and red cell volume of course could have helped in the 
understanding of these phenomena. However the use of the azo-dye Evans blue 
is prohibited by our as well as most other hospital ethical committees in The 
Netherlands because of its possible carcinogenic and teratogenic properties due 
to the accumulation in certain organs such as the liver, spleen, kidneys and 
lymph nodes as shown in dogs (Stoelinga and Van Munster, 1967). Other methods 
are not acceptable either because of their use of radioactive labels or because 
the methodology has not yet been properly validated. 
Systematic vascular resistance during an ad libitum diet was low as compared 
to 6 weeks post partum, a phenomenon attributed to a lowering of the vascular 
responsiveness to vasoconstrictive agents and thereby vascular tone (Abdul-Karim 
and Assali, 1961). Sodium restriction significantly increased systemic vascular 
resistance, which might point at either a rise of circulating vasopressor agents 
or an increase of the vascular responsiveness to these agents, or both. Angiotensin 
II, the most powerful circulating vasoconstrictor, is likely to rise during sodium 
restriction due to a stimulated renin-angiotensin system (figure 12.2). Jaspers 
et al. (1983), however, reported a decrease of angiotensin sensitivity after a 
strongly sodium restricted diet. They attributed this phenomenon to a direct 
effect of sodium on the vessel wall. 
The intake of calcium during pregnancy seems to be inversely correlated with 
vascular tone and blood pressure (Kawasaki et al., 1985; Belizan et al., 1988). 
Probably due to a reduced and altered food intake calcium intake appeared 
to be significantly lower in the low sodium group. In theory this could also 
contribute to an elevation in the systemic vascular resistance. 
As the here described study was not designed to make any statements as 
to whether sodium restriction does have any effects on the development of 
hypertension in pregnancy, our data on the incidence of gestational hypertension 
and proteinuria do not allow any conclusions in that regard. 
In view of the significant effects of sodium restriction on hemodynamics and 
weight gain found in our study one would have expected birthweight to be lower 
in the low sodium group as maternal weight gain and plasma volume have 
been reported to be positively related with birth weight (Duffus et al., 1971; 
Simpson et al., 1975). Furthermore dietary sodium restriction in rats has shown 
to result in smaller litters (Kirsey and Pike, 1962; Bursey and Watson, 1983). 
However, birthweights of children and placentae did not show major differences 
between the two groups. Apparently the availability of nutrients to the fetus 
is relatively independent of the alterations in maternal dietary intake brought 
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about by the low sodium diet applied in this study, probably as long as the 
nutritional status of the mother before pregnancy is satisfactory and sufficient 
maternal body reserves are present (Leichtig et al., 1975). 
In short, our results suggest that pregnancy during a reduced sodium intake 
is characterized by a diminished body fat accumulation and a reduction in 
circulating volume, due to both a decrease in plasma volume and red cell volume, 
in combination with a relatively high systemic vascular resistance, without major 
effects on blood pressure and birthweight. 
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Chapter 12 
SODIUM-BALANCE RELATED ENDOCRINE 
EFFECTS OF CHRONIC DIETARY 
SODIUM RESTRICTION 
INTRODUCTION 
Since normal pregnancy is characterized by a delicate balance between sodium 
retaining and natriuretic factors, one should consider the effects of chronic dietary 
sodium restriction on the major systems involved in preserving sodium homeos-
tasis. 
One of the systems determining sodium balance is the salt retaining renin-
aldosterone system. Why this system is stimulated throughout pregnancy (for 
reviews see chapter 2) is not fully understood. It has been suggested that the 
natriuretic effects of progesterone (Landau and Lugibihl, 1961; Oparil et al., 
1975), the concentrations of which in plasma rise due to placental production 
(Lindberg et al., 1974), together with the 50% increase in glomerular filtration 
rate (Lindheimer, 1970), necessitate enhanced activity of the renin-aldosterone 
system in order to prevent pregnant women from losing salt (Watanabe et al., 
1965). 
Short term (one week) sodium restriction has shown appropriate responses 
of the renin-aldosterone system during pregnancy (Gordon et al., 1973; Bay 
and Ferris, 1979; Brown et al., 1987; Brown et al., 1988). However whether 
this system can maintain homeostasis for sodium during long continued dietary 
sodium restriction is not known. 
This chapter deals with the effects of chronic dietary sodium restriction on 
the concentrations of sodium and potassium in urine and plasma, various 
components of the renin-aldosterone system, progesterone and atrial natriuretic 
peptide. 
MATERIAL AND METHODS 
The study population consists of the thirty-six women described in chapter 
11. Serial measurements of 24 h urine sodium and potassium excretion as well 
as plasma electrolyte determinations were made at weeks 12, 16, 20, 24, 28, 
32 and 36 of pregnancy and 1 and 6 weeks post partum. 
The following hormonal parameters were studied; renin (enzymatically active), 
prorenin which is the inactive precursor (zymogen) of renin, renin substrate 
(angiotensinogen), plasma renin activity, angiotensin converting enzyme (ACE), 
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aldosterone, free (non-protein bound) aldosterone, atrial natriuretic peptide (ANP) 
and progesterone. Plasma hormone concentrations were determined at weeks 
12, 20, 28 and 36 of pregnancy and again 1 (without angiotensin converting 
enzyme measurements) and 6 weeks after delivery. 
Venous blood was taken after 15-30 minutes rest in left lateral position. Blood 
sampling was performed between 1.00 and 5.00 h pm (from each individual 
woman at invariably the same time of the day). 
To be informed about the average 24 h dietary intake of sodium and potassium 
in the two groups, a dietary intake analysis was performed (in a way described 
in chapter 3) between the 20th and 28th week of pregnancy. 
Additional study. 
In order to compare the effects of a low sodium diet on plasma levels of 
renin and prorenin in pregnant versus non-pregnant women, a supplementary 
study was performed in two additional groups of women. Nine healthy pregnant 
women (also studied in chapter 5) during the third trimester of uneventful 
pregnancy (range 31-34 weeks) and 9 healthy non-pregnant females who were 
using neither medicines nor oral contraceptives were included in the study after 
informed consent was obtained. The mean ages in these groups were 29 years 
(range 23-36 years) and 34 years (range 26-40 years) respectively. Because 
the ovary secretes prorenin into the circulation in the early luteal phase of the 
menstrual cycle (Sealey et al., 1987b), all non-pregnant females were studied 
between the 2nd and 9th day of the cycle. Each woman was studied twice, 
once during unrestricted sodium intake (day 0) and again on day 6 of a low 
sodium diet (approximately 20 mmol /day). Urine samples were collected over 
24 h on day 0 and day 5 of the low sodium diet for measurement of sodium 
and creatinine. On both days 0 and 6, at the same time of day, venous blood 
was drawn in left lateral position after 15-30 min of rest. 
Statistical analysis. 
To compare the results of serial measurements after the start of the low sodium 
diet with the ad libitum control group (weeks 20-36), the Koziol test was used 
(see chapter 3). To test differences between the two groups at 12 weeks (start 
of the study) and 1 and 6 weeks post partum and to evaluate differences in 
dietary intake of sodium and potassium the Wilcoxon-Mann-Whitney two-sample 
test was used. The Wilcoxon matched-pairs signed-ranks test was used to test 
the effects of 6 days dietary sodium restriction in pregnant and non-pregnant 
females (the additional study). In all tests p-values were considered significant 
at the 5 percent level. 
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RESULTS 
At the start of the study (12th week) significant differences were present in 
neither of the variables studied. 
Effects of dietary sodium restriction on the intake of sodium and potassium, urinary 
excretion of sodium and potassium and the concentrations of these electrolytes 
in pbsma 
The average daily dietary intake of sodium and potassium is presented in 
table 12.1. Sodium intake in the low sodium group, as expected, was significantly 
lower than in the ad libitum group, whereas the intake of potassium was not 
significantly different. 
Table 12 1 Average 24 h dietary inlake of sodium and potassium in the ad libitum group (n=19) 
and low sodium group (n=17) between weeks 20 and 28 of pregnancy 
Ad libitum Low sodium 
Sodium (mmol /day) 
mean (range) 119 
(56,215) 
Potassium (mmol /day) 
mean (range) 134 
(84,205) 
*p<0 01, low sodium versus ad libitum group 
Mean values of serial measurements of urinary sodium and potassium excretion 
and the concentrations of these electrolytes in plasma are shown in figure 12.1. 
Urinary sodium excretion expressed as both mmol sodium per 24 h as well 
as mmol sodium per mmol creatinine were significantly lower in the low sodium 
group after the start of the diet (p<0.01). After delivery when the diet was 
stopped, sodium excretion was similar in both groups. Urinary potassium excretion 
did not differ significantly between the low sodium and ad libitum group. 
Mean concentrations of sodium and potassium in plasma from women with 
an ad libitum diet were lower during pregnancy as compared to 6 weeks post 
partum. Plasma sodium levels were not significantly altered by the low sodium 
diet. Plasma concentrations of potassium however were significantly lower 
(p=0.02) in the low sodium group. 
Effects of dietary sodium restriction on some components of the renin-angiotensin 
system 
Renin levels (figure 12.2) in the ad libitum group showed a four-fold rise 
during pregnancy as compared to measurements 6 weeks after delivery. Sodium 
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Figure 12.1. Mean values of 24 h urinary sodium and potassium excretion, sodium-creatinine ratio, 
potassium-creatinine ratio and concentrations of sodium and potassium in plasma in 
the ad libitum group (filled circles) and the low sodium group (open circles). Bars 
represent the SEM. 
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restriction caused a six-fold increase in concentrations of renin in plasma (p=0.01 
as compared with the ad libitum group of women). 
Plasma levels of prorenin were consistently five to six times elevated during 
pregnancy as compared to those post partum. In contrast to (active) renin, plasma 
concentrations of prorenin were not significantly affected by a low sodium diet 
during pregnancy. 
Concentrations of renin substrate in plasma showed a 4 to 5-fold rise during 
gestation in the ad libitum group as compared to those post partum. Sodium 
restriction had no influence on renin substrate levels. 
Plasma renin activity in the ad libitum group increased up to values 9-10 
times those 6 weeks after delivery. Women in the low sodium group showed 
significantly higher plasma renin activities throughout pregnancy (p<0.02) as 
compared to the ad libitum group. 
Mean concentrations of angiotensin converting enzyme in plasma were lower 
during pregnancy than values post partum. Plasma levels of this enzyme were 
not significantly different between the two groups. 
Effects of dietary sodium restriction on ANP, progesterone and (free) aldosterone 
Mean ANP levels (figure 12.3) were somewhat higher during mid-pregnancy 
(as described previously in chapter 6.1). The low sodium regimen did not induce 
a significant effect on ANP levels during pregnancy. 
Concentrations of progesterone showed an almost 100-fold increase during 
pregnancy. Progesterone levels were not significantly affected by the low sodium 
diet. 
Pregnancy caused a 7 to 8-fold increase in aldosterone as well as in free 
aldosterone levels. Mean levels of aldosterone and free aldosterone were higher 
in the low sodium group as compared to the ad libitum group, but no overall 
significant differences could be demonstrated (p<0.20). 
The statistical significance of differences, in all variables studied, between 
the low sodium and ad libitum sodium intake groups of women remains the 
same when the five women who developed gestational hypertension (see chapter 
11 ), are excluded from evaluation. 
Effects of dietary sodium restriction on renin and prorenin levels in non-pregnant 
women (additional study) 
Urinary sodium excretion showed a significant decline in response to the 6 
days period of sodium restriction in the non-pregnant as well as in the pregnant 
females (table 12.2). 
In pregnant women such low sodium intake caused a significant increase in 
renin levels, whereas prorenin concentrations were not affected (similar to the 
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response to the long term sodium restriction in the longitudinal study). However 
in the non-pregnant group of females next to renin also prorenin showed a 
significant rise in response to the low sodium diet. 
DISCUSSION 
To our knowledge the present study provides the first observations of the 
adjustments of sodium-related hormones in response to the stresses imposed 
upon sodium homeostasis by chronic dietary sodium restriction during pregnancy. 
Although women in the low sodium group were instructed to follow a diet 
containing approximately 20 mmol sodium per day, the mean 24 h urinary sodium 
Tdble 12 2 Unnary sodium excretion and concentrations of renin and prorenin in plasma from women during an unrestricted sodium 
intake and on day 6 of a low sodium diet 
24 h unnary sodium 
excretion (mmol /24h) 
sodium /creatinine 
ratio 
renin (iiU /ml) 
prorenin (μϋ /ml) 
pregnant 
unrestricted 
sodium intake 
129 
(76, 173) 
9 3 
(8 0, 12 8) 
25 4 
(9 4,56 8) 
448 
(288,710) 
women 
6th day of a 
low sodium diet 
35** 
(17,75) 
2 8** 
(15,6 8) 
44 5** 
(31 8, 122 5) 
456 
(303,686) 
non 
unrestricted 
sodium intake 
113 
(65, 168) 
9 4 
(5 3,13 3) 
103 
(4 1,25 4) 
78 
(38, 165) 
-pregnant women 
6th day of a 
low sodium diet 
10** 
(5,23) 
0 9** 
(0 4,2 2) 
35 9** 
(167 690) 
139** 
(67 328) 
Results are median values with range given in parenthesis ** [K0 01 signincantly different from values during an unrestricted sodium 
intake in the same group of women 
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excretion ranged between 30 and 60 mmol. This may indicate that the women 
have not always accurately followed the dietary prescription. The average 
individual sodium intake however, as estimated by the dietary history technique 
which provides a rather rough indication of dietary habits during a long period 
of time, ranged from 12 to 27 mmol daily. A certain imbalance in sodium 
homeostasis leading to a salt-loosing situation, although unlikely, can therefore 
not be ruled out. 
Effects of pregnancy on the components of the renin-angiotensin-aldosterone system, 
ANP and progesterone during an ad libitum sodium intake 
Human pregnancy is characterized by impressive changes in the renin-
angiotensin system. Our results obtained in the ad libitum group of women confirm 
those of earlier studies (recent review by August and Sealey, 1990). 
The active form of plasma renin rises during pregnancy, reaching highest 
levels in the third trimester (Oats et al., 1981; Sealey et al., 1982; Dcrkx et 
al., 1987b), as do renin substrate levels (Skinner et al., 1972; Weir et al., 1975). 
The increase in renin substrate levels during pregnancy is mainly due to the 
effects of estrogens on the liver (Immonen et al., 1983). A similar increase in 
renin substrate is observed in women taking oral contraceptives (Derkx et 
al.,1986). 
Plasma renin activity (PRA) showed the same pattern of change, however 
its nine-fold rise was more pronounced than the four-fold increase in renin. 
In the PRA assay the in vitro generation of angiotensin I depends on both the 
concentration of the enzyme, renin, and the concentration of renin substrate 
(angiotensinogen). The normal level of circulating renin substrate in non-pregnant 
women is close to Km (that particular substrate concentration at which half-
maximum velocity occurs), which means that the maximum increase in the rate 
of angiotensin I formation that can occur with an increase in plasma renin substrate 
concentrations is two-fold. So 50% of the nine-fold rise in PRA is due to an 
increase in renin substrate whereas the other four to five-fold must be due to 
an increase in circulating renin, which is in agreement with the four to five 
fold increase in renin concentrations observed in our study. In the method for 
measuring active renin concentrations the amount of angiotensin I is generated 
from exogenous added sheep renin substrate and therefore independent of the 
endogenous renin substrate concentrations (see chapter 3). 
Others reported plasma renin activity to peak at around 28-32 weeks with 
a small fall thereafter to term (Oats et al., 1981; Karlberg et al., 1984). 
Concentrations of prorenin were 6 times higher at the 12th week of gestation 
as compared to post partum and remained at approximately the same level 
throughout pregnancy. Prorenin, the enzymatically inactive precursor of renin, 
is the first component of the renin-angiotensin system that changes during 
pregnancy. Its rise parallels the increase in human chorionic gonadotrophin (HCG) 
and plasma levels are elevated within 2 weeks after conception (Sealey et al., 
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1985). The main source of prorenin in the first trimester of pregnancy is probably 
the ovary since this rise does not occur in women with ovarian failure who 
became pregnant after transfer of a donated fertilized oocyte and whose 
pregnancies where maintained with estrogen and progesterone replacement 
(Derkx et al., 1987b; Sealey et al., 1987a). The origin of prorenin in the second 
and third trimester of pregnancy is not completely understood but besides the 
ovary, the placenta and uterus are possible candidates (Symonds et al., 1968; 
Brar et al., 1986; Shaw et al., 1989). The placenta cannot be the only source 
of plasma prorenin in the third trimester of pregnancy because the post partum 
fall in plasma takes at least 7 days (as shown in chapter 9) whereas the half-
life of prorenin is much shorter, close to 2 h (Derkx et al., 1978; Sealey et 
al., 1980). 
Dipeptidylcarboxypeptidase or angiotensin converting enzyme (ACE) is the 
second enzyme in the renin-angiotensin cascade. It converts the inactive de-
capeptide angiotensin I, the result of the proteolytic action of renin on renin 
substrate, in the biologically active end-product of the renin-angiotensin system, 
angiotensin II. ACE is widely distributed in organs and body fluids. The pulmonary 
vascular bed is the most physiologically important site for the conversion of 
circulating angiotensin I (Ng and Vane, 1967). ACE molecules are localized 
at the luminal surface of the vascular endothelium in direct anatomical jux-
taposition to the circulating blood stream (Ehlers and Riordan, 1990). 
Mean concentrations of ACE in plasma were lower during pregnancy than 
those post partum, and did not change with increasing gestation. This confirms 
other reports (Oats et al., 1981; Dux et al., 1984; Goldkrand and Fuentes, 1986), 
while unaltered values as compared to those outside pregnancy have been reported 
as well (Oparil et al., 1978; Parente et al., 1979). Part of this discrepancy may 
be due to differences in posture during vena puncture. The fall in ACE runs 
in parallel with the decrease in hematocrit (see chapter 11). This might indicate 
that the lower ACE concentrations in plasma are due to hemodilution. 
Angiotensin II levels during pregnancy have been reported to be elevated 
by several authors (Gordon et al., 1973; Robertson et al., 1971; Weir et al., 
1975). This elevation can, at any rate partially, account for the finding of increased 
concentrations of aldosterone in plasma, as observed by us as well by others 
(Lindheimer et al., 1977). At the 36th week aldosterone showed an eight-fold 
increase as compared to 6 weeks post partum. However from the 12th to the 
20th week there seems to be a blunting of the stimulation of aldosterone secretion 
which has been suggested to be present by others as well (Dörr et al., 1989). 
In non-pregnant individuals albumin is the principal aldosterone-binding protein 
in plasma (Zipscr et al., 1980), but as the concentration of corticosteroid binding 
globulin (CBG) increases with advancing pregnancy, CBG may become the main 
aldosterone- binding protein (Dunn et al., 1981). As this may affect the degree 
to which aldosterone is bound, concentrations of total aldosterone do not 
necessarily accurately reflect the gestational changes which may occur in the 
levels of free (non-protein bound) aldosterone, and, in connection herewith, the 
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physiological activity of this steroid. To our knowledge no serial assessment 
of the concentrations of free aldosterone in plasma during pregnancy has yet 
been reported. 
Free aldosterone levels showed a similar rise after the 20th week as total 
aldosterone levels. The percentage free aldosterone fluctuated around 30% during 
pregnancy as well as one and six weeks post partum, which confirms the results 
of Few et al. obtained in a cross-sectional study (1986). Our results suggest 
that the increase in protein-binding proteins during pregnancy do not affect the 
equilibrium between protein-bound and non-protein bound aldosterone in plasma. 
The results of plasma levels of ANP during normal pregnancy have been 
discussed in chapters 6.1 and 6.2. 
Effects of dietary sodium restriction on the components of the renin-angiotensin-
aldosterone system, ANP and progesterone during pregnancy 
Long term sodium restriction caused a significant increase in plasma renin 
activity. This rise must be due to the observed rise in renin levels, as concentrations 
of renin substrate were not different between the two groups. The increase in 
renin substrate levels during pregnancy is mainly due to the effects of estrogens 
on the liver, so no sodium related differences would be expected to occur. The 
increase in plasma renin activity in the low sodium group was most pronounced 
during the third trimester of pregnancy, which might suggest that sodium balance 
is increasingly more difficult to maintain as pregnancy proceeds. In the sodium 
restricted women renin as well as plasma renin activity seemed to reach a plateau 
after the 28th week, where (lower) values in women on an unrestricted sodium 
intake continued to rise. This may indicate that the renin-angiotensin system 
at that point was maximally stimulated. 
In non-pregnant subjects, bilateral nephrectomy leads to an almost complete 
disappearance of active renin and PRA from blood (Derkx et al., 1978; Sealey 
et al., 1977). This suggests that circulating active renin is mainly or exclusively 
from renal origin. One may argue that during pregnancy part of the elevation 
in plasma levels of active renin is caused by active renin from extra-renal origin 
(similar to prorenin), since the uterus and placenta are also potential sources. 
A major stimulus for renin release by the kidney is a decrease in the amount 
of sodium delivered to the macula densa (Keeton and Campbell, 1981). Extra-
renal sites of active renin production, if existing, in all likelihood have no such 
mechanism. Therefore, the observed rises in PRA and active renin levels in 
response to the low salt regimen indicate that the kidney is also during pregnancy 
the most probable source of active renin. 
Next to a decrease in the concentration of sodium in the glomerular filtrate, 
other stimuli for renin release must also be taken into account, such as a decrease 
in the transmural pressure gradient across the afferent arterioles and juxtaglo-
merular apparatus, due to a decreased renal blood flow in case of a diminished 
plasma volume. The latter is likely to occur in response to sodium restriction, 
in view of the results presented in chapter 11. 
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In contrast to plasma levels of renin, concentrations of prorenin in plasma 
from pregnant women were not affected by sodium restriction. In the additional 
study in which the effects of a 6 days period of sodium restriction were investigated, 
the same observation was made. To date, this has never been reported in the 
literature. However, in the control group of non-pregnant females prorenin showed 
a significant increase in response to the low sodium diet, which confirms the 
results of others (Sealey et al., 1980). This discrepancy can be explained by 
the fact that in pregnant women, in contrast to non-pregnant females the majority 
of prorenin in plasma is from extrarenal origin, which does not respond to sodium 
excretion. 
Next to active renin, in theory ACE could be one of the rate limiting factors 
of angiotensin II production, the biologically active endproduct of the renin-
angiotensin system. The low sodium diet had no influence on plasma levels 
of ACE, which suggest that the conversion of angiotensin I to angiotensin II 
by ACE does not bear any direct relationship with sodium balance, although 
the meaning of plasma ACE concentrations in relation to tissue-bound ACE 
can be questioned. 
Although angiotensin II concentrations were not measured in our study, 
increased concentrations could be expected as a result of sodium restriction 
in view of the elevated active renin levels and enhanced plasma renin activity. 
As angiotensin II is an important stimulator of adrenal aldosterone secretion, 
chronic sodium restriction was expected to increase plasma aldosterone levels 
as has been shown in studies concerning the effects of a period of sodium restriction 
of one week (Bay and Ferris, 1979; Brown et al., 1987; Brown et al., 1988). 
Surprisingly both aldosterone as well as free aldosterone levels in plasma, 
however, were not significantly altered by chronic dietary sodium restriction. 
This may reflect a dissociation between the components of the renin-aldosterone 
system during pregnancy as reported by Weir et al. (1975). The causal mechanism 
for such a phenomenon, however, is as yet unclear. 
In vitro studies suggest that potassium may affect aldosterone secretion, 
independently of the influence of angiotensin II (Sealey and Laragh, 1990). This 
mediating role of potassium is further enhanced during sodium depletion (Carey 
and Sen, 1986). Small increases in plasma potassium of about 0.3 mmol /1 produces 
sharp rises in aldosterone secretion (Boyd and Mulrow, 1972), whereas potassium 
depletion inhibits aldosterone secretion. As plasma potassium concentrations were 
significantly lower (by approximately 0.2-0.3 mmol /1) in the pregnant women 
with a low sodium intake, this may also have influenced the aldosterone response 
to the low salt diet. 
Finally one should consider the possibility that the adrenal cortex is unable 
to maintain a high output of aldosterone during a long period of sodium restriction 
in pregnancy, as has been shown in rats (Smicklas et al., 1971). 
In theory, increased aldosterone levels could be balanced by an increase in 
the metabolic clearance of aldosterone, however we do not have the necessary 
data to investigate this any further. Stevens et al. (1989) showed that aldosterone 
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is secreted intermittently during pregnancy, resulting in considerable fluctuations 
in saliva aldosterone concentrations throughout the day. So hypothetically we 
could have missed high values in the low sodium group. However as all women 
were studied between 1.00 and 5.00 h pm, there was no systematic difference 
between the two groups with regard to the time of the day, blood samples were 
taken. A change in the pattern of diurnal fluctuations due to sodium restriction 
seems unlikely, but can not be ruled out. 
Plasma concentrations of sodium were not significantly affected by the low 
sodium intake. The finding of relatively unaltered aldosterone concentrations 
may therefore point at increased sodium retaining activity of other factors. A 
reduction in glomerular filtration rate due to a decreased intravascular volume 
and enhanced angiotensin II vasopressor activity could be one of them. An-
giotensin II itself may also have direct effects on proximal tubular sodium 
reabsorption (Zhuo et al., 1986). 
The involvement of other adaptive mechanisms in the maintenance of the 
concentration of sodium in plasma such as a mobilization of sodium from the 
interstitial fluid space (Gauer and Henry, 1976) or skeletal tissue (Michel! 1976) 
can not be ruled out. 
Progesterone has been reported to play a mediating role as well in the renal 
regulation of sodium in that it blocks the salt retaining effect of aldosterone 
in the distal nephron and may also directly inhibit proximal sodium reabsorption 
(Landau and Lugibihl, 195 8; Landau and Lugibihl, 1961 ; Ehrlich and Lindheimer, 
1972; Oparil et al., 1975). In contrast to earlier suggestions (Ehrlich et al., 1962) 
we did not find any evidence that progesterone levels are sodium related. We 
agree with Brown et al. (1986) that progesterone is not directly involved in 
the regulation of sodium homeostasis during pregnancy. 
As sodium restriction during a relatively short period of time (6 days) was 
shown to cause a significant decrease in ANP levels (chapter 5) and intravascular 
volume is likely to decline in response to the low sodium intake (chapter 11), 
lower ANP levels in the low sodium group of women would be expected. However, 
plasma concentrations of ANP were not affected by long continued dietary sodium 
restriction. Apparently, gradual (chronic) alterations in plasma volume in response 
to a long continued low sodium intake, change the relation between volume 
and atrial ANP secretion -a comparable process likely to occur also in normal 
pregnancy (chapter 6). Again (as pointed out in chapter 6.1) it seems that ANP 
is not a major hormonal determinant in maintaining long term sodium balance 
during pregnancy. 
In short our results suggest that long continued dietary sodium restriction 
during pregnancy induces a profound stimulation of renin release, without 
statistically significant changes in aldosterone secretion. As concentrations of 
sodium in plasma were not significantly affected, different sodium retaining 
mechanisms may operate. 

121 
EPILOGUE 
This thesis concerns a number of physiologic adaptive processes of the maternal 
body in response to pregnancy. The gestational changes in various sodium and 
volume balance-related parameters were investigated using three different 
methods: (a) by longitudinal observation, (b) by observing their reversed succession 
during the puerperium, and (c) by studying the effects of a specific intervention, 
viz., long-continued sodium restriction. 
The adjustments of cardiovascular and endocrine parameters are remarkable 
in that they show a consistent pattern both in their gradual development during 
pregnancy and in their regression after delivery of the fetoplacental unit. The 
physiological processes involved are, however, largely unknown. 
One of the main reasons for this lack of knowledge is that research in the 
field of clinical physiology in obstetrics is highly laborious. As hemodynamic 
and hormonal values vary widely between individuals, gestational changes must 
be studied simultaneously in a longitudinal manner, which is not only time-
consuming but also requires the recruitment of a highly motivated study population 
consisting of healthy individuals. Furthermore the fact that the well-being of 
the fetus is, naturally, of prime importance imposes stringent limitations on the 
research in question. However, despite its limitations clinical research is essential 
to understand the true nature of physiological processes accompanying human 
pregnancy. 
One of the crucial questions in the discussion regarding the adaptation of 
the maternal body following conception, is: does sodium and water retention 
precede or follow vasodilatation? If sodium and water retention is the primary 
event - resulting in increments in extracellular fluid volume, plasma volume 
and cardiac output, with secondary enlargement of the vascular compartment -, 
pregnancy can be characterized as an 'overfill' state (Schrier and Dürr, 1987; 
Schrier 1988). If, on the other hand, enlargement of the vascular compartment 
is primary - with secondary renal sodium and water retention - pregnancy should 
be considered as an 'underfill' state. 
There is no simple way to settle this question. As cardiac atrial natriuretic 
peptide (ANP) secretion, at any rate in the non-pregnant state, reflects the volume 
status as sensed by atrial volume receptors, the study of ANP levels during 
pregnancy might contribute to the solution of this important dilemma. 
Figure 1 recapitulates the results of serial measurements in two groups of 
subjects. The finding that concentrations of ANP in plasma rise during the first 
gestational trimester is in favour of the 'overfill' hypothesis, as underfilling would 
be expected to result in a lowering in ANP levels. 
Highest ANP levels were found during mid-pregnancy. Thereafter, contrary 
to what might have been expected, ANP showed a slight but statistically significant 
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Figure 1 Serial measurements of ANP concentrations in a group of women starting before conception 
and in the 6th and 10th gestational week (n=25, filled circles, chapter 6 3) and in a 
second group of women from the 14th week onwards up to the 6th week post partum 
(n=23, open circles, chapter 6 1) Results are means (SEM) All women had uneventful, 
normotensive pregnancies and were not restricted in their dietary intake of sodium 
decline towards levels not much different from those 6 weeks post partum. Thus 
it seems that the increased blood volume during the second half of pregnancy 
is not sensed as such by the atrial volume receptors, maybe because of the 
concomitant enlargement of the maternal vascular compartment, resulting in 
a condition of 'underfill'. 
Alternatively, the relation between volume and ANP secretion may have 
changed (a new 'set-point'). In that case, reflections in terms of 'underfill' or 
'overfill' are not valid. Figure 1 also reveals a phenomenon which seems to 
confound the validity of a comparison of ANP values found during pregnancy 
with those found some time after delivery. Values 6 weeks post partum tended 
to be higher than those before conception (p=0.07 by the Wilcoxon-Mann-
Whitney two-sample test) This might cast some doubt on the generally accepted 
view that 6 weeks post partum the cardiovascular system has completely returned 
to normal. Another observation made in the investigated women might point 
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in the same direction. It was found that left ventricular dimensions, which rose 
during gestation, remained significantly elevated 6 weeks post partum as 
compared to the 16th week of pregnancy (Van Lakwijk et al., 1989). 
ANP showed a striking rise in early Puerperium (chapter 8). This is probably 
due to a shift of the excess of interstitial fluid - an excess originated during 
pregnancy- into the circulation. Now, in contrast to pregnancy, atrial volume 
receptors seem to sense the intravascular volume as being expanded. This suggests 
that plasma ANP levels accurately reflect an increase in intravascular volume 
only in relation to the size of the vascular compartment, as after delivery there 
is reversal of the systemic vasodilatation accompanying pregnancy. It may also 
suggest that ANP levels only reflect an increase in circulating volume if such 
a rise takes place within a relatively short period of time. The stimulation of 
ANP release and the concomitant suppression of the renin-aldosterone system 
(which partly is caused by ANP itself) plays a part in the subsequent maternal 
diuresis by which maternal blood volume returns to normal. 
A hypothetical model of some changes in sodium and volume balance in 
the early puerperium, based on the results presented in chapters 8 and 9, is 
shown in figure 2. 
The randomized clinical trial revealed striking effects of chronic dietary sodium 
restriction on several cardiovascular and endocrine features involved in the 
homeostasis of sodium and volume. The possible implications of a low sodium 
diet, as deduced from the results presented in part IV of this thesis, are summarized 
in figure 3. 
A low salt regimen causes a decrease, or rather prevents an increase in the 
extracellular volume of fluid, blood volume and cardiac output. It markedly 
stimulates the renin-angiotensin system which, via enhanced circulating levels 
of angiotensin II, results in vasoconstriction of the peripheral arterioles and hence 
an increase in vascular resistance. Blood pressure, being the product of cardiac 
output and peripheral vascular resistance, remains unchanged. 
A relatively low circulating volume and enhanced peripheral vascular resistance 
are currently considered to be harmful during pregnancy. The increase in plasma 
volume, accompanied by a decrease in vascular tone and vasodilatation, is often 
said to be indicative of the 'normality' of pregnancy in terms of the weight 
of the baby (Hytten 1985). However, despite the (supposed) lowering in circulating 
volume together with the increased vascular resistance, the birthweights measured 
in our study were not significantly lower in the low sodium group of women. 
An explanation of this finding may be found in a redistribution of cardiac output 
in favour of the uterus, as a result of increased angiotensin II levels (Martin 
1980). 
Therefore, the generally accepted view among obstetricians that an increment 
in intravascular volume is essential to provide an adequate amount of oxygen 
and nutrients to the growing fetus, is not necessarily valid. 
A challenging question is whether the adaptations observed in pregnant women 
using salt according to their taste are to be regarded as 'normal physiology'. 
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Figure 2 Hypothetical model of some changes in sodium and volume balance in early puerpenum 
After delivery there is a sudden withdrawal of fetoplacental hormone synthesis The excess 
of interstitial fluid originated during pregnancy is set free (possibly due to the withdrawal 
of placental estrogen synthesis) and shifts into the circulation The subsequent increase 
in venous return of blood to the heart will result in enhanced atrial wall stretch and 
hence ANP secretion Blood pressure is elevated due to the nse in intravascular volume 
and a concomitant increase in vascular tone in response to a diminution of vasodilating 
factors, active during pregnancy Withdrawal of factors promoting natnuresis (such as 
progesterone) as well as enhanced ANP activity cause concentrations of renin and 
aldosterone to decrease The fall in activity of the salt-conserving renin-aldosterone system 
together with the stimulation of ANP secretion result in enhanced natnuresis and diuresis, 
by which maternal blood volume returns to normal 
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Figure 3. Summary of possible implications of long continued low sodium intake during pregnancy. 
These changes can also be viewed as the result of an adaptation to culturally 
determined copious use of salt as a dietary additive. Evolution has provided 
humans with very efficient regulatory mechanisms for sodium conservation, which 
are effective also during pregnancy, as observed in 'no-salt cultures' (Oliver 
et al., 1981). 
However, mechanisms for the elimination of excessive amounts of sodium may, 
over a period of no more than a few millennia, not have been able to sufficiently 
develop. 
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SUMMARY 
PARTI 
In chapter 1 a general introduction is presented and the objectives of the 
thesis are summarized as follows: 
1. to study cardiovascular and endocrine changes related to sodium and volume 
balance during normal pregnancy and puerperium, with special attention to 
atrial natriuretic peptide (a hormone produced by the heart with diuretic, 
natriuretic and vasorelaxant potencies) 
2. to study effects of chronic dietary sodium restriction on various maternal 
physiological changes that accompany normal pregnancy. 
The studies relating to the latter objective were conducted within the frame 
of a multicentered research project, initiated (by the Dutch 'Praeventiefonds') 
to evaluate the effect of dietary sodium restriction on the incidence of hypertension 
during pregnancy. 
In chapter 2 a synopsis is presented of the major gestational changes in the 
volumes of body fluid, the cardiovascular system and the control of sodium 
excretion. 
Chapter 3 describes the methodology employed: relation between study po-
pulations, echocardiography, analytical methods, dietary intake analysis and 
statistical analysis. 
PART II 
Part II concerns studies related to atrial natriuretic peptide (ANP). In chapter 
4 a review is presented of the pertinent literature. To date, there is no consensus 
as to whether cardiac ANP secretion and plasma ANP levels are increased during 
normal pregnancy. 
In chapter 5, the influence of a number of physiologic conditions on ANP 
levels during pregnancy were investigated. Plasma ANP levels in women between 
the 29th and 33rd week of normal pregnancy, significantly decreased (by 32%) 
in response to a 6 days period low sodium intake. Recovery experiments showed 
no differences in the degradation of ANP in blood from pregnant and non-
pregnant women. The profiles of ANP immunoreactivity in plasma, using high 
pressure liquid chromatography (HPLC) analysis, from a pregnant and non-
pregnant female exhibited no major differences. Both types of plasma showed 
a major peak corresponding to (99-126)hANP. So, a comparison of ANP levels 
during pregnancy with those in the non-pregnant state is, in all likelihood, not 
confounded by either an enhanced degradation of ANP (as described with 
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reference to for example vasopressin) or a pregnancy related increase in the 
secretion of one or more other molecular forms of ANP than (99-126)hANP. 
Chapter 6 describes the results of serial measurements of ANP during pregnancy 
in relation to a number of hemodynamic and urinary parameters. Plasma ANP 
concentrations significantly increased, together with a decrease in hematocrit 
values, during the 1st trimester of pregnancy as compared with those before 
conception. Highest ANP levels were found during mid-pregnancy. Thereafter 
ANP showed a slight, but statistically significant decline towards levels not much 
different from those 6 weeks post partum. Cardiac output, right and left atrial 
areas, and left atrial diameter were all significantly increased in the third trimester 
of pregnancy as compared to 6 weeks post partum. Neither of these hemodynamic 
parameters appeared to be significantly correlated with the concentrations of 
ANP in plasma. ANP was weakly though significantly inversely correlated with 
systolic blood pressure and systemic vascular resistance, but not with plasma 
sodium concentrations, 24 h urinary volume or 24 h sodium excretion. It remains 
to be determined whether ANP, which primarily seems to be a hormone protecting 
against situations of acute volume overload, is of any physiologic importance 
in the adaptation of sodium and fluid balance during the chronic hypervolemic 
state of pregnancy. 
Synthesis and secretion of ANP, in all likelihood, is not confined to the heart, 
but also present in other tissues (chapter 7). Concentrations of ANP-immuno-
reactive material in amniotic fluid were low in relation to those in plasma, although 
significantly higher at term than in mid-pregnancy. The results of HPLC analysis 
suggested that amniotic ANP-immunoreactivity may be due to other molecular 
forms than (99-126)hANP, the main immunoreactive molecular form of ANP 
present in plasma. 
ANP is known to affect steroidogenesis in the ovary. To assess the possibilities 
that (a) the human ovary is a source of ANP secretion and (b) ovarian ANP 
stimulates progesterone secretion we investigated ANP immunoreactivity as well 
as progesterone concentrations in pre-ovulatory ovarian follicular fluid from 
women in an in-vitro-fertilization program. In all women detectable ANP 
immunoreactivity could be demonstrated in ovarian follicular fluid (median 7.8 
pg /ml, range 3.3 - 60.1 pg /ml). Follicular ANP and progesterone concentrations 
were not significantly correlated. 
PART III 
In part III (chapters 8 and 9) two studies are described in which some aspects 
of puerperal sodium and water balance were studied in primiparous women 
after uneventful pregnancy and vaginal delivery. ANP levels were significantly 
elevated during the first two days after delivery, as compared to those in late 
pregnancy and 6 weeks post partum. Hematocrit values decreased post partum 
and remained significantly lower up into the 3rd puerperal week. Early puerperal 
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ANP levels were significantly inversely correlated with hematocrit values This 
suggests that the increase in ANP is due to a shift of interstitial fluid into the 
circulation Systolic and diastolic blood pressure were significantly elevated (by 
around 10 mm Hg) during the first puerperal week This is probably due to 
the increased intravascular volume and the concomitant reversal of the systemic 
vasodilatation accompanying pregnancy Renin and aldosterone concentrations, 
being significantly elevated during pregnancy, returned to values not significantly 
different from those 6 weeks post partum within one day Renin substrate 
(angiotensinogen) levels also diminished after delivery, but remained significantly 
elevated throughout the first puerperal week As a consequence, plasma renin 
activity (PRA), depending on both renin and renin substrate, returned to non-
pregnant values two days after delivery In each woman, a one to two days 
period of enhanced natnuresis and diuresis was observed Fluid balance (24 
h fluid intake minus urinary volume) was significantly lower during several days 
in the first puerperal week as compared to 6 weeks after delivery Correlation 
analysis indicated that both the stimulation of ANP release and the decrease 
in the components of the renin-aldosterone system (the latter partly being caused 
by ANP itself, as ANP was significantly inversely correlated with PRA and 
aldosterone) contribute to the enhanced puerperal natnuresis and diuresis, by 
which maternal blood volume returns to normal 
PART IV 
Chapter 10 reviews the major milestones in obstetric research in the past 
90 years, which have lead to the wide spread use of salt-restriction during 
pregnancy Possibly the most ardent advocate of the view that salt plays a major 
role in eclampsia was De Snoo (1877-1949), a Dutch obstetrician However, 
despite many enthusiastic clinical reports, no convincing evidence has ever been 
produced that salt restriction helps in the prevention of hypertension during 
pregnancy 
Since sodium balance and volume homeostasis are closely interrelated, long 
continued reduced salt intake in all likelihood influences the changes in the 
cardiovascular and endocrine systems which accompany pregnancy 
In chapters 11 and 12 a longitudinal prospective randomized clinical trial 
is described, in which the effects were investigated of a long continued low 
sodium intake (aimed at approximately 20 mmol of sodium a day) on weight 
gain, food intake and a number of cardiovascular and sodium balance related 
endocrine parameters Seventeen women on a low sodium intake and nineteen 
women on an ad libitum sodium intake were studied (all women were healthy 
nulliparas) Serial measurements were made at monthly intervals from the 12th 
gestational week onwards and again at 1 and 6 weeks post partum The low 
sodium diet was started in the 14th gestational week and stopped after delivery 
Total weight gain as well as puerperal weight were significantly lower in 
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the low sodium group (chapter 11). Dietary intake analysis demonstrated a 
significant smaller intake of all nutrients and calcium. Blood pressure during 
pregnancy was not significantly affected by the low sodium intake, however 
at one week after delivery systolic and mean arterial blood pressure were 
significantly lower in the former low sodium group. Sodium restriction caused 
a significant decrease in stroke volume and cardiac output during pregnancy 
whereas systemic vascular resistance was significantly increased in response to 
the low sodium regimen. Hematocrit values in the low sodium group tended 
to be lower during pregnancy as compared to the ad libitum group, but were 
significantly lower at one and six weeks post partum. Birth weights of both 
children and placentae did not show major differences between the two groups. 
These results suggest that pregnancy during chronic dietary sodium restriction 
is characterized by a diminished body fat accumulation, a reduction in circulating 
volume due to both a decrease in plasma volume as well as red cell volume, 
accompanied by a high systemic vascular resistance and nevertheless adequate 
intrauterine growth. 
In women with an unrestricted intake of sodium, concentrations in plasma 
of the components of the renin-aldosterone system and progesterone were elevated 
during pregnancy as compared to post partum, with the exception of angiotensin 
converting enzyme (ACE) exhibiting lower plasma concentrations during ges-
tation (chapter 12). Chronic dietary sodium restriction induced a significant 
increase in plasma levels of active renin as well as plasma renin activity throughout 
pregnancy as compared to the ad libitum group of women. Concentrations of 
prorenin, renin substrate, ACE, aldosterone, free (non-protein bound) aldosterone 
and progesterone were not significantly affected by the low sodium intake. 
In conclusion, a low salt regimen seems to cause a decrease, or rather prevents 
an increase in the extracellular volume of fluid, blood volume and cardiac output. 
It markedly stimulates the renin-angiotensin system which results in vasocon-
striction of the peripheral arterioles and hence an increase in vascular resistance. 
Blood pressure, being the product of cardiac output and peripheral vascular 
resistance, remains unchanged. To establish whether or not a low sodium intake 
significantly influences birthweight, study of larger groups of women is required. 
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SAMENVATTING 
DEEL I 
In hoofdstuk 1 wordt een algemene introductie gegeven en worden de doel-
stellingen van dit proefschrift als volgt samengevat: 
1. het bestuderen van cardiovasculaire en aan de water- en zouthuishouding 
gerelateerde endocriene veranderingen gedurende de ongestoorde zwanger-
schap en het kraambed, met speciale aandacht voor het atrium natriuretisch 
peptide (een hormoon geproduceerd door het hart met diuretische, natriure-
tische en vaatverwijdende eigenschappen). 
2. het bestuderen van de effecten van chronische natriumbeperking op verschei-
dene matemale fysiologische parameters in de zwangerschap. 
De studies betreffende de tweede doelstelling werden verricht in het kader van 
een 'multicentered' onderzoeksproject, hetgeen werd geïnitieerd (door het 'Prae-
ventiefonds') om de effecten van natriumbeperking op de incidentie van hyper-
tensie in de zwangerschap te evalueren. 
In hoofdstuk 2 wordt een kort overzicht gegeven betreffende de belangrijkste 
veranderingen tijdens de zwangerschap in de volumina van lichaamsvloeistoffen, 
het cardiovasculaire systeem en de controle van de natriumexcretie. 
In hoofdstuk 3 wordt een overzicht gegeven van de gebruikte methodiek: 
de relatie tussen studiegroepen en een beschrijving van de echocardiografie, 
laboratoriumbepalingen, dieetanalyse en statistische toetsing. 
DEEL II 
In deel II van dit proefschrift worden studies beschreven betreffende het atrium 
natriuretisch peptide (ANP). In hoofdstuk 4 wordt een overzicht gegeven van 
de relevante literatuurgegevens dienaangaande. Er blijkt geen consensus te 
bestaan over de vraag of cardiale ANP secretie en plasma concentraties van 
het ANP zijn verhoogd gedurende de normale zwangerschap. 
Het in hoofdstuk 5 beschreven onderzoek werd uitgevoerd om de invloed 
van verschillende physiologische factoren na te gaan op de ANP waarde in 
het bloed gedurende de zwangerschap. 
Plasma ANP concentraties in zwangere vrouwen (tussen de 29e en 33e week 
van een normale zwangerschap) daalden significant (met 32%) in respons op 
een 6 daagse periode van natriumbeperking. 'Recovery' experimenten toonden 
geen verschil aan tussen de degradatie van ANP in bloed van zwangere en 
niet-zwangere vrouwen. Het ANP-immunoreactief profiel in plasma van een 
zwangere en een niet-zwangere vrouw, gebruikmakend van hoge-druk vloei-
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stofchromatografie (HPLC), vertoonde geen grote verschillen. In beide plasma 
monsters werd een duidelijke piek gevonden, overeenkomend met(99-126)hANP. 
De vergelijking van ANP spiegels in en buiten de zwangerschap lijkt dus niet 
te worden beïnvloed door of een verhoogde afbraak van ANP (zoals beschreven 
met betrekking tot bijvoorbeeld Vasopressine) of een door de zwangerschap 
geïnduceerde toename van de secretie van een of meer andere vormen van ANP 
danhet(99-126)hANP. 
In hoofdstuk 6 worden de resultaten beschreven van seriële metingen van 
ANP gedurende de zwangerschap in relatie tot een aantal haemodynamische 
en urine variabelen. Concentraties van ANP in plasma vertoonden gedurende 
het eerste trimester van de zwangerschap een significante stijging, tegelijk met 
een daling van de haematocriet, indien vergeleken met preconceptionele waarden. 
De hoogste ANP spiegels werden halverwege de zwangerschap gevonden. Daarna 
vertoonde de ANP spiegel een lichte, zij het significante, daling tot spiegels 
die niet verschilden van die 6 weken post partum. Het hartminuutvolume, de 
oppervlakten van het rechter en linker atrium en de diameter van het linker 
atrium bleken allen significant groter in het derde trimester van de zwangerschap 
vergeleken met de waarden 6 weken post partum. Geen van deze haemody-
namische parameters bleek significant gecorreleerd te zijn met de concentraties 
van ANP in plasma. ANP was zwak, doch significant invers gecorreleerd met 
de systolische bloeddruk en de systemische vasculaire weerstand. Geen correlatie 
werd aangetoond met de plasma natrium concentraties, het 24-uurs urine volume 
of de 24-uurs natrium excretie. Het blijft te bezien of het ANP, dat op de eerste 
plaats een hormoon lijkt te zijn wat beschermt tegen situaties van acute volume-
overbelasting, van enige fysiologische betekenis is in de adaptatie van de water-
en zouthuishouding aan de chronische hypervolemische toestand van de zwan-
gerschap. 
De synthese en de secretie van het ANP beperkt zich, in alle waarschijnlijkheid, 
niet tot het hart maar vindt ook plaats in andere organen en weefsels (hoofdstuk 
7). De concentraties van ANP-immunoreactief materiaal in vruchtwater waren 
laag in vergelijking tot die in plasma, echter hoger gedurende de bevalling dan 
in het 2e trimester van de zwangerschap. Gebruikmakend van HPLC-analyse 
werd aannemelijk gemaakt dat dit immunoreactief ANP toegeschreven moet 
worden aan andere moleculaire vormen dan het (99-126)hANP, de belangrijkste 
vorm in het bloed. 
Van ANP is bekend dat het de steroïdhormoonproductie in het ovarium kan 
beïnvloeden. Om de mogelijkheden te onderzoeken dat (a) het humane ovarium 
een bron is van ANP secretie en (b) ovarieel ANP progesteron secretie stimuleert 
werden ANP-immunoreactiviteit en progesteron concentraties gemeten in pre-
ovulatoir ovarieel follikelvocht van vrouwen in een in-vitro-fertilisatie pro-
gramma. Bij alle vrouwen werden in follikelvocht detecteerbare hoeveelheden 
ANP-immunoreactief materiaal aangetroffen (mediaan 7.8 pg /ml, spreiding 3.3-
60.1 pg /ml). Folliculaire ANP en progesteron concentraties waren niet significant 
gecorreleerd. 
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DEEL III 
In deel ΠΙ (hoofdstukken 8 en 9) worden 2 studies beschreven waarin enkele 
aspecten van de puerperale water- en zouthuishouding werden bestudeerd bij 
eerstbarenden na een ongestoorde zwangerschap en vaginale bevalling. ANP 
spiegels waren significant verhoogd gedurende de eerste 2 dagen na de partus, 
vergeleken met die aan het einde van de zwangerschap en die 6 weken post 
partum. De haematocriet waarden daalden na de bevalling en bleven significant 
verlaagd tot in de 3e week van het kraambed. ANP spiegels in de eerste puerperale 
dagen waren significant, invers gecorreleerd met de haematocriet waarden. Dit 
suggereert dat de stijging in ANP wordt veroorzaakt door een verplaatsing van 
interstitieel vocht naar de circulatie. De systolische en diastolische bloeddruk 
waren significant verhoogd (met ongeveer 10 mm Hg) gedurende de eerste week 
post partum. Dit vindt waarschijnlijk zijn oorsprong in het vergrote circulerend 
volume en de tegelijkertijd optredende normalisering van de door de zwan­
gerschap geïnduceerde systemische vasodilatatie. De concentraties van renine 
en aldosteron (significant verhoogd in de zwangerschap) daalden binnen 1 dag 
na de partus tot waarden die niet significant verschilden van die 6 weken post 
partum. Renine substraat (angiotensinogeen) spiegels daalden eveneens, maar 
bleven gedurende de eerste kraambedweek significant verhoogd. De plasma-
renine-activiteit (PRA), afhankelijk van zowel de renine als de substraat spiegels, 
bereikte daardoor pas 2 dagen na de bevalling een niveau vergelijkbaar met 
de niet-zwangere toestand. Bij elke vrouw werd gedurende een periode van een 
of twee dagen een toename van de natriurese en diurèse waargenomen. De 
vochtbalans (gedefinieerd als het verschil tussen de 24-uurs vocht inname en 
het 24-uurs urine volume) was significant lager gedurende verscheidene dagen 
na de partus indien vergeleken met de vochtbalans 6 weken post partum. 
Correlatieberekeningen toonden aan dat zowel de stijging van het ANP als ook 
de daling van de componenten van hel renine-aldosteron systeem (het laatste 
voor een deel veroorzaakt door de stijging van het ANP omdat ANP spiegels 
significant invers gecorreleerd bleken te zijn met de PRA en de aldosteron 
concentraties) bijdragen aan de versterkte puerperale natriurese en diurèse 
waardoor het toegenomen maternale bloedvolume zich weer normaliseert. 
DEEL IV 
In hoofdstuk 10 wordt een overzicht gegeven van de belangrijkste bevindingen 
in obstetrisch onderzoek gedurende de laatste 90 jaar, die hebben geleid tot 
de wijdverbreide toepassing van natriumbeperking in de zwangerschap. Een van 
de meest fervente aanhangers van het idee dat zout een belangrijke rol speelt 
in het ontstaan van eclampsie was De Snoo (1877-1949), een Nederlandse 
obstetricus. Ondanks vele enthousiaste klinische berichten is er echter nooit enig 
overtuigend bewijs naar voren gebracht dat de beperking van de inname van 
zout van nut is bij de preventie van hypertensie in de zwangerschap. Omdat 
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de zouthuishouding en de volume-homeostasis nauw zijn gerelateerd is het zeer 
waarschijnlijk dat langdurige natriumbeperking invloed heeft op de veranderingen 
in de cardiovasculaire en endocriene systemen die gepaard gaan met de 
zwangerschap. 
In de hoofdstukken 11 en 12 wordt een longitudinaal prospectief gerando-
miseerd klinisch onderzoek beschreven, waarin de effecten werden bestudeerd 
van langdurige natriumbeperking (waarbij werd gestreefd naar een inname van 
20 mmol natrium per dag) op de gewichtstoename, voedselinname en een aantal 
cardiovasculaire en met de zoutbalans gerelateerde endocriene parameters. 
Zeventien vrouwen met een natriumbeperkt dieet en negentien vrouwen met 
een ad libitum inname werden bestudeerd (allen gezonde nulliparae). Er werden 
maandelijks metingen verricht vanaf de 12e week van de zwangerschap die 
werden herhaald 1 en 6 weken post partum. Het natriumbeperkte dieet werd 
gestart in de 14e week van de zwangerschap en gestopt na de bevalling. 
Zowel de totale gewichtstoename in de zwangerschap als de gewichten in 
het kraambed waren significant lager in de natriumbeperkte groep (hoofdstuk 
11). Dieetanalyse toonde een significant geringere inname aan van alle voe-
dingsstoffen en van calcium. Natriumbeperking had geen significant effect op 
de bloeddruk in de zwangerschap. Een week na de bevalling waren de systolische 
en de gemiddelde arteriële bloeddruk echter significant lager in de voorheen 
natriumbeperkte groep. Natriumbeperking veroorzaakte een significante daling 
in het slagvolume en het hartminuutvolume gedurende de zwangerschap, terwijl 
de systemische vasculaire weerstand een significante stijging vertoonde. De 
haematocriet gedurende de zwangerschap tendeerde in de natriumbeperkte groep 
tot lagere waarden vergeleken met de ad libitum groep. De haematocriet was 
significant lager een en zes weken post partum. De geboortegewichten van de 
kinderen en de placentae vertoonden geen grote verschillen tussen beide groepen. 
Deze resultaten suggereren dat een zwangerschap tijdens natriumbeperking 
wordt gekenmerkt door een verminderde vetstapeling, een daling in het cir-
culerend volume door zowel een daling van het plasma volume als van het 
erythrocytenvolume in combinatie met een verhoogde systemische vasculaire 
weerstand en een desondanks adequate intrauteriene groei. 
De plasma concentraties van de componenten van het renine-aldosteron 
systeem en progesteron bij vrouwen met een ad libitum inname van natrium 
waren verhoogd gedurende de zwangerschap indien vergeleken met die post 
partum (hoofdstuk 12). Een uitzondering werd gevormd door het angiotensine-
converterend-enzym (ACE) dat lagere concentraties vertoonde in de zwanger-
schap. Chronische natriumbeperking induceerde een significante stijging in de 
plasma spiegels van renine en de plasma-renine-activiteit vergeleken met de 
ad libitum groep. De concentraties van prorenine, renine substraat, ACE, 
aldosteron, vrij (niet eiwit gebonden) aldosteron en progesteron werden niet 
significant beïnvloed door de gereduceerde inname van natrium. 
Concluderend: Een lage natrium inname veroorzaakt een daling, of beter 
uitgedrukt voorkomt een stijging in de hoeveelheid van het extracellulaire vocht, 
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bloedvolume en hartminuutvolume. Het stimuleert aanzienlijk het renine-an-
giotensine-systeem hetgeen resulteert in een vasoconstrictie van de perifere 
arteriolen en dus een stijging van de vasculaire weerstand. De bloeddruk, het 
product van het hartminuutvolume en de perifere vasculaire weerstand, blijft 
onveranderd. Om te kunnen vaststellen of natriumbeperking een significante 
invloed heeft op het geboortegewicht is de bestudering van een grotere groep 
vrouwen noodzakelijk. 
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tot 1984 was hij als student-assistent verbonden aan het Laboratorium voor 
Anatomie en Embryologie (hoofd: Prof.Dr.HJ. Lammers) en de afdeling Patho-
logische Anatomie (Hoofd: Prof.Dr.G.P. Vooijs) van de Katholieke Universiteit 
Nijmegen. Hij bezocht gedurende een jaar (1982-1983) de avondcolleges van 
de cursus Organisatie van de Gezondheidszorg' (DrJ.P. Heesters, Prof.Dr.H.A. 
Tiddens) aan de faculteit der Economische Wetenschappen van de Katholieke 
Hogeschool Tilburg, waarvan het examen met goed gevolg werd afgelegd. In 
het kader van een studenten uitwisselings-programma verbleef hij in 1983 
gedurende een periode van 2 maanden op de chirurgische afdeling van het 
Suburban Hospital in Bethesda, Maryland, U.S.A. In 1984 volgde een verblijf 
van 4 maanden binnen het Instituut voor Obstetric en Gynaecologie (hoofd: 
Prof.Dr.E.M. Symonds) van het Queen's Medical Centre, University of Notting-
ham in Engeland, in het kader van het onderzoeksproject 'Obstetrical policy 
during labour and perinatal results' (geïnitieerd door Prof.Dr.T.K.A.B. Eskes). 
Het co-assistentschap Sociale Geneeskunde (1985) werd doorgebracht bij de 
Nationale Raad voor de Volksgezondheid in Zoetermeer. Van 1986 tot en met 
1989 was hij als wetenschappelijk medewerker werkzaam binnen het Instituut 
voor Obstetric en Gynaecologie (hoofd: Prof.Dr.T.K.A.B. Eskes) van het Sint 
Radboudziekenhuis te Nijmegen. Gedurende deze periode werden de in dit 
proefschrift beschreven studies verricht. Voor dit werk werd hem de Wyeth-
Verenigings-Jaarprijs 1988 van de Nederlandse Vereniging voor Obstetric en 
Gynaecologie toegekend. In hetzelfde instituut werd in januari 1990 aangevangen 
met de opleiding tot vrouwenarts. 
STELLINGEN 
behorende bij het proefschrift 
"Salt and pregnancy. Some aspects of sodium balance during 
pregnancy and the (patho)physiological implications of dietary 
sodium restriction" 
I 
Langdurige natriumbeperking in de zwangerschap leidt tot vermagering van de 
vrouw en een halvering van de totale gewichtstoename. 
II 
Het prorenine in het plasma gedurende de zwangerschap is grotendeels van 
extrarenale oorsprong. 
III 
De eerste dagen post partum worden gekenmerkt door een toename van de 
cardiale afgifte van het diuretisch hormoon 'atrial natriuretic peptide (ANP)'. 
IV 
De hemoglobine-bepaling gedurende de eerste dagen post partum is van weinig 
klinische betekenis, door de verschuiving van een onbekende hoeveelheid 
lichaamswater naar de circulatie. 
V 
Het blijft de vraag welke zwangerschap als 'fysiologisch' moet worden beschouwd: 
die tijdens een ad libitum natrium inname of die tijdens natriumbeperking. 
VI 
De weegschaal dient een minder prominente plaats in de verloskundige zorg 
in te nemen. 
VII 
Het feit dat het verrichten van klinisch verloskundig wetenschappelijk onderzoek 
altijd een aantal beperkingen met zich meebrengt met betrekking tot het aantal 
variabelen dat kan worden bestudeerd, leidt vaak ten onrechte tot onderwaar-
dering van de verkregen resultaten. 
Vili 
Wanneer men in het kader van prenatale diagnostiek over preventie spreekt, 
bedoelt men meestal interventie. 
IX 
Er zijn nog altijd geen middelen gevonden om een normale bevalling te verbeteren. 
(afscheidscollege K.de Snoo, 1947) 
X 
Bij het zogenaamde 'Doppler-flow' onderzoek van de arteria uterina en arteria 
umbilicalis wordt meestal geen flow gemeten. 
XI 
Het feit dat in Nederland slechts 1% van de vruchtbare populatie de methode 
van natuurlijke geboorteregeling toepast, kan ten dele worden verklaard door 
een onvoldoende biologische kennis van de menstruele cyclus van zowel de 
medicus, de pastor als van de 'gebruikers'. 
XII 
De keuze van de universiteit door toekomstige studenten dient meer te worden 
bepaald door de signatuur en profilering van die universiteit dan door de afstand 
tot het ouderlijk huis. 
XIII 
Wetenschap is als topsport; naast een goede training is het van belang te pieken 
op de juiste momenten. 
XIV 
Intra-uteriene hartchirurgie lijkt heden net zo utopisch als neonatale hartchirurgie 
dat was in de zeventiger jaren. 
XV 
Het condoom lijkt geen goed middel om preeclampsie te voorkomen. 
(Klonoff-CohenHSetaUJAMA 1989;262:3143-3147) 
XVI 
'Gezonde concurrentie' binnen de gezondheidszorg leidt tot het ongezond worden 
van de minder bedeelden in de samenleving. 
Nijmegen, 27 juni 1990 E.A.P. Steegers 


